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ABSTRACT
Phosphofructokinase from Bacillus stearothermophilus.  (August 2003)
Allison Dawn Ortigosa, B.A., Kalamazoo College
Chair of Advisory Committee:  Dr. Gregory D. Reinhart
Phosphofructokinase from Bacillus stearothermophilus (BsPFK) is a
homotetrameric enzyme with an average of one active site and one allosteric site
per subunit.  BsPFK is inhibited by phosphoenolpyruvate (PEP) and how this
inhibitory signal is propagated throughout the enzyme is the main question we
address through this investigation.  By possessing a total of eight binding sites, a
potential for twenty-eight total pair-wise allosteric interactions result within
BsPFK, ten of which are unique.  Of these ten interactions, four are heterotropic
interactions, or interactions between unlike binding sites, while the remaining
six interactions are homotropic interactions, or interactions between like binding
sites.  Thus, to address the question of how BsPFK is inhibited by PEP, each of
these ten interactions needs to be quantified and their roles in the inhibition
process assessed.
In order to quantify the roles of the 10 allosteric interactions, we created,
purified and characterized several different hybrid enzymes by using site-
directed mutagenesis to reduce the number of native active sites and native
allosteric sites to permit the isolation of specific allosteric interaction(s).
Through the creation and isolation of 1:3 hybrid enzymes, in which one native
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active site and one native allosteric site remain, each of the four heterotropic
interactions were characterized.  Moreover, through the creation and isolation of
the 2:2 hybrid enzymes, in which two native active sites and two native
allosteric sites remain, characterization of the remaining six homotropic
interactions was performed.  Utilizing a linked function approach to quantify
the heterotropic and homotropic effects for each hybrid enzyme, we determined
that 5 to 6 of the ten pair-wise allosteric interactions found in BsPFK are
involved in the inhibition process depending upon pH.
More importantly however, our data provides definitive results that the
traditional two-state models used to describe an allosteric effect are not
sufficient to describe the allosteric effect measured for BsPFK.  Rather, our
results show that the linked function approach is a more appropriate way to
unambiguously measure the nature and magnitude of an allosteric effect.
Moreover, this approach can also be used to explain the allosteric behavior of a
dimeric enzyme.
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P Generally denotes product
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PAGE Polyacrylamide gel electrophoresis
PEP Phosphoenolpyruvate
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PG 2-Phospoglycolate
Q Single letter code for glutamine
R Single letter code for arginine
RmPFK Phosphofructokinase from rabbit muscle
S Generally denotes substrate or the single letter code for
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ScCPS Carbamoyl-phosphate synthetase from Saccharomyces
cerevisiae
SDS Sodium dodecyl sulfate
Tris Tris[hyroxymethyl]aminomethane
UMP Uridine monophosphate
W Single letter code for tryptophan
X Generally denotes an allosteric ligand
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code for tyrosine
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Mathematical Terms
  K ia
o Thermodynamic dissociation constant for A in the absence of
effector
  K ia
• Thermodynamic dissociation constant for A in the saturating
presence of effector
  
† 
Kiyo Thermodynamic dissociation constant for Y in the absence ofsubstrate
  
† 
Kiy• Thermodynamic dissociation constant for Y in the saturatingpresence of substrate
e Extinction coefficient
[A] Concentration of ligand/substrate
[E] Concentration of enzyme
[ES] Concentration of enzyme substrate complex
∆G Coupling free energy
∆Ga Coupling free energy for A
∆Gaa Coupling free energy for the interaction between A and A
∆Gapp The apparent coupling free energy
∆Gaa/yy Coupling free energy for the interaction between A and A with
two equivalents of Y bound
∆Ga/y Coupling free energy for A in the saturating presence of Y
∆Gay Coupling free energy for the interaction between A and Y
∆Gay1 Coupling free energy for the interaction between A and Y for one
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∆Gay2 Coupling free energy for the interaction between A and Y for one
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∆Ghomo-allos Coupling free energy for the homotropic interaction between
allosteric sites
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∆Ghomo-active Coupling free energy for the homotropic interaction between
active sites
∆Gy Coupling free energy for Y
∆Gyy Coupling free energy for the interaction between Y and Y
∆Gyy/aa Coupling free energy for the interaction between Y and Y with
two equivalents of A bound
∆Gy/a Coupling free energy for Y in the saturating presence of A
∆∆GpH The difference between the ∆Gay at low and high pH
mM Micromolar
mg Microgram
IC50 Inhibition constant at which 50% of the maximal activity is
reduced
K Dissociation constant
Ka The association constant or the Michaelis constant for A
K1/2 The concentration of ligand that produces half-maximal change
kcat The catalytic rate constant at saturating substrate concentrations
Kd Dissociation constant
Km Michaelis constant
L Allosteric constant
M Molar
Max∆ Maximal change in activity or Hill number
mg Milligram
mL Milliliter
mM Millimolar
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n Binding stoichiometry
nH Hill number
  
† 
nH1 /2 Concentration of PEP resulting in half-maximal Hill numbervalue
nm Nanometer
Q Coupling constant for an allosteric interaction which alters
binding affinity
Qaa Coupling constant for the interaction between A and A
Qaa/yy Coupling constant for the interaction between A and A with two
equivalents of Y bound
Qapp The apparent coupling constant
Qay Coupling constant for the interaction between A and Y
Qay1 Coupling constant for the interaction between A and Y for one of
two heterotropic interactions found in a dimer
Qay2 Coupling constant for the interaction between A and Y for one of
two heterotropic interactions found in a dimer
Qhomo Coupling constant for the homotropic interaction
Qyy Coupling constant for the interaction between Y and Y
Qyy/a Coupling constant for the interaction between Y and Y with one
equivalent of A bound
Qyy/aa Coupling constant for the interaction between Y and Y with two
equivalents of A bound
R Gas constant
[S] Concentration of substrate
T Temperature
U Units
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v Initial velocity
Vmax Maximal velocity
Vo Initial rate of turnover
[Y] Concentration of inhibitor
YS Fractional saturation
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1CHAPTER I
INTRODUCTION
For all the diversity in life on our planet, ranging from prokaryotes to
eukaryotes, regulation is one of the few things that is common to all of them.  Of
course, there are many different forms of regulation found in any given cell,
proven by the number of “hits” received when the word “regulation” is entered
into the Medline database (over 650,000 hits).  However, for this investigation
we are only going to focus upon the allosteric regulation of enzymes.
When the words “allosteric regulation” are entered into the Medline
Database, over 4,000 “hits” are received.  Thus, even though our investigation
has been significantly narrowed, the field of allosteric regulation as a whole is
still relatively large as is the number of opinions regarding how allosterism
occurs in proteins.  Over the past 40 years, many different models have been
proposed to describe an allosteric effect, and many methods have been both
developed and applied to identify specific residues and regions of proteins
involved in the transmission of an allosteric signal.  Furthermore, this allosteric
signal, whether activating or inhibiting, is transmitted via all the different
allosteric interactions found between the binding sites of a particular enzyme.
Thus, to gain a better understanding of how an allosteric enzyme “works”, we
first want to quantify the roles each of the 10 unique pair-wise allosteric
interactions found in the allosteric enzyme phosphofructokinase from Bacillus
________________________
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2stearothermophilus  (BsPFK) plays in the inhibition of the enzyme by
phosphoenolpyruvate (PEP) and second, apply these findings to gain a better
understanding of how multiple allosteric interactions combine in an oligomer.
Allosterism literally derives from allos = other and steoros = space (Greek),
but allosterism is defined more specifically as the binding of an effector
molecule(s) to a site distinct from the substrate binding site that regulates
enzyme activity either by activation or inhibition.  This regulation can occur two
ways: (1) by altering substrate affinity (K-type system) or (2) by altering the
catalytic rate (V-type system).  Since a greater percentage of allosteric enzymes
are regulated via changes in substrate affinity (K-type system), including
phosphofructokinase, we are going to focus on K-type regulation and the
models used to account for these types of allosteric effects.
Models commonly used to describe an allosteric effect
The following models have all been formulated to describe the allosteric
behavior of proteins.  However before continuing, a few features common to
most of the models need to be described.  Cooperativity is a characteristic
common to most oligomeric allosteric proteins and is a result of a change in
ligand-binding affinity with increasing concentrations of a particular ligand.
Thus, positive cooperativity is defined as an increase in ligand-binding affinity
with increasing ligand concentration, while negative cooperativity is defined as
a decrease in ligand-binding affinity with increasing ligand concentration.
These phenomena result in a non-hyperbolic ligand-binding curve, which
cannot be adequately described by Michaelis-Menten kinetics.  Thus, Archibald
3Hill formulated what we have now come to know as a Hill plot to describe the
cooperative behavior of oxygen binding to hemoglobin (Hill, 1910).
We begin by first considering an enzyme E consisting of n subunits that
can each bind ligand S:
  
† 
E + nS ¤ ESn (1-1)
By assuming infinite cooperativity in which all or none of the ligand binding
sites are occupied, we obtain the following dissociation constant, K, and
fractional saturation, Ys, for the above reaction:
  
† 
K = E[ ] ⋅ S[ ]
n
ESn[ ]
(1-2)
  
† 
Ys =
ESn[ ]
E[ ] + ESn[ ]( )
(1-3)
After combining Eqs. 1-2 and 1-3 and performing some algebraic rearrangement,
the Hill equation is obtained:
  
† 
Ys =
[S]n
K + [S]n
(1-4)
Equation 1-4 can be applied to describe the degree of saturation for an
oligomeric protein as a function of ligand concentration.  Since the assumption
of infinite cooperativity is physically impossible, n must be considered not as a
number of subunits per protein, but rather as a measurement of the degree of
cooperativity among interacting ligand-binding sites.  Thus, if n = 1, ligand
binding is non-cooperative and should follow Michaelis-Menten kinetics.
However, for a positively cooperative ligand-binding curve, n > 1, and for a
negatively cooperative ligand-binding curve, n < 1.
4Also, in the realm of allosterism, the terms heterotropic and homotropic
interactions (effects) are commonly used.  A heterotropic interaction is defined as
an interaction between unlike binding sites or ligands, while a homotropic
interaction is defined as an interaction between like binding sites or ligands.
Thus, a cooperative ligand-binding curve would reflect a homotropic effect since
it involves the binding of one ligand influencing the binding of the same ligand
to a different binding site, while an example of a heterotropic effect would be
the binding of an inhibitor influencing the binding of substrate at a separate site.
The concerted and sequential models.  Two of the most widely used
models in the allosteric field are the concerted and sequential models and both
were formulated to describe an allosteric response for a protein.  The concerted
model or Monod-Wyman-Changeux (MWC) model, was originally formulated
to describe the allosteric effect observed for hemoglobin and simplified the
allosteric transition into an all-or-none phenomenon (Monod et al., 1965).  The
concerted model begins by considering any allosteric enzyme existing in one of
two functional/conformational states based upon the ligand(s) bound.  The “R-
state” or relaxed state preferentially binds substrates and activators with high
affinity, and the “T-state” or taut state preferentially binds inhibitors and thus
binds substrate with low affinity.  According to the concerted model, the “R-
state” and “T-state” are in equilibrium whether or not ligand is bound to the
enzyme and the equilibrium constant for the R ÷ T transition is denoted “L”.
Thus, when the substrate binds the free enzyme form, the equilibrium is shifted
towards the “R-state”, and the enzyme undergoes a concerted transition making
5more “R” sites accessible for substrate binding leading to a cooperative
(positive) substrate binding profile.  Activators also bind to the “R-state”,
however, they too shift the equilibrium towards the “R-state”, but since the
enzyme is already in the “R-state”, the substrate saturation profile lacks
cooperativity.  On the other hand, when inhibitor binds to the enzyme, the
equilibrium is shifted towards the “T-state” in a concerted transition reducing
the number of “R” sites available to bind substrate.  Thus, when performing a
substrate saturation profile at any given inhibitor concentration, positive
cooperativity will always be observed because as the amount of substrate is
increased, the equilibrium is shifted back towards the “R-state” increasing the
number of accessible “R” sites.  Thus, the major component of the concerted
model is that when the protein goes from one state to another state after only
one binding event, its molecular and conformational symmetry is conserved and
this distinction is shown schematically for a homotetramer in Fig. 1-1.  A major
drawback to the concerted model is its inability to describe negative
cooperativity, part of which was the motivation for the formulation of the
sequential model.
The sequential model or Koshland-Nemethy-Filmer (KNF) model, also
uses the “R-state”, “T-state” and “L” notation, but differs from the concerted
model in several ways (Koshland et al., 1966).  First, the sequential model does
not restrict the enzyme to exist at equilibrium between two defined
conformational states, but rather allows the ligand (substrate, activator or
inhibitor) that binds to the enzyme to determine the conformation adopted by
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FIGURE 1-1  Schematic diagrams of the concerted (MWC) and sequential (KNF) models
of allosteric regulation of a homotetramer.  For the concerted model, only one
equivalent of inhibitor (I) is required to bind for the enzyme to undergo the allosteric
transition from the R-state (circles) to the T-state (squares – inhibited form) (Monod et
al., 1965).  The sequential model, on the other hand, requires four equivalents of
inhibitor to bind for the enzyme to be converted from the R-state to the T-state
(Koshland et al., 1966).
7the protein.  Furthermore, instead of a concerted allosteric transition upon
ligand binding, only the subunit that binds the ligand undergoes the allosteric
transition or conformational change.  However, that one subunit also influences
the neighboring subunits, giving rise to either positive or negative cooperativity.
If the influence upon the neighboring subunits is favorable, positive
cooperativity is observed, and if the influence is unfavorable, negative
cooperativity is observed.  Both activation and inhibition are easily rationalized
by this phenomenon, as an activator would have a favorable influence upon
substrate binding, whereas an inhibitor would have an unfavorable influence
upon substrate binding.  Most importantly however, the sequential model
requires saturation to occur in order for the entire enzyme to adopt either the
“R-state” or “T-state” forms (see Fig. 1-1).  Thus, from examining Fig. 1-1, the
biggest difference between the concerted and sequential models is the extent of
conformational changes the enzyme experiences upon binding the first
equivalent of ligand (the case of inhibitor binding in Fig. 1-1).  Consequently, a
great deal of information would be gained about the applicability of these two
models if the first binding event could be isolated.
Several variations of the concerted and sequential models (two-state
models) have been formulated in order to try to describe an observed allosteric
effect that cannot be adequately described by either model.  Eigen (1967)
developed a unifying model that combines the extremes of both the concerted
and sequential models, while a series of “nested” models have also been created
which invoke different degrees of either the concerted or sequential models
8simultaneously, depending upon the ligation state of the enzyme (Ackers et al.,
2000; Ackers et al., 1992; Herzfeld and Stanley, 1974; Decker and Sterner, 1990).
Common to all these secondary model formulations is the inability of the
concerted or sequential models to adequately describe an allosteric effect on
their own, mainly because the enzyme is restricted to two conformational states,
the “R-state” or the “T-state”.  Thus, a third model or approach is warranted in
which more “conformational freedom” is granted to the protein and which
would permit any range of functionality to the various ligand-bound forms of
the enzyme.
Linked-function analysis.  The idea of linkage was first proposed by
Wyman (1964 and 1967) and later adapted by Weber (1972 and 1975) to describe
an observed allosteric effect between two ligands binding to two separate sites
on a protein.  Furthermore, linkage states that the interaction between these two
ligands must be  equivalent regardless of the order of ligand binding.  When
considering these effects of ligand binding in free energy terms, a
thermodynamic basis is established that can successfully describe activation,
inhibition or no allosteric effect at all (Weber, 1972, 1975; Reinhart, 1983, 1988).
Let’s begin by considering an enzyme E that binds two different ligands,
A and Y, to two different binding sites on the enzyme.
  
† 
Y + E + A ´ Y - E - A (1-5)
Next, for the enzyme to proceed from its unbound form to having both A and Y
bound (ternary complex), two binding events must occur, with the order of
ligand binding generating a potential of four different binding events.  First,
9either A or Y can bind to E resulting in either a binding free energy of   
† 
DGa  or
  
† 
DGy  respectively.  After that, the remaining ligand, either Y or A binds to the
enzyme resulting in two additional binding free energy terms,   
† 
DGy/a  or   
† 
DGa/y
which describe the binding free energy of either binding Y to E with A already
bound or binding A to E with Y already bound respectively.  Thus, the binding
free energies of both ligand binding events, regardless of order, must equal the
following (Weber 1972, 1975; Reinhart, 1983, 1988):
  
† 
DGa + DGy /a = DGy + DGa / y (1-6)
Moreover, the magnitude of the interaction between the two ligands (  
† 
DGay ) can
be defined by the following equation:
  
† 
DGay ≡ DGa / y - DGa = DGy /a - DGy (1-7)
Figure 1-2 illustrates the three cases possible upon both A and Y binding
to E.  First, if the binding of Y augments the binding of A and vice versa, a
coupling free energy less than zero will be observed (activation; Fig. 1-2 A).
Second, if the binding of Y antagonizes the binding of A and vice versa, a
coupling free energy greater than zero will be observed (inhibition; Fig. 1-2 B).
Finally, if the binding of Y has no effect upon the binding of A and vice versa, no
allosteric regulation exists between the two ligands (Fig. 1-2 C).  Figure 1-3 also
illustrates the basic linkage idea in terms of a thermodynamic box, with the
macromolecular dissociation constants for each binding event also included.
Reinhart (1983) applied these ideas to predict the observed allosteric
response in a single substrate-single modifier system.  Using linked function
10
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∆Gy
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∆Ga
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∆Gay = 0
E + A + Y
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∆Gy
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INHIBITION
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}
FIGURE 1-2  Three coupling free energy diagrams depicting either activation,
inhibition or no allosteric effect at all for the binding of two individual ligands
(A or Y) to an enzyme (E) in which   
† 
DGay  is the coupling free energy associated
with binding A and Y.  (A)  When   
† 
DGay  < 0, activation occurs.  (B)  When   
† 
DGay  >
0, inhibition occurs.  (C)  When   
† 
DGay  = 0, no allosteric effect is measured.
Diagrams adapted from Weber (1972 and 1975).
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E + A
+
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E-A
Y-E
+
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o
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•
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FIGURE 1-3  The thermodynamic box of an allosteric mechanism involving a
single substrate (A) and a single modifier (Y) binding to the enzyme (E).  The
dissociation constants for each binding event are also shown.
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analysis, both the nature (activation or inhibition) and magnitude of an allosteric
effect can be determined by measuring the coupling constant (  
† 
Qay ) which is
derived from the dissociation constants defined by the thermodynamic box
shown in Fig. 1-3 (Botts and Morales, 1953; Freiden, 1964; Reinhart, 1983).  Each
binding event is governed by individual dissociation constants termed either
  
† 
Kiao ,   
† 
Kia• ,   
† 
Kiyo  or   
† 
Kiy•  in which the subscript denotes the ligand bound and the
superscript denotes the degree of saturation of the other ligand.  Thus,   
† 
Kiao  is the
dissociation constant for A in the absence of Y and   
† 
Kia•  is the dissociation
constant for A in the saturating presence of Y, in which A is the substrate and Y
is an inhibitor.  The notation utilized here expands on the notation introduced
by Cleland (1963a) in which the terms   
† 
Ka  and   
† 
Kia  were used to distinguish
between the Michaelis constant and the thermodynamic dissociation constant of
the substrate A respectively.  Thus, from Fig. 1-3 the dissociation constants are
determined as follows:
  
† 
Kiao =
E[ ] A[ ]
E - A[ ]
(1-8)
  
† 
Kia• =
Y - E[ ] A[ ]
Y - E - A[ ]
(1-9)
  
† 
Kiyo =
E[ ] Y[ ]
Y - E[ ]
(1-10)
  
† 
Kiy• =
E - A[ ] Y[ ]
Y - E - A[ ]
(1-11)
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The coupling constant,   
† 
Qay , can then be calculated by taking the ratio of
the dissociation constants determined for A or Y in the absence and saturating
presence of Y or A respectively:
  
† 
Qay =
Kiao
Kia•
=
Kiyo
Kiy•
(1-12)
Moreover, if   
† 
Qay  < 1 the allosteric ligand is an inhibitor, and if   
† 
Qay  > 1 the
allosteric ligand is an activator.  If   
† 
Qay  = 1 then the allosteric ligand has no effect
on the binding of substrate or vice versa.
It should be noted that the thermodynamic parameters,   
† 
Kiao  and   
† 
Kia• , are
not necessarily interchangeable with their Michaelis constant counterparts,   
† 
Kao
and   
† 
Ka•.  However, they are equivalent if the rapid equilibrium assumption is
valid (Reinhart, 1983).  Furthermore, Symcox and Reinhart (1992) developed a
steady-state kinetic method to determine if in fact the rapid equilibrium
assumption is valid.  Essentially, independent determinations of   
† 
Kiao /  
† 
Kia•  and
  
† 
Kiyo /  
† 
Kiy•  must be equivalent if the allosteric ligand has reached rapid
equilibrium.
The coupling parameter can also be used to calculate the coupling free
energy associated with the interaction between substrate and allosteric effector
using the following equation:
  
† 
DGay = -RTln Qay( ) (1-13)
where ∆Gay is the coupling free energy between Fru-6-P and PEP as defined in
Eq. 1-7, R is the gas constant which is equivalent to 1.987 x 10-3 kcal/degûmol,
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and T is absolute temperature in Kelvin.  Allosteric inhibition is defined by ∆Gay
> 0, allosteric activation by ∆Gay < 0, and if no coupling between the two ligands
occurs, ∆Gay = 0 (see Fig. 1-2).  A further elaboration of applying linked function
analysis to a symmetrical dimer is discussed in both Chapter II and Chapter VI.
One shortcoming of using a linked-function approach to study
allosterism is the lack of a model to describe an allosteric effect.
Conceptualization via circles and squares for the two-state models is a big
advantage, but with the linked-function approach, having only mathematical
relationships to describe the allosteric effect makes describing an observed
allosteric effect a bit more challenging.
Phosphofructokinase background
Phosphofructokinase (PFK) (EC 2.7.1.11) is the third enzyme found in the
glycolytic pathway and catalyzes the phosphorylation of fructose-6-phosphate
(Fru-6-P) to fructose-1,6-bisphosphate using MgATP as the phosphoryl donor
(Fig. 1-4).  For both the eukaryotic and prokaryotic forms of the enzyme, PFK is
allosterically regulated by numerous metabolites in the glycolytic and energy
production pathways (Bloxham and Lardy, 1973; Kolartz and Buc, 1982; Evans
et al., 1981).  However, for purposes of this investigation, our focus is on the
regulatory behavior of phosphofructokinase from two well known bacterial
sources, Escherichia coli (a mesophile) and Bacillus stearothermophilus (a moderate
thermophile).
For both of the enzymes, several molecules have been found to regulate
the activity of the enzyme, but the two main effector molecules are MgADP
15
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FIGURE 1-4  The reaction catalyzed by PFK and the metabolites responsible for
either inhibiting (PEP) or activating (MgADP) PFK activity.
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(activator) and phosphoenolpyruvate (PEP; inhibitor) (Uyeda, 1979; Evans et al.,
1981 and Kolartz and Buc, 1982).  In response to the energy requirements of the
cell, MgADP has been shown to activate PFK activity by binding to the enzyme
and increasing the enzyme’s affinity for the substrate Fru-6-P.  On the other
hand, PEP inhibits PFK by binding to the same allosteric sites and decreasing
the enzyme’s affinity for Fru-6-P (feedback inhibition).  Thus, PFK is subject to
“K-type” regulation.  Other molecules that have been shown to regulate PFK
activity include MgGDP (activator), MgATP (inhibitor) and 2-phosphoglycolate
(inhibitor) (Blangy et al., 1968; Bloxham and Lardy, 1973; Kolartz and Buc, 1981;
Evans et al., 1981; Johnson and Reinhart, 1992 and 1994, Tlapak-Simmons and
Reinhart, 1994).
With such a high degree of nucleotide (58%) and amino acid (55%)
identity between PFK from E. coli (EcPFK) and B. stearothermophilus (BsPFK), it is
not surprising that the allosteric properties of the two enzymes are similar
(French and Chang, 1987).  The biggest difference in the nucleotide sequence
between the two species is the elevated guanine (G) and cytosine (C) content at
the third position of BsPFK’s codons (71.3% G or C for BsPFK compared to
57.5% G or C for EcPFK). This is consistent with other mesophilic and
thermophilic bacteria and supports the idea that the higher G and C content
increases the stability of the nucleic acid interactions in thermophiles (Kagawa et
al., 1984 and Hellinga and Evans, 1985).
Based on crystal structures for both EcPFK and BsPFK in the presence of
several ligand combinations, it is clear that the two enzymes are very similar.
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Both enzymes are homotetramers (subunit MW ~34,000) arranged as a dimer of
dimers with the crystal structure of BsPFK shown in Fig. 1-5 (Evans and
Hudson, 1979; Evans et al., 1981; Evans et al., 1986; Schirmer and Evans, 1990).
They share the same secondary structural elements, and, when comparing their
a-carbon traces, the enzymes are nearly superimposable (Evans et al., 1981 and
Shirakihara and Evans, 1988).
Each subunit is comprised of a large domain and a small domain, with
each domain containing a central b-sheet sandwiched between several a-helices
(Fig. 1-5 B).  The Fru-6-P binding site is located at the cleft between the two
domains and at the interface of the protein.  Thus, residues from either side of
the interface are involved in binding Fru-6-P, and it is this site that will be
referred to as the active site.  The MgATP binding site, located next to the Fru-6-
P binding site, is located entirely in the large domain.  The allosteric site, which
is capable of binding both MgADP and PEP, is located at the interface of the
protein in both the large and small domains.  Therefore, each subunit
contributes two half Fru-6-P (active) sites and two half allosteric sites, resulting
in an average of each subunit containing one full active site and one full
allosteric site.  Moreover, all four active sites are arranged along one dimer-
dimer interface, while all four allosteric sites are situated along the other dimer-
dimer interface (Fig. 1-5).
With such a high degree of sequence and structural similarity between
the two enzymes, one might expect the enzymes to perform and act identically
with respect to ligand binding, allosteric behavior and protein stability, but this
18
FIGURE 1-5  The crystal structure of BsPFK solved to a resolution of 2.4 Å
(Schirmer and Evans, 1990).  (A)  A space-fill representation of BsPFK with each
subunit colored green, blue, yellow or red.  The ADP molecules bound in the
allosteric sites are shown in black and the Fru-6-P molecules bound in the active
sites are shown in gray.  (B) A diagram of two of the four subunits shown as
ribbons in order to show the two domains of each subunit.
A
B
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is not the case.  First, the two enzymes differ in their individual Fru-6-P
saturation profiles.  For EcPFK, the binding of Fru-6-P displays positive
cooperativity in the presence of saturating MgATP.  By contrast, Fru-6-P binding
to BsPFK shows little to no cooperativity under the same conditions.  However,
Fru-6-P binding becomes cooperative in BsPFK in the presence of the inhibitor
PEP, whereas cooperativity diminishes in the presence of inhibitor in EcPFK
(Blangy et al., 1968 and Valdez et al., 1989).
Secondly, MgADP (or MgGDP) activates and PEP inhibits both EcPFK
and BsPFK.  However, the two enzymes differ in the degree of activation and
inhibition measured at room temperature.  For EcPFK activation is easily
observed under normal assay conditions, but for BsPFK activation is practically
undetectable under the same conditions.  Fortunately, by altering the
temperature and pH of the assay conditions, binding of MgADP can be detected
and hence its effects upon Fru-6-P binding observed for BsPFK.  What is more,
MgADP has been shown to become an inhibitor of BsPFK at low temperatures.
As for inhibition, PEP is a better inhibitor of BsPFK than EcPFK at room
temperature  (Braxton et al., 1994; Byrnes et al., 1994; Tlapak-Simmons and
Reinhart, 1994 and 1998).  Thus, although similar structurally, the kinetic
behaviors of EcPFK and BsPFK are quite different.
A third difference between EcPFK and BsPFK involves the stability of the
two enzymes at room temperature.  EcPFK undergoes dimer exchange across
the active site dimer-dimer interface quite readily (in the absence of Fru-6-P) at
25 °C (Fenton and Reinhart, 2002), while no exchange between dimers has been
20
observed under the same conditions in BsPFK (data not shown).  Furthermore,
exchange of the subunits at the monomer level has been observed for EcPFK
with the addition of only 0.4 M KSCN, while BsPFK requires 2 M KSCN to
achieve the same results (Deville-Bonne et al., 1989; Johnson et al., 2001; Fenton
and Reinhart, 2002; Kimmel and Reinhart, 2001).  Finally, when the two
enzymes are subjected to hydrostatic pressure, EcPFK dissociates by
approximately 1000 bar, while for BsPFK, no evidence for dissociation of the
tetramer is observed up to 2500 bar (Johnson and Reinhart, 1996; Quinlan and
Reinhart, unpublished results).  Thus, at room temperature and in the absence of
KSCN, the BsPFK enzyme is far more stable than the EcPFK enzyme.
For this investigation we have chosen to focus on the allosteric properties
of BsPFK and more specifically, inhibition of BsPFK by PEP. As mentioned
previously, a lot is known about BsPFK and its regulatory behavior, but how the
enzyme is inhibited is the focus of this investigation.  However, before
addressing how the enzyme is inhibited, we have to first identify the potential
allosteric interactions involved in the inhibition process.
Identifying the ten unique allosteric interactions in BsPFK.  In order to
get a better idea of how the subunits are organized in BsPFK as well as to
emphasize the location of the binding sites, we have converted the crystal
structure into a two-dimensional schematic (Figs. 1-6, A and B) (Schirmer and
Evans, 1990).  All four subunits are shown in a different color (green, blue,
yellow and red) with the active site dimer-dimer interface located between the
green and blue subunits and the red and yellow subunits (positioned vertically
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in Fig. 1-6), and the allosteric site dimer-dimer interface located between the
green and red subunits and the blue and yellow subunits (positioned
horizontally in Fig. 1-6).
As mentioned previously, all eight of the binding sites are located at the
subunit interfaces within the protein, with each subunit contributing two half-
active sites and two half-allosteric sites per subunit.  In order to differentiate
between these four different half-sites within the two-dimensional schematic,
different geometric shapes have been used to represent the different “sides” of
the binding sites (see Fig. 1-6, B and C).  The active sites are represented as being
formed by a combination of a triangle and a half-hexagon, while the allosteric
sites are represented by a combination of a semi-circle and a rectangle.
Furthermore, specific residues that contribute to the binding sites have also been
included in the schematic (Schirmer and Evans, 1990).  For example, the active
site is lined with R162 from one side (triangle) and R252 from the other side
(half-hexagon), while the allosteric site is lined with R211 and K213 on one side
(semi-circle) and R25 on the other side (rectangle).
With a total of four active sites and four allosteric sites, 28 total pair-wise
allosteric interactions are possible between the eight binding sites.  Of those 28
interactions, 16 are heterotropic interactions with the rest being homotropic
interactions.  Of the 28 total pair-wise allosteric interactions, only 10 are unique.
Moreover, all of the interactions are shown in Fig. 1-6 C with each of the 10
unique interactions designated a distinct color.
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R162 R252
R25R211 K213
FIGURE 1-6  Relating the crystal structure of BsPFK to a two-dimensional
schematic in order to stress how the subunits are organized and the location of
the active sites and allosteric sites.  (A)  The crystal structure of BsPFK indicating
both the active site dimer-dimer interface (vertical) and the allosteric site dimer-
dimer interface (horizontal).  (B)  The two dimensional schematic of BsPFK with
the “sides” of the binding sites represented by a different geometrical figure and
the specific residues on either side of the binding sites shown.  (C)  The 28
potential pair-wise allosteric interactions found in BsPFK, 10 of which are
unique with each one designated a different color.
Active Site Dimer-Dimer
Interface
Allosteric Site
Dimer-Dimer
Interface
A
B
C
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In order to identify the structural relationships corresponding to each of
the 10 pair-wise interactions, we simply use the aforementioned binding site
residues (R162 and R252 at the active sites and R211/K213 and R25 at the
allosteric sites) as “landmarks” within the crystal structure, and proceed to map
each of the 10 allosteric interactions from the three-dimensional structure to the
two-dimensional schematic.  A unique distance is also measured between the
different pairs of binding sites (depending upon the interaction of interest) and
that distance is then used to identify that particular interaction.  Fig. 1-7 walks
through this process for identifying the 30 Å heterotropic interaction.
This process was performed for the remaining three heterotropic
interactions resulting in distances of 22 Å, 32 Å and 45 Å.  These distances were
measured within the crystal structure from the phosphorous atom of one of the
bound Fru-6-P molecules to the b-phosphorous atom on the bound ADP
molecules in each of the four allosteric sites (Fig. 1-8).
The distances were then measured between the four active sites in order
to distinguish the 3 unique homotropic interactions between active sites from
one another (2 copies of each in the tetramer).  Measuring from the phosphorous
atom of one of the Fru-6-P molecules bound in the active site to the phosphorous
atoms on each of the other three Fru-6-P molecules bound in the active sites
generated the distances of 28 Å, 45 Å and 47 Å (Fig. 1-9).
The distances corresponding to the 3 homotropic interactions between
allosteric sites were also measured within the crystal structure (2 copies of each
in the tetramer).  The distances were measured from the b-phosphorous atom on
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R162 R252
R25R211 K213
FIGURE 1-7  The identification of the 30 Å heterotropic interaction (red line in
all three figures).  (A)  The crystal structure of BsPFK with the binding site
residues R162, R252, R211, K213 and R25 (the “landmarks”) shown in the color
of the subunit from which they originate, the Fru-6-P molecules shown in gray
and the ADP molecules shown in black.  (B)  Same as A except the protein
“scaffold” is removed in order to see all the ligands and binding sites more
easily.  Moreover, the identities of the binding site residues are also shown.  (C)
The “mapping” of the 30 Å heterotropic interaction from the blue-R162/green-
R252 binding site pair to the green-R25/red-R211/K213 binding site pair.
R252
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FIGURE 1-8  The four unique heterotropic interactions in BsPFK.  The 22 Å
heterotropic interaction is blue, the 30 Å heterotropic interaction is red, the 32 Å
heterotropic interaction is green and the 45 Å heterotropic interaction is
magenta.  (A)  The crystal structure of BsPFK showing just the “landmark”
residues (in the color of the subunit from which they come from), Fru-6-P bound
in the active sites (gray) and ADP bound in the allosteric sites (black).  The four
heterotropic interactions are also shown.  (B)  The two-dimensional schematic
with the four heterotropic interactions mapped onto it.
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FIGURE 1-9  The three unique homotropic interactions between active sites in
BsPFK.  The 28 Å homotropic interaction is cyan, the 45 Å homotropic
interaction is orange, and the 47 Å homotropic interaction is purple.  (A)  The
crystal structure of BsPFK showing just the “landmark” residues (in the color of
the subunit from which they come from), Fru-6-P bound in the active sites (gray)
and ADP bound in the allosteric sites (black).  The three homotropic interactions
between active sites are also shown.  (B)  The two-dimensional schematic with
the three homotropic interactions between active sites mapped onto it.
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FIGURE 1-10  The three unique homotropic interactions between allosteric sites
in BsPFK.  The 23 Å homotropic interaction is black, the 39.9 Å homotropic
interaction is dark green, and the 40 Å homotropic interaction is brown.  (A)
The crystal structure of BsPFK showing just the “landmark” residues (in the
color of the subunit from which they come from), Fru-6-P bound in the active
sites (gray) and ADP bound in the allosteric sites (black).  The three homotropic
interactions between allosteric sites are also shown.  (B)  The two-dimensional
schematic with the three homotropic interactions between allosteric sites
mapped onto it.
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one of the ADP molecules bound in the allosteric site to the b-phosphorous
atoms on each of the other three ADP molecules bound in the allosteric sites
resulting in the 23 Å, 39.9 Å and 40 Å homotropic interactions (Fig. 1-10).
Methods used to probe the possible mechanism of allosteric regulation
The following text summarizes various approaches used to better
understand the mechanism of allosteric regulation.  Moreover, if a method or
approach has been used for better understanding the allosteric regulation of
PFK, it is included in this review.
The structural stability of proteins and its role in transmitting an
allosteric signal.  To identify the structural components involved in the
transmission of an allosteric signal, Freire and colleagues (1999 and 2000; Pan et
al., 2000) conducted a structure-based thermodynamic stability analysis of
homologous enzymes for which high-resolution structures in various ligated
states are available.  Basically, they determine the structural stability constants
for each residue found in an enzyme (based upon the comparison to other
crystal structures and using the COREX algorithm; Hilser et al., 1998), and
“map” these stability constants onto the structure of the protein to see what role
protein stability plays in ligand binding and the transmission of the allosteric
signal.  For example, for any given protein it is postulated that the protein is
dynamic and undergoes various local unfolding reactions scattered throughout
the enzyme.  Moreover, Freire and coworkers believe these unfolding reactions,
occurring independently of one another, can involve only a few amino acids, or
the entire protein, leading to a large number of potential conformational states a
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given protein can “sample”.  Furthermore, this collection of states is termed “the
native state ensemble”, and by using the COREX algorithm, each residue of the
protein is assigned a stability constant which reflects its probability of being
either folded or unfolded within the native state ensemble.
Freire and coworkers have performed this analysis on over 20
structurally diverse proteins to date (16 of which are found in the Luque and
Freire (2000) paper), and discovered some common themes in protein structure
and stability.  First, regions of both high stability and low stability were found
distributed throughout each protein.  Furthermore, the binding sites of the
proteins were found to have “dual character”, meaning the residues comprising
the ligand binding pocket(s) were either highly stable or unstable.  This
phenomenon was attributed to the residues being involved in either catalysis
and/or ligand binding specificity (stable) or in the transmission of an allosteric
signal (less stable).  Moreover, in the allosteric enzymes, the allosteric sites were
found to be markedly unstable.  Thus, based impart upon their results with
glycerol kinase, Freire and coworkers conclude that transmission of the
allosteric signal involves a unique set of residues connecting the active and
allosteric sites that are unstable in the unbound form of the enzyme and become
stabilized upon effector binding due to the cooperative interactions between the
residues; this effectively constitutes the “mapping” of the residues involved in
the transmission of the allosteric signal.  Moreover, Pawlyk and Pettigrew (2002)
have used these theoretical calculations to confirm the requirement of these
“cooperative interactions” in transmitting the allosteric signal in glycerol kinase
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(see Genetic approach – chimeric proteins section).
Structure determination of an enzyme in different ligated states.
Obtaining numerous structures of a given allosteric enzyme in as many different
ligation states as possible is a highly desired goal because of the information one
could gain from these various “snap shots” of enzyme function and regulation.
Schirmer and Evans (1990) were successful in crystallizing and solving two
different ligation states of BsPFK, one with Fru-6-P and MgADP bound and the
other with the non-physiological inhibitor 2-phosphoglycolate (PG) bound.
Upon examining the two structures, the biggest difference was a 7° rotation of
two of the four subunits (rigid dimers) about the active site interface.  Thus,
binding of PG at the effector sites (along the allosteric site dimer-dimer
interface) causes a significant alteration of the active site dimer-dimer interface.
Another significant change involves the positions of E161 and R162.  In
the Fru6-P/MgADP structure, the side chain of R162 hydrogen bonds with the
Fru-6-P molecule bound in the active site, while the side chain of E161 is
positioned in the opposite direction.  However, in the PG structure, the two
residues switch positions as the side chain of E161 is now found in the active site
and the side chain of R162 replaces the previous E161 position.  From these
results Schirmer and Evans formulated a model for PG inhibition: upon PG
binding, E161 replaces R162, thus introducing a negative charge into the active
site, resulting in a decrease in Fru-6-P affinity because of charge repulsion.
Kimmel and Reinhart (2000) later provided evidence that this proposed
mechanism is wrong using site-directed mutagenesis studies.  Thus, although
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crystal structures may provide insight into the conformational response of an
enzyme upon ligand binding, crystal structures can also be misleading if
superficial functional inferences are drawn.  Thus, definitive experiments are
necessary before any kind of functionality of an enzyme is assumed from a
crystal structure.
Genetic approach — chimeric proteins.  As mentioned initially, allosteric
regulation is common to both eukaryotic and prokaryotic organisms.  However,
a specific enzyme found in two different organisms might be allosterically
regulated in one but not the other.  Due to this evolutionary divergence, a
sequence comparison is commonly performed to determine which amino acids
are different between the two enzymes.  With the residues identified subsequent
experiments are then performed to try to identify the conserved residue(s) or
region(s) responsible for transmitting the allosteric signal.  This identification
involves making either chimeric proteins in which entire regions of the enzymes
are “swapped” and their allosteric properties characterized, or by making single
amino acid changes from one enzyme to the other and determining if the
changes affect the allosteric properties of either enzyme.
The first example of the chimera-based approach is the formation of a
chimeric phosphofructokinase between E. coli (EcPFK) and B. stearothermophilus
(BsPFK) to investigate why MgATP is a much better inhibitor of EcPFK than
BsPFK.  Byrnes et al. (1995) hypothesized that this disparity could be a result of
the structural response incurred by MgATP binding in EcPFK, but not in BsPFK.
Thus, a chimeric protein (ChiPFK) was made to contain the MgATP binding
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domain of BsPFK (residues 1-122 including part of the allosteric site) grafted
onto the remainder of the EcPFK subunit (residues 123-319 containing the Fru-6-
P binding site).
Upon characterizing ChiPFK and the two parent proteins (EcPFK and
BsPFK), Byrnes et al. determined that the kinetic properties of the three enzymes
are quite similar with respect to their catalytic activities and their affinities for
MgATP.  The major differences arose in their binding affinities for Fru-6-P and
the degree of Fru-6-P cooperativity measured for the three proteins.  ChiPFK
was found to behave more like BsPFK with respect to both Fru-6-P binding and
cooperativity, with the antagonism between MgATP and Fru-6-P still present in
ChiPFK.  Furthermore, and rather surprisingly, ChiPFK was also found to be
insensitive to regulation by PEP binding leading to the conclusion that the
structural components involved in the transmission of the allosteric signal are
different for EcPFK and BsPFK.
Another example of using chimeric proteins to investigate the mechanism
of allosteric regulation involves the enzyme carbamoyl-phosphate synthetase
(CPS).  Eroglu and Powers-Lee (2002) used a chimeric CPS to examine the
possible structural basis to why E. coli CPS (EcCPS), which provides carbamoyl-
phosphate (CP) for both arginine and pyrimidine biosynthesis, is allosterically
regulated by UMP, IMP and ornithine, and Saccharomyces cerevisiae CPS (ScCPS),
which provides CP for only arginine biosynthesis, is not.  Thus, a chimera of
EcCPS and ScCPS was made (ChiCPS) in which the C-terminal 136 residues of
EcCPS (residues 937-1073 from the D domain which is termed the “allosteric
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domain”) are replaced by the corresponding residues of ScCPS (residues 959-
1118) in an effort to define the structural basis for the allosteric
unresponsiveness of ScCPS.
With the catalytic effectiveness of ChiCPS verified, the allosteric
characterizations of the parental proteins and the chimera were performed.
From the analysis it was determined that ornithine is unable to bind to ChiCPS
and ScCPS, but that both UMP and IMP bind to ChiCPS and ScCPS without
altering the activities of the respective enzymes.  Thus, the residues involved in
binding two of three allosteric effectors are intact for both ChiCPS and ScCPS.
Nevertheless, the structural components found in the D domain of EcCPS
involved in transmitting the heterotropic signal are different in ScCPS,
rendering ScCPS and hence ChiCPS, unresponsive to UMP and IMP binding.
Thus, with the D domain now identified as the region responsible for
transmitting the allosteric signal, subsequent mutagenesis studies are necessary
to pinpoint the responsible residues.
Glycerol kinase is another enzyme that displays different regulatory
properties in different organisms.  Pawlyk and Pettigrew (2002) have used the
chimera-based approach to determine the possible structural components
involved in binding and transmitting the allosteric signal in glycerol kinase from
IIAGlc binding in E. coli (EcGK).  IIAGlc, a phosphotransferase system protein, is
known to inhibit EcGK activity, but glycerol kinase from Haemophilus influenzae
(HiGK) neither binds IIAGlc nor is inhibited by IIAGlc, even though the primary
structures of EcGK and HiGK are 87% similar (76% identical).  Thus, a number
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of successive chimeric proteins were made in order to determine the least
amount of genetic information in EcGK required to confer not only IIAGlc
binding but inhibition of HiGK activity as well.
After making several chimeras, Pawlyk and Pettigrew found that by
“transplanting” only 11 residues from EcGK to HiGK (8 residues that interact
with IIAGlc and 3 residues at the catalytic core of the protein) conferred both
IIAGlc binding and inhibition.  Thus, a majority of the residues involved in the
transmission of the allosteric signal incurred by IIAGlc binding are already poised
for inhibition, agreeing with the earlier data regarding EcCPS and ScCPS.
Moreover, from using this chimera-based approach, Pawlyk and Pettigrew have
been able to identify an allosteric locus that is essential for inhibition to occur.
This finding is also consistent with the residues identified by Luque and Freire
(2000), using the COREX algorithm, as being involved in the network of
cooperative interactions found between the active site and the allosteric site.
Due to the potential of the chimera-based approach, our lab is currently
using the amino acid sequence of a PFK from Lactobacillus delbrueckii (LdPFK)
(47% sequence identity to EcPFK) as a chimeric partner to identify the residues
responsible for transmitting the allosteric signal in EcPFK and BsPFK.  In
addition, the reverse experiment is also being performed in an attempt to make
LdPFK allosterically responsive to either MgADP (activator) or PEP (inhibitor).
Genetic approach — site-directed mutagenesis.  Site-directed
mutagenesis is another approach used to elucidate the mechanism of allosteric
regulation.  Residues highlighted in sequence alignments or structural
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considerations are changed and the allosteric properties of the mutant enzyme
characterized.  For this approach we will only focus on residues mutated in PFK.
Serre and coworkers (1990), using the crystal structure of EcPFK, chose
L178 to mutate due to its location in an a-helix that “connects” one of the active
sites and one of the allosteric sites (Shirakihara and Evans, 1988).  L178 was
changed to a tryptophan in hopes of destroying the “structural connection”
between the two binding sites and rendering the enzyme unresponsive to
allosteric regulation.  Upon characterizing the L178W mutant protein, Serre et al.
discovered that a majority of its binding properties are quite similar to wild-type
EcPFK.  The mutant binds both MgATP and Fru-6-P with wild-type affinity, and
the Fru-6-P saturation profile is still cooperative (nH mutant = 3.3, nH EcPFK =
3.7) indicating that the homotropic interactions between the active sites are
essentially conserved.  Interestingly, however, the L178W mutant protein is
virtually unresponsive to both MgGDP activation and PEP inhibition.  Thermal
denaturation protection experiments were performed in the presence and
absence of the effector molecules (one at a time) to show that MgGDP and PEP
were still able to bind to the mutant protein.  Thus, Serre and coworkers
conclude that the L178W mutation has disrupted the heterotropic
communication between the active sites and allosteric sites, implicating a-helix 7
as playing a major role in transmitting both the activation and inhibition signals.
Furthermore, these results also suggest a common pathway for the two allosteric
signals, which is difficult to rationalize since the two effectors produce opposite
effects upon Fru-6-P binding.  However, a tree analogy can be made in which a-
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helix 7 would serve as the “trunk” of the allosteric signal, and differentiation
into either activation or inhibition would occur in the “branches” of the tree.
Thus, by affecting the trunk (via the L178W mutation), the branches are affected
as well (transmission of both allosteric signals).
Another example of using site-directed mutagenesis to probe the
mechanism of allosteric regulation resulted in disproving a widely accepted
mechanism for the inhibition of BsPFK by PEP.  Kimmel and Reinhart (2000)
tested the proposed charge-repulsion mechanism of Schirmer and Evans (1990)
regarding the roles of E161 and R162 in the inhibition process of BsPFK by
simply substituting either residue or both simultaneously with alanines.
Upon characterizing the steady-state kinetics of each of the three mutant
proteins it was found that all three mutant proteins are still inhibited by PEP,
although to varying degrees.  The E161A mutant protein was least affected in its
ability to be inhibited by PEP (~10% change in coupling free energy, ∆Gay), while
the R162A and R162A/E161A mutant proteins displayed an approximate 40%
loss in PEP’s inhibitory effects.  However, regardless of the degree of PEP
inhibition measured, what is important is that all three mutant proteins are still
inhibited by PEP, thus eliminating Schirmer and Evans’ proposed charge-
repulsion model.  Nevertheless, some loss in PEP’s effects is observed in either
case, thus, R162 and E161 may be involved in part of the transmission of the
allosteric signal.
The final example of using site-directed mutagenesis to probe the
allosteric properties of PFK involves the mutation of the residues lining the
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putative Fru-2,6-P2 activating site found in rabbit muscle PFK (RmPFK).  Chang
and Kemp (2002) constructed three mutant proteins S530D, R292A and H662A,
to test their hypothesis regarding the evolutionary divergence of the duplicated
active sites into allosteric sites specific for Fru-2,6-P2 activation.  In these
proteins, S530 , R292 and H662 of RmPFK are analogous to D127, R243 and H249
of EcPFK.
Upon characterizing the three mutant proteins via steady-state kinetics,
Chang and Kemp discovered that the binding affinity for Fru-6-P was nearly
identical to wild-type, thus supporting the hypothesis that the duplicated active
sites were no longer binding Fru-6-P, and had in fact evolved to bind Fru-2,6-P2.
Moreover, a significant change in the ability of Fru-2,6-P2 to activate RmPFK was
also observed.  The S530D mutant protein did not respond to the concentrations
of Fru-2,6-P2 used, while the R292A and H662A mutant proteins were still
activated by Fru-2,6-P2, but to a lesser degree.  Thus, from these mutational
studies, Change and Kemp were able to confirm the identity of the Fru-2,6-P2
allosteric activating sites in RmPFK.
Using hybrid enzymes to isolate and characterize specific allosteric
interactions.  Using hybrid enzymes to study the behavior of enzymes is not
new to the field of enzymology, but using hybrid enzymes to isolate and
characterize specific allosteric interactions found within a particular allosteric
enzyme is.  Four examples will be discussed: hybrid tetramers of porcine liver
fructose-1,6-bisphosphatase; hybrid tetramers of human hemoglobin; and
hybrid tetramers of EcPFK and BsPFK.
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Fructose-1,6-bisphosphatase (FBPase) is a homotetramer that catalyzes
the hydrolysis of Fru-1,6-P2 to Fru-6-P and inorganic phosphate, and the reaction
is inhibited by AMP binding 28 Å away from the nearest active site (Nelson et
al., 2002).  To address the mechanism by which AMP inhibits FBPase, Nelson et
al. (2002) have created and isolated FBPase hybrids that contain either wild-type
subunits or AMP-binding deficient subunits.  Moreover, it was previously
reported that AMP must bind to two subunits of FBPase to cause inhibition
(Kelly-Loughnana and Kantrowitz, 2001).  Thus, three different 2:2 hybrids of
wild-type FBPase and AMP-binding deficient subunits were isolated to
determine which two AMP-binding sites triggered inhibition, or if the identity
of the two AMP-binding sites was insignificant (Fig. 1-11 illustrates the three 2:2
hybrids in question and their designations).
Unfortunately for Nelson et al., they were only able to separate the 2:2p
hybrid away from the 2:2q and 2:2r hybrids using anion exchange
chromatography and a glutamate tag on the c-terminus of the mutated subunits.
Due to this inadequate degree of separation, their comparisons of AMP
inhibition and AMP cooperativity are only between the 2:2p hybrid and a
mixture of the 2:2p and 2:2r hybrids.  Interestingly, upon characterizing the 2:2
hybrids via steady-state kinetics and fluorescence, it was found that an AMP
molecule must bind to a top and bottom subunit to display cooperativity in
AMP binding and inhibition of FBPase activity (nH = 1.5 ± 1) (either 2:2q or 2:2r
hybrids).  However, AMP molecules bound to the same half (both top or both
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Wild-Type FBPase
2:2p Hybrid 2:2q Hybrid 2:2r Hybrid
AMP-Binding Deficient
Mutant FBPase
FIGURE 1-11  The three 2:2 FBPase hybrids (2:2p, 2:2q and 2:2r) examined to
address both the inhibition of the enzyme by AMP and the cooperative effects
observed in AMP binding for the native enzyme.
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bottom – 2:2p hybrid) of the tetramer can still inhibit the enzyme (to a lesser
degree, IC50-AMP 2:2q/2:2r = 6.8 ± 0.5 and IC50-AMP 2:2p = 43 ± 2), but in the absence
of cooperativity in AMP binding to the enzyme (nH = 0.99 ± 0.5).  Thus, by
characterizing the 2:2 hybrids, Nelson et al. (2002) have shown a variability in
the contributions of both the heterotropic and homotropic interactions in AMP
inhibiting FBPase, a result consistent with our own data.
Ackers and coworkers have used hybrids to gain insight into the possible
mechanism of allosteric regulation of hemoglobin.  Hemoglobin (Hb), a tetramer
consisting of two ab dimers, is the protein responsible for oxygen transport in
blood.  It displays positive cooperativity upon oxygen binding leading to the
development of numerous models to explain the allosteric behavior of proteins
and enzymes.  By making various hybrid forms of hemoglobin which contain
varied amounts of oxygenated subunits (resulting in the 10 possible hybrids
shown in Fig. 1-12), Ackers et al. sought to identify the mechanism by which the
cooperative signal is transmitted through the protein.
To summarize a great deal of work from the last 20 years involving
hybrids, Ackers and coworkers have devised an alternative model to explain the
positive cooperativity measured for oxygen binding in Hb.  The model is called
the Symmetry Rule and is based upon the cooperative free energies measured in
each of the 10 species (Fig. 1-12) in which the cooperative free energy is the
difference in the binding free energy measured for the hybrid tetramer and the
two dimers that comprise that hybrid tetramer.  For example, to determine the
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FIGURE 1-12  The 10 hybrid hemoglobin species (adapted from Ackers et al.,
2000).  Deoxygenated subunits are “open” while oxygenated subunits are
“shaded”.  The different ligated species are also “named” in the figure with the
first number indicating the number of oxygen molecules bound and the second
number indicating what number species of the ligated form it is: fully
deoxygenated = ‘01’; singly ligated = ‘11’ or ‘12’; doubly ligated = ‘21’, ‘22’, ‘23’
or ‘24’; triply ligated = ‘31’ or ‘32’; fully oxygenated = ‘41’.
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cooperative free energy for the ‘11’ hybrid, the binding free energies are first
determined for a singly ligated ab dimer and an oxygen-free ab dimer and those
two values are added together.  Next, that value is subtracted from the binding
free energy measured for the ‘11’ hybrid resulting in a cooperative free energy.
Thus, if Hb was not cooperative, the binding free energy measured for the ‘11’
hybrid would equal the sum of the binding free energies measured for the two
dimers that comprise the ‘11’ hybrid.
Utilizing this analysis, Ackers and coworkers found that the cooperative
binding free energies determined for the 10 hybrid species were segregated into
four unique energy levels.  The unligated molecule (10) occupies the first energy
level (zero), while the singly ligated molecules (11 and 12) occupy the next
energy level (~3 kcal/mol).  The ‘21’ doubly ligated molecule occupies an
energy level all its own at ~5 kcal/mol and the remaining species then comprise
the final energy level (~6 kcal/mol) and includes the other three doubly ligated
molecules (22, 23 and 24), the triply ligated molecules (31 and 32) and the fully
ligated molecule (41).  Since the ‘21’ species is different than either the 11/12 or
22/23/24 species, each interface is suggested to have a different role in the
transmission of the allosteric signal.  Ackers and coworkers have also performed
a great deal of site-directed mutagenesis and characterization of the residues in
between the dimer-dimer interfaces supporting their observations that the two
dimers act autonomously until an oxygen molecule binds to both dimers
(Ackers et al., 1992, 2000 and 2002; Holt and Ackers, 1995).
Finally, Kimmel and Reinhart (2001) and Fenton and Reinhart (2002) have
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successfully isolated one of four specific heterotropic interactions found in either
the BsPFK or EcPFK enzymes utilizing the same hybrid approach.  For both
enzymes, mutations at both the active sites and allosteric sites were made to
diminish both Fru-6P binding and PEP binding for BsPFK or MgADP binding
for EcPFK.  Two residues on the surface of the mutant protein were also
mutated so that the various hybrid species could be separated via anion
exchange chromatography.  Hybrids were then made between the wild-type
enzyme and the ligand binding deficient mutant protein and applied to an anion
exchange column in order to separate the 1:3 hybrid (1 wild-type subunit:3
mutated subunits) from the other hybrid species.  The method for the hybrid
making procedure can be found in Chapter II.  Thus, for both BsPFK and EcPFK,
a hybrid enzyme containing one native active site and one native allosteric site
was isolated, and more importantly contained only one of the 28 total native
allosteric interactions found in the native enzymes.
For the BsPFK 1:3 hybrid, Kimmel and Reinhart chose to investigate the
contribution the isolated heterotropic interaction made to the inhibition of
BsPFK by PEP.  After a thorough steady-state kinetic analysis was performed, it
was determined that the isolated heterotropic interaction contributes about 41%
to the inhibition measured for the wild-type enzyme.  It was concluded that the
diminished amount of inhibition measured for the 1:3 hybrid was either a result
of the mutations made to isolate the 1:3 hybrid or that the one heterotropic
interaction is one of many allosteric interactions involved in transmitting the
inhibitory signal.  Only further analysis of the other three possible 1:3 hybrids
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can resolve this issue.
For the EcPFK 1:3 hybrid, Fenton and Reinhart examined the contribution
the isolated heterotropic interaction made to the activation of EcPFK by
MgADP.  Consistent with the results of the BsPFK 1:3 hybrid, the 1:3 hybrid
retained about 37% of the wild-type activation.  However, comparison to the
wild-type enzyme in this case was not appropriate due to the loss in Fru-6-P
cooperativity in the 1:3 hybrid.  Thus, an additional hybrid was constructed to
contain one native active site and four native allosteric sites to eliminate any of
the allosteric effects incurred by the homotropic interactions between the active
sites (cooperativity) in the wild-type enzyme.  After the characterization of this
secondary hybrid was performed, the percent contribution of the isolated
heterotropic interaction to MgADP activation was decreased from ~37% to
~20%.  This reduction is explained by the increased activation measured in the
secondary hybrid and the fact that the homotropic interactions between the
active sites in the wild-type EcPFK enzyme diminish the allosteric effect
incurred by MgADP binding.  Again, like BsPFK, further analysis of the other
three 1:3 hybrids is required to address if the strategy in isolating the
heterotropic interaction is responsible for the less than 100% contribution or if
the isolated heterotropic interaction is merely one of the many players involved
in the activation process in EcPFK.
Gene duplication.  The final section of this review concerns sequence
alignments to identify gene duplication events, which in turn enables the
identification of putative binding sites in enzymes for which structural
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information is missing.  Poorman et al. (1984) have postulated that rabbit muscle
PFK (RmPFK) is a gene duplication of a bacterial PFK, based upon the sequence
homology between the N and C-termini of RmPFK, EcPFK and BsPFK.
Moreover, this duplication pattern has also been observed in several other
eukaryotic PFK’s (yeast, liver, brain and fruit fly) (Gehnrich et al., 1988; Li et al.,
1994; Heinisch et al., 1989 and Currie and Sullivan, 1994).  Unfortunately, no
crystal structure is available for the mammalian enzyme.
The major differences between RmPFK, EcPFK and BsPFK are the relative
sizes of the three proteins (RmPFK is about twice the size as EcPFK and BsPFK)
and the number of effector molecules that regulate enzyme activity.  Poorman et
al. postulate that each monomer of RmPFK (tetramer) is composed of two
monomers of bacterial PFK linked with approximately 30 amino acids, resulting
in eight active sites and eight allosteric sites for RmPFK.  Interestingly,
experiments have only indicated four active sites in RmPFK; suggesting that
four of the eight active sites have mutated into allosteric sites that are now
capable of binding Fru-2,6-P2 as an activator.  This idea is substantiated by the
sequence alignments of the Fru-6-P binding sites that show D127 mutated to a
serine in four of the binding sites, a residue implicated for catalysis in BsPFK.
Furthermore, by removing the negative charge of D127 in RmPFK, more room is
provided for Fru-2,6-P2 binding.  Thus, rationalizing how Fru-2,6-P2 is an
activator of RmPFK is not difficult due to the significant amount of positive
cooperativity measured for Fru-6-P binding in EcPFK.  Furthermore, from this
sequence comparison it is quite possible to believe that the structural
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components involved in transmitting the allosteric signal between Fru-2,6-P2
and Fru-6-P in RmPFK were previously established in the bacterial enzyme
(EcPFK) via the homotropic interactions between Fru-6-P binding sites.  It
should be noted that Li et al. (1999) and Chang and Kemp (2002), using site-
directed mutagenesis, have further substantiated that the four putative Fru-2,6-
P2 binding sites do in fact bind Fru-2,6-P2.
Kemp and Gunasekera (2002) have built upon the ideas established by
Poorman et al., using the same gene-duplication approach to identify the origins
of the ATP and citrate allosteric sites in mouse PFK (mPFK).  From the same
sequence comparisons used by Poorman et al., it was proposed that the bacterial
MgADP/PEP binding sites evolved to become the MgATP inhibitory sites and
citrate inhibitory sites in mPFK.  Based upon the sequence alignments of the N
and C-termini with the sequences from EcPFK and BsPFK, residues from mPFK
were selected as candidates (R47, R429 and R433) for site-directed mutagenesis
to determine if inhibition by MgATP or citrate was diminished.  Kemp and
Gunasekera constructed three mutant proteins, R47L (N-terminus half;
analogous to R25 in EcPFK and BsPFK), R429A and R433A (C-terminus half;
analogous to R21 and R25 in EcPFK and BsPFK), and characterized their
allosteric properties.  The specific activities of all three mutant proteins were
found to be virtually identical to wild-type as well their binding affinities for
Fru-6-P and MgATP.  The differences between the mutant proteins arose when
comparing their allosteric properties.  For the R47L mutant protein, MgATP was
found to inhibit the enzyme while citrate was not, while the R429A and R433
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mutant proteins were inhibited by citrate but not MgATP.  Thus, from these
results, Kemp and Gunasekera (2002) have proposed that the ancestral
(bacterial) MgADP/PEP allosteric sites have evolved to become either a citrate
inhibitory site (R47) or a MgATP inhibitory site (R429 and R433) in mammalian
PFK.
Figure 1-13 summarizes the results of Kemp and Gunasekera, Poorman et
al. (1984), Li et al. (1999) and Change and Kemp (2002) in a schematic of how the
active and allosteric sites of the bacterial PFK enzyme evolved into the active
and allosteric sites of the mammalian enzyme. Interestingly, the new inhibitory
sites found in mPFK (citrate and MgATP) seem to have evolved from the
duplicated MgADP/PEP allosteric sites, whereas the new activating sites (Fru-
2,6-P2 and MgADP or MgAMP) appear to have evolved from the duplicated
active sites.  Thus, by simply using a sequence alignment and simple
mutagenesis, putative active sites and allosteric sites have been identified for the
mammalian enzyme in the absence of any kind of structural data.
The results summarized here are representative examples of how the
field of allosterism has benefited from the approaches taken by numerous labs
and how each result provides additional information into answering the enigma
of how allosterism “works”.  By using structural data, amino acid sequence
comparisons, site-directed mutagenesis and hybrid enzymes, specific residues
and regions of proteins have either been suggested or shown to be involved in
the transmission of an allosteric signal.  Thus, by using a combination of these
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FIGURE 1-13  A model for the evolution of a monomer of mammalian PFK from
a dimer of a bacterial predecessor (adapted from Kemp and Gunasekera (2002)).
For the mammalian form, both inhibitory sites (citrate and MgATP) seem to
have evolved from the MgADP/PEP allosteric sites, while the activating sites
(Fru-2,6-P2 and MgAMP or MgADP) appear to have evolved from the
duplicated substrate binding/active sites.
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approaches, we hope to elucidate the mechanism of allosteric regulation
specifically in BsPFK by measuring the contributions of each of the 10 unique
allosteric interactions found in the enzyme to the inhibition response.  In turn,
we will be able to better understand the basis for how PEP inhibits PFK activity
and we will also be able to address the roles each interaction plays in
transmitting the allosteric signal between the eight binding sites.
Present study
The main goal of our investigation is to gain a better understanding of
how allosteric regulation occurs, and more specifically how inhibition by PEP
occurs in BsPFK.  The common link among all four data chapters (III, IV, V and
VI) is the use of hybrid tetramers to take a divide-and-conquer approach in
assessing the role of each interaction individually in order to address how they
ultimately combine in the tetramer.
Chapter II provides a detailed explanation of most the materials and
methods that were used to form, isolate, identify and characterize, utilizing
linked-function analysis, all the different hybrid enzymes used in our
investigation (1:3 hybrids and 2:2 hybrids).  Chapter III explains the strategy as
well as the trials and tribulations behind individually isolating two of the four
unique heterotropic interactions (the 30 Å and 32 Å heterotropic interactions)
via the 1:3 hybrids, and concludes with the results from the allosteric
characterizations of the 30 Å and 32 Å heterotropic interactions to assess their
roles in the inhibition process.  Chapter IV is an extension of Chapter III as it
discusses the contributions of all four heterotropic interactions to the inhibition
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process, and also addresses how their contributions compare not only to one
another, but to the overall inhibition measured in the native tetramer and a
wild-type variant that lacks PEP cooperativity.
With four of the ten unique allosteric interactions characterized, the next
step was to determine the roles each of the six homotropic interactions play in
the inhibition process, and we addressed that question via the 2:2 hybrids.
Thus, Chapter V discusses how nine different 2:2 hybrids were formed, isolated
and identified using the same mutant proteins previously used in Chapters III
and IV.  Furthermore, the strategy of isolating and identifying the 2:2 hybrids
with the use of strategically placed charge tag mutations on the surface of the
protein is also described.  Chapter VI discusses the allosteric characterizations of
the nine 2:2 hybrids and also talks about the characterizations of the six unique
homotropic interactions as well as how the allosteric interactions combine
uniquely in each of the nine 2:2 hybrids.  Finally, Chapter VII summarizes all of
the results discussed in the previous chapters and elaborates upon possible
future work.
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CHAPTER II
GENERAL METHODS
Materials and methods
Materials. All chemical reagents used in buffers, protein purifications
and enzymatic assays were of analytical grade, purchased from either Fisher or
Sigma.  The Matrex Gel Blue A-agarose resin for was purchased from Amicon
Corporation.  Creatine kinase and the coupling enzymes (aldolase,
triosephosphate isomerase and glycerol-3-phosphate dehydrogenase in
ammonium sulfate suspensions) were purchased from Roche.  The coupling
enzymes were dialyzed against buffer containing 50 mM MOPS-KOH, 100 mM
KCl, 5 mM MgCl2 and 0.1 mM EDTA at pH 7.0 before use.  Creatine phosphate,
NADH, and the sodium salts of Fru-6-P and PEP were purchased from Sigma.
The sodium salt of ATP was obtained from either Sigma or Roche.  Site-directed
mutagenesis was performed using the Altered Sites In Vitro Mutagenesis System
which was purchased from Promega and included the pALTER mutagenesis
vector, the pALTER control vector, and ampicillin repair and control
oligonucleotides.  All other oligonucleotides were synthesized using an Applied
Biosystems 392 DNA/RNA synthesizer at the Gene Technologies Laboratory at
the Institute of Developmental and Molecular Biology at Texas A&M University.
DNA modifying enzymes (T4 polynucleotide kinase, T4 DNA polymerase and
T4 ligase) were purchased from Promega.  The plasmid used for all mutagenesis
reactions, pGDR26 (Riley-Lovingshimer et al., 2001), was derived from
pBR322/Bs-pfk (French et al., 1987), a plasmid obtained from Dr. Simon Chang
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(Louisiana State University).  A glycerol stock of E. coli DF1020 cells, which were
used to express both wild-type and mutant forms of BsPFK, was obtained from
Dr. Robert Kemp (Chicago Medical School).  Deionized distilled water was used
throughout.
Nomenclature.  In order to differentiate among all the different BsPFK
hybrid species created for this investigation, several notations have been
introduced for clarification.  The first notation is used when identifying the
different BsPFK hybrid enzymes, and refers to the number of subunits each
parental enzyme contributes to the hybrid enzyme.  For example, to isolate one
of the four possible heterotropic interactions, a 1:3 hybrid is isolated.  The 1:3
notation refers to 1 wild-type subunit and 3 mutant subunits.  Thus, a 2:2 hybrid
is 2 wild-type subunits and 2 mutant subunits.
The second notation, introduced by Fenton and Reinhart (2002), refers to
the number of native binding sites a hybrid enzyme contains.  Using the same
example as above, the 1:3 hybrid can also be designated as a 1|1 hybrid where
the left side of the slash refers to the number of native active sites and the right
side of the slash refers to the number of native allosteric sites.  Thus, wild-type
BsPFK would be designated 4|4 and a mutant form of BsPFK where both the
active sites and allosteric sites have been mutated to discourage ligand binding
would be designated 0|0.  Control hybrids or hybrids that contain only one
native active and no native allosteric sites have also been made to assess the
influence upon the observed allosteric effect in a 1:3 hybrid from the mutated
allosteric sites, and its notation would be 1|0.
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The last notation introduced by Ortigosa et al. (2003), refers to the sides of
the binding sites mutated in the mutant parental protein used in making the
BsPFK hybrids.  As Chapter I introduced, all of the binding sites found in BsPFK
are located along the dimer-dimer interfaces of the protein, thus two subunits
are required to constitute a full binding site.  To orientate ourselves within the
structure, we have designated the two sides of the active site as the a-side (R162
and R243) and the b-side (R252), while the allosteric site has been divided into
the a-side (R211,K213) and the b-side (R25).  The amino acids in parentheses are
the residues found on those respective sides of the interface, and are the
residues mutated for this study.  Thus, in order isolate the 30 Å heterotropic
interaction via it’s respective 1:3 hybrid, the mutant parental protein (0:4 or 0|0)
must have the b-side of the active site mutated and the b-side of the allosteric
site mutated generating the [b,b] mutant parental protein.  Moreover, to isolate
the 32 Å heterotropic interaction, the [b,a] mutant parental protein is required.
Site-directed mutagenesis.  Mutagenesis was performed following the
protocol for the Altered Sites in Vitro Mutagenesis System as provided by
Promega.  Single stranded DNA (ssDNA) of pGDR26 was made using the
helper phage R408 (Hutchinson et al., 1978) and isolated.  pGDR26 is a plasmid
previously constructed containing the BsPFK gene ligated into the pALTER
mutagenesis vector (Riley-Lovingshimer et al., 2001).
Prior to performing the mutagenesis, phosphorylation of the 5’-end of
each oligonucleotide (both the mutant and ampicillin repair oligonucleotides)
was performed using T4 polynucleotide kinase to increase the number of
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mutants obtained, and subsequently annealed to the previously isolated ssDNA
from pGDR26.  A five to one ratio of mutant oligonucleotide to ampicillin repair
oligonucleotide was used to increase the chance of creating a plasmid containing
both the ampicillin repair oligonucleotide and the mutant oligonucleotide(s).
Furthermore, a five to one ratio of ampicillin oligonucleotide to ssDNA was
used to increase the probability of the oligonucleotide(s) annealing to the DNA.
At this point, as long as oligonucleotide overlap was not a problem, all the
desired mutant oligonucleotides were annealed at once.  The oligonucleotides
were extended and ligated using T4 DNA polymerase and T4 DNA ligase
respectively.  The resulting plasmids were transformed into competent BMH 71-
18 mutS cells (thi, supE, ∆(lac-proAB), [mutS::Tn10] [F’, proA-B-, lacIqZ∆M15])
(Kramer et al., 1984), which are deficient in DNA mismatch repair functions
(Zell et al., 1987), using the calcium chloride method (Cohen et al., 1972).  The
entire transformation reaction was then plated on a Luria-Bertani plate (10 g/L
tryptone, 5 g/L yeast extract and 10 g/L sodium chloride) containing ampicillin
(LB Amp) at a concentration of 100 mg/mL and incubated overnight at 37°C.
Ampicillin resistant plasmids were transformed into competent XL1-Blue
cells, (endA1, recA1, gyrA96, thi-1, hsdR17, relA1, supE44, lac[F’, proA-B-,
lacIqZ∆M15, Tn10 (Tetr)]) (Bullock et al., 1987) and the resulting ampicillin
resistant plasmids sequenced.  The entire BsPFK gene was sequenced to confirm
the desired mutations by the Sanger dideoxy method using an Applied
Biosystems sequencer and dye-labeled terminators (Sanger et al., 1977).
Wild-type BsPFK and all of the mutant proteins were expressed from the
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pALTER mutagenesis vector that was transformed into competent DF1020 cells
[a recA derivative of DF1010: pro-82, ∆pfkB201, recA56, ∆(rha-pfkA)200, endA1,
hdsR17, supE44], a PFK-1 and PFK-2 deficient strain (Daldal, 1983).
Enzymatic activity assays.  The activity of the various BsPFK enzyme
species were measured by coupling the production of fructose-1,6-bisphosphate
to the oxidation of NADH (Babul, 1978; Kolartz and Buc, 1982), and monitoring
the corresponding decrease in absorbance at 340 nm.  The entire coupled assay
(enzymes and the intermediates necessary), as well as the MgATP regeneration
system, is shown in Fig. 2-1.  Assays were carried out in either a 1.0 mL or 0.6
mL reaction volume of 50 mM MES-KOH (pH 6.0), 50 mM MOPS-KOH (pH 7.0)
or 50 mM EPPS-KOH (pH 8.0) buffer containing 100 mM KCl, 5 mM MgCl2, 0.1
mM EDTA, 2 mM DTT, 0.2 mM NADH, 250 mg of aldolase, 50 mg of glycerol-3-
phosphate dehydrogenase and 5 mg of triosephosphate isomerase adjusted to
the pH of choice.  MgATP was held constant at 3 mM and the concentrations of
Fru-6-P and PEP were adjusted as indicated.  Assays were initiated with 1/100th
of the reaction volume (10 mL or 6 mL) of appropriately diluted BsPFK so that the
amount of activity would not result in a change of absorbance greater than 0.02
absorbance units/minute.  For experiments involving the analysis of the effect of
PEP on the binding affinity of Fru-6-P or vice versa, creatine kinase and creatine
phosphate were added to regenerate MgATP from MgADP to prevent the
accumulation of MgADP (shown in Fig. 2-1). All activity measurements were
performed on Beckman Series 600 spectrophotometers using a linear regression
calculation to convert the change in absorbance at 340 nm to enzyme activity.
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FIGURE 2-1  The coupling enzyme system used to assay BsPFK activity.  The
production of fructose-1,6-bisphosphate by phosphofructokinase is coupled via
three enzymes (aldolase, triose phosphate isomerase and glycerol-3-phosphate
dehydrogenase) to the oxidation of NADH to NAD+, which is monitored
spectroscopically at 340 nm.  The enzymes involved in this process are in italics
and the regeneration system used to regenerate ATP and avoid accumulation of
ADP during the assay is shown in the gray box.
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One unit (U) of activity is defined as the amount of enzyme needed to produce 1
µmol of fructose 1,6-bisphosphate per minute.
Protein purification.  Purification of wild-type and mutant BsPFK
proteins was performed as described by Valdez et al. (1989).  DF1020 cells
containing the plasmid of interest were grown to stationary phase
(approximately 20-24 hours) in LB broth containing 100 mg/mL ampicillin at
37°C.  Cells were harvested by centrifugation at 4,000 RPM using a Beckman
Model J-6B centrifuge.  Pelleted cells were either stored at 0°C for later use or
stored at –80°C until the cells were frozen.  The frozen cells were resuspended in
approximately 30-40 mL of cell lysis buffer (50 mM Tris-HCl pH 7.5, 1 mM DTT
and 1 mM EDTA) and set on ice.  Cells were lysed by sonication using a Sonic
Dismembrator Model 550 (Fisher Scientific).  Fifteen-second pulses were used
followed by a one-minute rest period to allow the cells to cool for a total time of
at least 40 minutes.  The crude lysate was clarified by centrifugation at 12,000
RPM for 1 hour in a Beckman J2-21 centrifuge equipped with a JA-20 rotor.  The
supernatant containing BsPFK and other soluble E. coli proteins was heated for
10-12 minutes at 70°C and then set on ice for 10-15 minutes to cool.  Since BsPFK
is from the thermophilic bacterium B. stearothermophilus, it survived the high
temperature, while most of the host E. coli proteins denatured.  The cooled
sample was centrifuged as before, and the supernatant (~30 mL) applied to a 10-
15 mL Matrex Blue-A agarose column previously equilibrated with wash buffer
(50 mM Tris-HCl pH 7.5, 0.1 M NaCl, 1 mM DTT and 1 mM EDTA).  After
loading the supernatant, the column was washed with 5-10 bed volumes of
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wash buffer.  BsPFK was eluted using a linear salt gradient (0.1-1.5 M NaCl) and
3 mL fractions collected.  Depending upon whether the protein being purified
was wild-type BsPFK or a mutant, the protein eluted from the column between
0.2 M NaCl and 1 M NaCl.  Variation in the elution was due to the introduction
of mutations at the actives site of the protein and was not problematic as most of
the contaminating proteins were either denatured during the heat step or were
washed through the column during the load and wash steps.  The absorbance of
the fractions was monitored at 280 nm and the fractions assayed for BsPFK
activity.  Figure 2-2 shows a typical elution profile for a mutant BsPFK protein
from the Matrex Blue-A agarose column.  Fractions containing the greatest
amount of BsPFK activity were pooled together and concentrated using an
Amicon ultra-filtration apparatus equipped with a YM10 10,000 molecular
weight cut-off membrane filter.  Concentrated enzyme (7-13 mL typically) was
dialyzed into MOPS storage buffer (50 mM MOPS-KOH pH 7.0, 5 mM MgCl2,
100 mM KCl and 0.1 mM EDTA) and stored at 4°C.
Assessment of BsPFK purity was performed via SDS-PAGE analysis
(Laemmli, 1970) using a 4% polyacrylamide stacking gel and a 12%
polyacrylamide resolving gel.  Prior to electrophoresis, 5-10 mL from each
purification step and 1-2 mL of concentrated purified protein was suspended in a
sample loading buffer that contained 12.5 mM Tris-HCl, 10% SDS, 50% glycerol,
2 mM DTT and bromphenol blue.  All samples were heated at 100°C for 3-5
minutes to denature the protein(s) and loaded into their respective wells.
Electrophoresis was performed using a Mini-PROTEAN 3 Cell system (BioRad)
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FIGURE 2-2  Elution profile of a mutant BsPFK (R252A/R25A/K90E/K91E)
from the Matrex Blue-A column.  Absorbance at 280 nm (l) and activity in
U/mL (o) are plotted versus salt concentration for each 3 mL fraction.  The
elution of the protein was begun at 0.1 M NaCl (wash buffer contains 0.1 M
NaCl) and activity measurements were performed at 20 mM Fru-6-P because of
the R252A mutation in the active site.
60
set at a constant voltage of 220 V for the entire run.  The gel was stained for
approximately 1 hour using a solution of 40% methanol, 10% glacial acetic acid
and 0.1% Coomassie brilliant blue, and destained for 2-3 hours using a solution
of 40% methanol and 10% glacial acetic acid.  Gels were documented using
either a Polaroid Photo-Documentation Camera (Fisher) or an AlphaImager 950
Documentation System.  A single band on the gel defined a “pure” sample, and
an example of a typical SDS-PAGE gel showing the individual steps of
purification is shown in Fig. 2-3.
Protein concentration was determined by using the bicinchoninic acid
protein assay (Smith et al., 1985) or by using e280 = 18910 M-1 cm-1 (Riley-
Lovingshimer et al., 2001) where the extinction coefficient was determined using
the method described by Pace et al. (1995).  The concentrations calculated with
either method were always in agreement.  Moreover, whenever pure BsPFK
protein was being used, the concentration of protein was always determined by
the absorbance at 280 nm.  Table 2-1 shows a typical purification for wild-type
BsPFK.
Hybrid formation, isolation and identification via monomer exchange.
Kimmel and Reinhart (2001) devised a method for dissociating BsPFK tetramers
into their individual subunits by modifying a method described previously by
Deville-Bonne et al. (1989) and later by Le Bras et al. (1995) for dissociating
EcPFK tetramers into their individual subunits.  The method involves
incubating the two parental BsPFK proteins of interest simultaneously (usually
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FIGURE 2-3  12% SDS-polyacrylamide gel of a typical BsPFK purification.
Samples were taken at each step of the purification process and the lanes
correspond to the following:  Lane 1 shows the wild-type BsPFK standard
previously purified (MW 34,000).  Lane 2 shows a sample of the supernatant
after the first centrifugation step (crude lysate).  Lane 3 shows a sample of the
supernatant after the second centrifugation step (post-heat step).  Lane 4 shows
a sample of the flow-through collected when loading the lane 3 sample.  Lane 5
shows a sample of the wash collected prior to elution.  Lane 6 shows the purified
sample of BsPFK.
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TABLE 2-1  Purification table for wild-type BsPFK
Volume
(mL)
Activity
(U/mL)
Total
Units
[Protein]
(mg/mL)
Total
Protein
Specific
Activity
(U/mg)
% Yield
1a 24.0 460 11000 18.5 444 24.8 100
2b 21.4 420 9000 9.2 197 45.4 81.3
3c 10.0 850 8500 7.6 76 111.7 77.1
aSupernatant from cell lysate.
bSupernatant after heat step.
cConcentrated protein.
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wild-type BsPFK and a mutant) in 2 M KSCN and 20 mM Tris-HCl (pH8.5) for
30 minutes at room temperature to facilitate breakdown of the parental
tetramers into their individual subunits.  A final protein concentration of 2
mg/mL was used with a total volume between 7-10 mL.  Furthermore, the
relative ratio of the two parental proteins was varied depending upon the
desired hybrid.  For instance, if a 1:3 hybrid was desired, a greater amount of
mutant protein was used relative to wild-type, whereas for isolating a 2:2
hybrid, equal amounts of the two parental proteins was used.
In order to separate the hybrid species, we needed a way to differentiate
chromatographically between the two types of subunits; thus, a surface “charge
tag” was added to one of the proteins to facilitate this separation via anion
exchange chromatography.  The surface “charge tag” is simply a mutation of
two charged residues on the surface of the protein (or one charged and one
neutral) to the opposite charge, e.g. two lysines at positions 90 and 91 on the
surface of the protein mutated to glutamates.  In all cases, as Chapter V
describes, these charge changes on the surface of the protein have no dramatic
effect upon the allosteric properties of the enzymes.
After incubating the two proteins in KSCN, the hybrid mixture was
dialyzed at room temperature into 20 mM Tris-HCl (pH 8.5) for 4 1/2 hours
replacing the buffer every 90 minutes.  Next, the protein mixture was passed
through a 0.22 mM membrane filter and loaded onto a Pharmacia Mono-Q HR
10/10 FPLC anion-exchange column previously equilibrated with 20 mM Tris-
HCl (pH 8.5).  After washing the column with 3-5 bed volumes, the hybrid
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proteins were eluted with a linear NaCl gradient (1.77 mM NaCl/mL) and 1.5
mL fractions collected.
The absorbance of the fractions was monitored at 280 nm and the
fractions assayed for activity.  Figure 2-4 shows a typical elution profile for
hybrids between wild-type and the K90E/K91E charge tag protein from the
Mono-Q HR 10/10 column.  Six peaks are observed in Fig. 2-4 but, depending
upon the location of the charge tag mutation, one can observe between 5 to 7
peaks.  This difference is due to the variable separation of the three 2:2 hybrids
(isomers) that form when monomers recombine.
To identify the different hybrid species, the fractions exhibiting the
greatest absorbance at 280 nm were pooled together and a 10-15 mL sample was
suspended into a solution containing 12.5 mM Tris-HCl, 50% glycerol, 2 mM
DTT and bromphenol blue.  Next, 20-25 mL of each sample was loaded onto a
native PAGE gel consisting of a 4% polyacrylamide stacking gel and 10%
polyacrylamide resolving gel (Laemmli, 1970), and run for 3 hours using a
constant voltage of 100 V.  The electrophoresis system was also set on ice during
the run to prohibit any dissociation of the hybrid tetramers. After
electrophoresis, the gel was stained in a solution containing 40% methanol, 10%
glacial acetic acid and 0.1% Coomassie brilliant blue for approximately 1 hour
prior to destaining and analysis.  Figure 2-5 shows a typical native-PAGE gel
used to identify the various hybrids isolated.  The isolated hybrids were then
stored at 4°C to prevent re-hybridization.
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FIGURE 2-4  Elution profile of hybrids made via monomer exchange from the
Mono-Q anion exchange column.  Equal amounts of wild-type BsPFK and the
K90E/K91E mutant were mixed together with 2 M KSCN and incubated for 30
minutes.  The proteins were dialyzed and loaded onto the Mono-Q column.  A
linear salt gradient was used to elute the proteins (1.77 mM NaCl/mL) and 1.5
mL fractions collected.  Since the K90E/K91E mutant has more net negative
charge than wild-type BsPFK at pH 8.5, the K90E/K91E mutant binds to the
column longer.  Absorbance at 280 nm (l) is plotted versus fraction number,
and the dashed line (---) indicates the salt gradient used to elute the hybrid
proteins from the column.  Six peaks are observed and each peak was identified
as the following: Peak 1: Wild-type BsPFK (4:0).  Peak 2: The 3:1 hybrid.  Peaks 3
and 4: The 2:2 hybrids.  Peak 5: The 1:3 hybrid.  Peak 6: The K90E/K91E mutant
(0:4).
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                                      1        2        3        4         5         6         7
FIGURE 2-5  10% native polyacrylamide gel identifying the hybrids obtained via
monomer exchange and isolated from the Mono-Q column.  Samples were taken
from each of the six peaks (Fig. 2-3) and the lanes correspond to the following:
Lane 1 shows the hybrid mix prior to separation.  Lane 2 is empty.  Lane 3
shows peak 1 corresponding to wild-type BsPFK (4:0).  Lane 4 shows peak 2
corresponding to the 3:1 hybrid.  Lane 5 shows peak 4 corresponding to one of
the 2:2 hybrids.  Lane 6 shows peak 5 corresponding to the 1:3 hybrid.  Lane 7
shows peak 6 corresponding to the K90E/K91E mutant (0:4).
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Data analysis.  All data analysis was performed on either a Power
Macintosh 7100/80AV or a Macintosh G4 using Kaleidagraph 3.08 or 3.51
(Synergy Software).  Initial velocity activity as a function of Fru-6-P
concentration was fit to the Hill equation (Hill, 1910):
  
† 
v = Vmax[A]
n H
K1 /2n H + [A]n H
(2-1)
where v equals the steady-state rate of turnover, Vmax represents the maximal
specific activity, [A] equals the concentration of Fru-6-P, K1/2 is the concentration
of Fru-6-P resulting in half maximal specific activity, and nH is the Hill
coefficient.  Furthermore, all the above terms refer to the kinetic parameters
obtained for the high affinity (native) binding sites.
Data obtained from hybrid enzymes, which exhibited two distinct
affinities for Fru-6-P, were fit to either Eq. 2-2 or Eq. 2-3 depending upon the
necessity of the Hill coefficient (nH) to improve the fit:
  
† 
v = Vmax[A]
K1 /2 + [A]
Ê 
Ë 
Á 
ˆ 
¯ 
˜ +
Vmax' [A]
K1 /2' + [A]
Ê 
Ë 
Á 
ˆ 
¯ 
˜ 
È 
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Í 
˘ 
˚ 
˙ (2-2)
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v = Vmax[A]
n H
K1/2
n H + [A]n H
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Vmax' [A]n H
'
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n H' + [A]n H'
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Á 
ˆ 
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(2-3)
where   
† 
Vmax' ,   
† 
K1/2'  and   
† 
nH'  refer to the maximal specific activity, apparent
dissociation parameter and the Hill coefficient for the low affinity (mutated)
binding site population, respectively.
The variation in   
† 
K1 /2  as a function of PEP concentration was fit to the
following equation:
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† 
K1 /2 = Kiao
Kiyo + [Y]
Kiyo + Qay[Y]
Ê 
Ë 
Á Á 
ˆ 
¯ 
˜ ˜ (2-4)
where   
† 
K1 /2  is the concentration of Fru-6-P resulting in half-maximal activity for
the high affinity site obtained from either Eqs. 2-1, 2-2 or 2-3.  To be consistent
with previously adopted notation (Cleland, 1963a, 1963b; Tlapak-Simmons and
Reinhart, 1994, 1998; Johnson and Reinhart, 1994, 1997), A refers to the substrate
Fru-6-P and Y represents the allosteric inhibitor PEP.  Furthermore,   
† 
Kiao  is the
apparent dissociation constant for the substrate Fru-6-P in the absence of PEP,
  
† 
Kiyo  is the dissociation constant for PEP in the absence of Fru-6-P, and   
† 
Qay  is the
coupling parameter describing the extent to which the binding of PEP affects the
binding of Fru-6-P and vice versa as defined by the following equation:
  
† 
Kiao
Kia•
=
Kiyo
Kiy•
= Qay (2-5)
where   
† 
Kia•  and   
† 
Kiy•  represent the dissociation constants for Fru-6-P and PEP,
respectively, in the saturating presence of the other ligand.  By resolving both
the terms   
† 
Kiyo  and   
† 
Qay , Eq. 2-4 allows the separate quantification of both PEP
binding affinity and its allosteric effect once bound, respectively.
The coupling parameter,   
† 
Qay , describes both the nature and magnitude of
the effect the allosteric ligand has upon the binding of the substrate.  If   
† 
Qay  < 1
the allosteric ligand is an inhibitor, and if   
† 
Qay  > 1 the allosteric ligand is an
activator.  If   
† 
Qay  = 1 then the allosteric ligand has no effect on the binding of
substrate.  In the case of the inhibitor PEP, the smaller the value of   
† 
Qay , the
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greater the extent of inhibition by PEP upon substrate binding.  Figure 2-6
shows an example of the inhibition of wild-type BsPFK by PEP at pH 8.0 and
25°C, where   
† 
Qay  is the ratio of the two plateaus.
The coupling parameter can also be used to calculate the free energy
associated with the interaction between substrate and allosteric effector,
provided the rapid equilibrium assumption is valid as it is for BsPFK (Tlapak-
Simmons and Reinhart, 1998) using the following equation:
  
† 
DGay = -RTln Qay( ) (2-6)
where ∆Gay is the coupling free energy of inhibition by PEP, R is the gas constant
which is equivalent to 1.987 x 10-3 kcal/degûmol, and T is absolute temperature
in Kelvin.  Allosteric inhibition is defined by a ∆Gay value greater than zero,
while allosteric activation results in a ∆Gay value less than zero.  When no
coupling between the ligands occurs, ∆Gay = 0.
When using a single substrate, single modifier model, the coupling
measured,   
† 
Qay , is a composite of all the possible allosteric interactions (both
heterotropic and homotropic) that may exist regardless of the number of active
and allosteric sites.  Thus, for the native BsPFK tetramer, individual
quantification of each of the ten unique allosteric interactions is impossible.
However, if the number of functional binding sites is reduced, as it is in a 2:2
hybrid, we can assess the individual allosteric interactions directly using the
following equation (Reinhart, 1988):
  
† 
Q = Qay1 ⋅ Qay2 ⋅
Qyy /a
Qyy
È 
Î 
Í 
Í 
˘ 
˚ 
˙ 
˙ 
⋅
Qaa / yy
Qaa
È 
Î 
Í 
˘ 
˚ 
˙ 
1 /2
(2-7)
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FIGURE 2-6  The apparent dissociation constant measured for Fru-6-P versus
PEP concentration for wild-type BsPFK at pH 8.0, 25°C and [MgATP] = 3 mM.
The K1/2 values were obtained from individual Fru-6-P saturation profiles (data
fit to Eq. 2-1) at varying concentrations of PEP.  The error for each of the points
is plotted, but the error is smaller than the points so they cannot be seen.  The
solid line represents the best fit to Eq. 2-4.
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where Q is the overall coupling measured for the 2:2 hybrid,   
† 
Qay1  and   
† 
Qay2  are
the couplings for the two heterotropic interactions where the values of   
† 
Qay1  and
  
† 
Qay2  are obtained from the characterization of their respective 1:3 hybrids
(Ortigosa et al. (2003)).    
† 
Qyy  and   
† 
Qaa  are the couplings for the homotropic
interactions between allosteric sites and active sites respectively.  Figure 2-7
shows schematically these four individual allosteric interactions in both a
symmetrical dimer and a 2:2 hybrid (Reinhart, 1988).    
† 
Qyy/a  is the coupling for
the homotropic interaction between allosteric sites with a single equivalent of
Fru-6-P bound, and   
† 
Qaa/yy  is the coupling for the homotropic interaction
between active sites with both equivalents of PEP bound.  Thus, Eq. 2-7 states
that besides the individual heterotropic interactions (  
† 
Qay1  and   
† 
Qay2) contributing
to the apparent coupling for the 2:2 hybrid (Q), the homotropic interactions also
contribute to the magnitude of the apparent coupling only when the homotropic
couplings change in response to the binding of the heterotropic ligand.
Unfortunately,   
† 
Qyy/a  cannot be determined explicitly, thus we need to
consider the two extremes that are possible upon binding each equivalent of
Fru-6-P to the two native active sites found within the 2:2 hybrid.  First, we can
imagine that the entire change in the homotropic interactions is realized upon
the first binding event (i.e.   
† 
Qyy ≠ Qyy /a = Qyy /aa ) or second, that both equivalents
are required to bind before any change in the homotropic interactions is
observed (i.e.   
† 
Qyy = Qyy /a ≠ Qyy /aa ).  However, a third case can also be imagined
as an “average” between these two extremes.  This means that the binding of
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Qay1 =
Qay2 =
Qaa =
Qyy =
FIGURE 2-7  A schematic depicting the pair-wise allosteric interactions possible
in either a symmetrical dimer (left) or a 2:2 hybrid (right).  The active sites
consist of the triangle and half-hexagon, and the allosteric sites consist of the
rectangle and semi-circle.  For the 2:2 hybrid, to indicate the presence of a
mutation, a closed shape is used, while the native, non-substituted binding sites
remain open.  There are two copies of two unique heterotropic interactions
shown in red (  
† 
Qay1) and green (  
† 
Qay2), and two homotropic interactions, one
between active sites shown in purple (  
† 
Qaa) and one between allosteric sites
shown in dark green (  
† 
Qyy ).  The coupling constants correspond those described
in the text.
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each equivalent of Fru-6-P contributes equally to the observed allosteric effect,
and this case is how we will be considering the allosteric behavior of the 2:2
hybrids (Reinhart, 1988).  This would result in:
  
† 
Qyy /a
Qyy
È 
Î 
Í 
Í 
˘ 
˚ 
˙ 
˙ 
 2
=
Qyy /aa
Qyy
È 
Î 
Í 
Í 
˘ 
˚ 
˙ 
˙ 
(2-8)
Thus, Eq. 2-7 becomes the following:
  
† 
Q = Qay1 ⋅ Qay2 ⋅
Qyy /aa
Qyy
È 
Î 
Í 
Í 
˘ 
˚ 
˙ 
˙ 
1 /2
⋅
Qaa / yy
Qaa
È 
Î 
Í 
˘ 
˚ 
˙ 
1 /2
(2-9)
where   
† 
Qyy/aa  is the coupling for the homotropic interaction between allosteric
sites with both equivalents of Fru-6-P bound.
The coupling for the homotropic interaction between two bound ligands
of A can be measured directly when [Y] = 0 using the following equation
(Reinhart, 1988):
  
† 
Qaa =
nH
2 - nH
È 
Î 
Í 
˘ 
˚ 
˙ 
 2
(2-10)
where   
† 
nH is the Hill number obtained from the individual Fru-6-P saturation
profile used in determining the K1/2 value for the high affinity active sites when
[Y] = 0.  One may use the same equation to also obtain   
† 
Qaa/yy  if   
† 
nH is determined
when [Y] is saturating.  Moreover,   
† 
Qyy  and   
† 
Qyy /aa  may also be determined using
Eq. 2-10 by measuring the Hill number for PEP binding using activity assays
(see Chapter VI), and extrapolating to [A] = 0 or [A] = ∞, respectively.  It should
be noted however, that an apparent positive cooperativity results from the
partial saturation of the heterotropic ligand that does not depend on true
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homotropic interactions (Reinhart, 1988).  Consequently, the determination of
the values   
† 
Qaa / yy and   
† 
Qyy /aa  requires the extrapolation to true saturation of the
heterotropic ligand (see Chapter VI).
Eq. 2-9 can simplify to Eq. 2-11 when considering either of the following
two cases: (1) when all the homotropic couplings are equal to 1 or (2) when there
is no net change in the Hill number upon saturation of the opposing ligand:
  
† 
Q = Qay1 ⋅ Qay2 (2-11)
and with using Eq. 2-6, Eq. 2-11 becomes:
  
† 
DG = DGay1 + DGay2 (2-12)
where ∆G equals the coupling free energy for the 2:2 hybrid, and ∆Gay1 and ∆Gay2
represent the coupling free energies for the individual heterotropic interactions
respectively.
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CHAPTER III
ISOLATION AND CHARACTERIZATION OF TWO OF THE FOUR
POSSIBLE HETEROTROPIC INTERACTIONS FOUND WITHIN
PHOSPHOFRUCTOKINASE FROM Bacillus stearothermophilus
Introduction
Over several decades, the mechanism by which allosteric regulation
occurs in oligomeric proteins has long been an issue of debate and many models
proposed.  The most popular models, the concerted (MWC) model (Monod et
al., 1965)  and the sequential (KNF) model (Koshland et al., 1966), consider an
enzyme (or the individual subunits of an enzyme) existing in two
conformational states, an active state (R-state, “relaxed”) or an inactive state (T-
state, “tense”), with the substrate and the allosteric effector(s) altering the
equilibrium between these two states.
Applying these two models to a homotetramer containing one active site
and one allosteric site per subunit, several presumptions can be made about the
first binding equivalent of an allosteric effector, in our case an inhibitor, to the
observed allosteric response in the subunits of the enzyme.  The concerted
model would predict that all four subunits would undergo the allosteric
transition upon binding, while the sequential model would predict that only the
subunit that bound the inhibitor would undergo the allosteric transition (Fig. 3-
1).  Due to these contrasting predictions, isolating the first binding event would
differentiate between the validity of these models or their insufficiencies in
describing an observed allosteric effect.
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Sequential ModelConcerted Model
Free Enzyme
INHIBITOR
SUBSTRATE
Allosteric Site
Active Site
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affected
FIGURE 3-1  A two-dimensional schematic of the concerted and sequential models representing
contrasting predictions regarding the influence of the binding of a single allosteric ligand upon
the binding of the substrate at a single active site.  The allosteric site is represented by an open
square and an active site is represented by an open circle.  In the concerted model, binding of the
inhibitor to any of the four allosteric sites influences the binding at the active site to the same
degree as is evident by the change in the conformation of all four subunits.  In the sequential
model, binding the inhibitor to only one site influences the binding of the substrate at only the
active site which is contained within the same subunit that bound the inhibitor.  Again, this
effect is seen as a change in the conformation of the subunits, however this time only one of the
four subunits change conformation.
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However, before considering only these two models, a more systematic
approach in determining the mechanism of allosteric regulation needs to be
considered in which the enzyme is not limited to two conformational states.
Instead, one needs to consider the enzyme as a network of communication
pathways between binding sites in which each binding site affects one another
in a reciprocal manner.  This idea of linkage was first proposed by Wyman (1964
and 1967), and later modified by Weber (1972 and 1975) to consider the
observed allosteric effect in free energy terms.  Reinhart (1983 and 1988) then
applied these ideas to predict the observed allosteric response in both a single
substrate-single modifier system (monomer) and also in a symmetrical dimer.
Applying this linkage approach to the aforementioned homotetramer, the
potential for four unique allosteric heterotropic interactions exist between an
individual allosteric site and each of the four active sites (Fig. 3-2).  Upon
binding one equivalent of inhibitor, one can envision its allosteric effect
traversing throughout the enzyme to each of the four active sites via these four
communication pathways and vice versa upon binding one equivalent of
substrate.  The question then arises, not regarding what the conformation of the
subunits themselves are after inhibitor binding, but rather what are the relative
contributions of each of the four heterotropic interactions in producing the
observed allosteric effect upon inhibitor binding?
Applying this systematic approach to the concerted and sequential
models, predictions can be made about these relative contributions if each of the
four interactions and hence each of the four possible first binding events, were
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Sequential ModelConcerted Model
Free Enzyme
INHIBITOR
SUBSTRATE
Allosteric Site
Active Site
The 4 Possible
Heterotropic Interactions
All 4 interactions
are equivalent
One interaction
dominates; other
three are zero.
FIGURE 3-2  A two-dimensional schematic of the concerted and sequential models representing
contrasting predictions regarding the influence of the binding of a single allosteric ligand upon
the binding of the substrate at a single active site as it pertains to the measured allosteric effect
for each of the four heterotropic interactions.  Applying the idea of isolating the individual
heterotropic interactions, predictions can be made regarding the magnitude of each heterotropic
interaction upon binding one equivalent of inhibitor and substrate.  The concerted model would
predict equivalent contributions to the measured allosteric effect, while the sequential model
would predict that only one of the four heterotropic interactions would possess any measurable
allosteric effect (the other three would be zero).  The arrows between binding sites represent the
interactions that would be observed (and thus have a measurable allosteric effect) upon binding
only one equivalent of inhibitor and one equivalent of substrate based upon these two models.
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isolated individually.  The concerted model would predict that binding one
equivalent of inhibitor would influence binding at each of the four active sites
equally, thus all four interactions would be equivalent in their relative
magnitudes and would measure 100% of the allosteric effect; whereas, the
sequential model would predict that binding one equivalent of inhibitor would
influence biding at only one of the four active sites, resulting in only one
interaction possessing the maximal allosteric effect (Fig. 3-2).  Thus, to either
validate or disprove the concerted or sequential models, or possibly provide
credence for our “conformational free/linkage” model where each individual
allosteric interaction is considered, the first binding event needs to be isolated
and characterized.
PFK background.  Phosphofructokinase from Bacillus stearothermophilus
(BsPFK) is the model enzyme used for this investigation, as BsPFK is a tetramer
consisting of four identical subunits, arranged as a dimer of dimers.  Contained
within the enzyme are four active sites and four allosteric sites, with the active
sites located along one dimer-dimer interface and the allosteric sites located
along the other dimer-dimer interface (Fig. 3-3 A) (Schirmer and Evans, 1990).
BsPFK is subject to K-type allosteric regulation, meaning the allosteric
effector (activator or inhibitor) regulates BsPFK activity by binding to the
allosteric sites and either increasing or decreasing the protein’s affinity for the
substrate, fructose-6-phosphate (Fru-6-P).  One aspect of this regulation is
heterotropic regulation, which involves the interaction between unlike binding
sites.  Since BsPFK contains four active sites and four allosteric sites, 16 total
80
A
B C
D
22 Å
45 Å 32 Å
30 Å
A
B C
DB
Active Site
Interface
Allosteric Site
Interface
A
FIGURE 3-3  A two-dimensional schematic of BsPFK.  (A ) BsPFK is a
homotetramer consisting of four active sites and four allosteric sites.  Within this
representation, the active sites are located along the vertical dimer-dimer
interface, while the four allosteric sites are located along the horizontal dimer-
dimer interface.  Since there are four active sites and four allosteric sites, 16 pair-
wise heterotropic interactions are possible between the different binding sites
indicated by the colored lines drawn in between each of the active sites and
allosteric sites.  (B) Of these 16 pair-wise heterotropic interactions, four are
unique to BsPFK and have been assigned a distance, which differentiates them
from one another.  The 22 Å interaction is blue, the 30 Å interaction is red, the 32
Å interaction is green, while the 45 Å interaction is magenta.  These distances
correspond to the actual distances between the binding sites within the crystal
structure, but in no way imply the pathway of allosteric communication.
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pair-wise heterotropic interactions are possible, 4 of which are unique as shown
in Fig. 3-3 B (four-fold redundancy).  The four heterotropic interactions have
been designated as either the 22 Å, 30 Å, 32 Å or 45 Å heterotropic interactions,
and these distances correspond to the distance measured within the crystal
structure (Schirmer and Evans, 1990) between the phosphorous atom of the Fru-
6-P molecule bound in the active site to the b-phosphorous atom of the ADP
molecule bound in each of the four allosteric sites.  Up until this point, the
measured allosteric effect produced from the binding of an effector molecule(s)
has been an average of these interactions (plus any contribution from the
homotropic interactions) occurring simultaneously within the tetramer.  If it is
our goal to better understand the mechanism of allosteric regulation and more
specifically, the mechanism of inhibition, this complexity must be reduced in
order to resolve the contribution each of the four heterotropic interactions makes
to the measured allosteric response of the tetramer upon binding the inhibitor
phosphoenolpyruvate (PEP).
Using a method developed by Deville-Bonne et al. (1989) and Le Bras et
al. (1995), and later adapted by Kimmel and Reinhart (2001), a hybrid tetramer
of BsPFK containing only one copy of the 22 Å heterotropic interaction was
isolated and characterized.  The process began by mutating specific residues
within the active site and allosteric site to discourage both the binding of the
substrate Fru-6-P and the inhibitor PEP.  Next, this mutant tetramer and wild-
type BsPFK were dissociated into their individual subunits using KSCN.
Dialysis was then used to permit the random re-association of the subunits to
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generate the 7 possible enzyme species.  Moreover, two lysine residues on the
surface of the mutant protein, far removed from the ligand binding sites, were
mutated to glutamates prior to the KSCN treatment to facilitate the separation of
the various hybrid species via anion exchange chromatography.  The process
concluded with variable separation of the hybrid species, the subsequent
identification of the 1:3 hybrid peak via native PAGE analysis and finally the
characterization of the 1:3 hybrid via linked function analysis.  Figure 3-4
illustrates this hybrid-making scheme used to isolate the 22 Å interaction
(Kimmel and Reinhart, 2001).
The procedure outlined above is used for this current investigation to
isolate the 30 Å and 32 Å interactions.  In order to accomplish this, additional
mutations on the opposite sides of both the active site and allosteric site need to
be found that effectively decrease BsPFK’s affinity for both Fru-6-P and PEP.
Once achieved, the 1:3 hybrids corresponding to each interaction will be isolated
and characterized in the same manner as described by Kimmel and Reinhart
(2001).  This characterization will then enable us to assess if either of the two,
two-state models can be applied to BsPFK because if the interactions are
measured and found to be equivalent, the concerted model would be supported.
Conversely, if the interactions were found to have no measured allosteric effect,
the sequential model would be supported since an allosteric effect was already
observed for the 22 Å interaction at pH 8.0.  More importantly however, if the
interactions proved to be unique, our third “conformational free/linkage”
model previously described would be supported.
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FIGURE 3-4  A diagram showing the various steps involved in isolating the 1:3
hybrid as determined by Kimmel and Reinhart (2001) for isolating the 22 Å
heterotropic interaction.  First, the mutant protein must be generated in which
specific sides of the binding sites are mutated to discourage ligand binding
indicated by the filled-in symbols.  Moreover, a surface charge tag (indicated by
the “lolli-pop” on each subunit) must also be added to the protein to facilitate
separation of the various hybrid species via anion exchange chromatography.
Next, the proteins are mixed together and KSCN is added to dissociate the
tetramers into monomers.  The mixture is dialyzed, and upon removal of the
KSCN, the subunits re-associate to form five different hybrid species, with the
2:2 hybrids having 3 unique orientations.  The 1:3 hybrid is then separated away
from the other hybrids via anion exchange chromatography and its identity
confirmed via native PAGE analysis.
84
 
A
B C
D A
B C
D
Mix together and add KSCN to dissociate the
parental enzymes into their individual subunits
A
B C
D
Dialyze to remove KSCN and allow for
the random re-association of subunits
into the various hybrid species
A
B C
D A
B C
D A
B C
D A
B C
D
A
B C
D
A
B C
D
A
B C
D
Apply the hybrid mixture to an
anion exchange column for separation
Wild-Type
BsPFK
A BsPFK mutant where
the active sites and allosteric
sites are mutated to discourage
Fru-6-P and PEP binding
Identification of the 1:3 hybrid isolating
the 22 Å interaction via native PAGE
analysis and then characterize.
1:3 0:4
mutant
2:2's
3:14:0
wild-type
85
Materials and methods
The materials used for the experiments described in this chapter are the
same as those described in Chapter II.  Site-directed mutagenesis, protein
purification, hybrid formation via monomer exchange and subsequent isolation,
enzymatic activity measurements at various pH values, and data analysis were
performed as described in Chapter II.  Additional methods used to characterize
the stability of the mutant proteins made for use in making the hybrids are
described below.
Protein stability measurements.  In order to assess the stability of the
various mutant BsPFK proteins, KSCN denaturation profiles were performed in
which BsPFK activity was monitored as a function of KSCN concentration.
KSCN was dissolved in MOPS buffer containing 50 mM (MOPS), 100 mM KCl, 5
mM MgCl2 and 0.1 mM EDTA at pH 7.0 to a final concentration of 10 M.  The
proteins assayed were diluted with MOPS buffer to have a final concentration in
the eppendorf tube of 0.02 mg/mL to prevent the need for further dilution when
assayed for activity. Individual eppendorf tubes were labeled from 0 M KSCN to
2.0 M KSCN in 0.1 M increments, and each tube was set up to contain the
appropriate concentration of protein, buffer and KSCN with a final volume of 1
mL.  The tubes were incubated at room temperature for 18 hours and then
assayed for BsPFK activity at 20 mM Fru-6-P using the method described in
Chapter II.
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Results
Strategy.  The subunits of BsPFK are organized as a dimer of dimers with
the 4 active sites located along one dimer–dimer interface and the 4 allosteric
sites located along the other dimer–dimer interface (Schirmer and Evans, 1990).
This arrangement was previously depicted in Fig. 3-3 A.  In considering only the
heterotropic interactions, 16 pair-wise interactions are possible in which 4 of the
heterotropic interactions are unique to BsPFK as shown previously in Fig. 3-3 B.
Each interaction has been assigned a given distance unique to each interaction
(22 Å, 30 Å, 32 Å or 45 Å) to provide a method of identifying and discriminating
among the four heterotropic interactions.
Due to the interfacial nature of these binding sites, residues that define
the binding sites originate from both participating subunits; i.e. from opposite
“sides” of a subunit–subunit interface.  In particular, this pertains to the
numerous positively charged residues that line each binding site (each ligand is
negatively charged).  For example, the Fru-6-P binding site includes R162 and
R243 from one subunit (a-side) and R72, H249 and R252 from the other subunit
(b-side).  Similarly, each allosteric site has R154, R211, and K213 from one
subunit (a-side) and R21 and R25 from the other subunit (b-side).  A schematic
indicating the relative positions within each binding site is shown in Fig. 3-5.  A
nitrogen from each of these positively charged side-chains is found to make at
least one close contact with, i.e. appears in the X-ray structure within 3 Å of, a
negatively charged phosphate oxygen of the corresponding ligand (Fru-6-P or
the PEP analog phosphoglycolate, respectively).
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R252
H249R162
R243
R21 R25
R211 K213
R154
A D
B C
R72
a-side
b-side
a-side b-side
Active Site
Allosteric Site
A
FIGURE 3-5  Schematic of the positively charged residues that line the active site
and allosteric site binding pockets.  Each subunit contributes a full active site
and a full allosteric site but does so by contributing two half active sites and two
half allosteric sites.  Each “side” of the active site has been designated as either
the a-side or the b-side and each “side” of the allosteric site has been designated
as either the a-side or the b-side as shown in the bottom schematic.  Different
shapes are used to represent the different “sides” of each binding site, with the
active sites being represented by a triangle (a-side = R162 and R243) and half-
hexagon (b-side = R252, H249 and R72), and the allosteric sites by a semi-circle
(a-side = R211, K213 and R154) and rectangle (b-side = R21 and R25).  The
residues contributing to their respective “sides” are shown indicated in the top
schematic as well as in parentheses in the figure text (Schirmer and Evans, 1990).
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These positively charged residues serve as excellent candidates for site-
directed mutagenesis as one of our goals is to discourage both Fru-6-P and PEP
binding at three of the four active sites and three of the four allosteric sites.
Thus, it might be expected that each of these positively charged residues
contribute significantly to the binding energy of these ligands, and in fact that is
the case.  In probing the active site, Kimmel and Reinhart (2000) observed that
mutating R162 to an alanine in BsPFK increases the dissociation constant of Fru-
6-P 30-fold, while the R162E mutation increases the Kd by nearly 3-orders of
magnitude (Kimmel and Reinhart, 2001).  Moreover, Valdez, et al. (1989)
reported a 1500-fold increase in the dissociation constant for Fru-6-P upon
implementing the R252A mutation at the active site.  As for the allosteric site,
Lau and Fersht have mutated 4 arginine residues and 1 lysine residue in the
Escherichia coli form of the enzyme (EcPFK) and observed 30-100 fold increases
in the dissociation constants for each allosteric ligand.  In addition, Valdez, et al.
(1989) reported a 100-fold increase in the dissociation constant for the inhibitor
PEP in the R25A and R211A variants of BsPFK.  Thus, one can substantially
diminish ligand binding with mutations to the positively charged residues on
either of the subunits that contribute to the binding site.
This ability to mutate either “side” of the binding site provides the key
opportunity to individually isolate each of the four heterotropic interactions, but
in this chapter, only the isolation and characterization of the 30 Å and 32Å
heterotropic interactions is discussed.  Figure 3-6 illustrates the basic strategy.
The formation of 1:3 (1 wild-type subunit: 3 mutant subunits) hybrid tetramers
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30 Å
A
B C
D
32 Å
A
B C
D
A
B
b-side of the active site mutated
b-side of the allosteric site mutated
b-side of the active site mutated
a-side of the allosteric site mutated
FIGURE 3-6  An illustration of the two 1:3 hybrid combinations used to isolate
the 30 Å  and 32 Å heterotropic interactions.   The different “sides” of the active
sites and allosteric sites requiring to be mutated so as to isolate that particular
interaction are shown.  To indicate the presence of a mutation on a specific
“side” of a binding site, a closed shape is used, while the native, non-substituted
binding sites remain open.  The arrow drawn between the two remaining native
binding sites depicts the specific heterotropic interaction isolated within each of
the 1:3 hybrids.  (A )  The 1:3 hybrid that isolates the 30 Å heterotropic
interaction.  (B)  The 1:3 hybrid that isolates the 32 Å interaction.
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in which the mutant subunits contain modifications to positively charged
residues in both the Fru-6-P and allosteric binding sites, will yield a specific
unmodified Fru-6-P binding site and a specific unmodified allosteric binding
site provided that the mutations are only located on a single side of the subunit
interface for each site that is mutated.  Thus, through mutating the b-side of the
active site and the b-side of the allosteric site, the 30 Å interaction can be
isolated, while mutating the b-side of the active site and the a-side of the
allosteric site isolates the 32 Å interaction.  Table 3-1 lists the different BsPFK
variants used in this study to try to isolate the two interactions and the
mutations they contain.
The active site and allosteric site mutations.  In order to isolate the 30 Å
and 32 Å interactions, mutations were required on the b-side of the active site.
According to the crystal structure, an arginine at position 252 interacts with the
phosphate group of the Fru-6-P molecule (Schirmer and Evans, 1990).  Thus, to
discourage Fru-6-P binding, the R252E mutation was introduced, however, the
mutation dramatically affected the enzymatic turnover so a more conservative
mutation was necessary.  R252A was constructed, and exhibited the desired
increase in the   
† 
K1 /2  for Fru-6-P (approximately 1000 fold) while having no effect
upon the turnover of the enzyme.  Figure 3-7 shows the effects of these two
mutations at the active site as compared to wild-type BsPFK.
As for the allosteric site, the mutations on the a-side had already been
found (R211E/K213E by Kimmel and Reinhart, 2001) permitting use in isolating
the 32 Å interaction; however, to isolate the 30 Å interaction, the b-side of the
91
TABLE 3-1  The BsPFK variants used in attempting to isolate the 30 Å
and 32 Å interactions via their respective 1:3 hybrids
Interaction
Isolated via the 1:3
Hybrid
Active Site
Mutation
(All on b-side)
Allosteric Site
Mutation
(a or b-side)
Charge Tag
Mutation
R252A R25E (b) K90E/K91E
R252A R25A (b) none
R252A R25A (b) K90E/K91E
H249E R25E (b) K90E/K91E
H249N R25E (b) K90E/K91E
30 Å interaction
R252A/D12A R25E (b) K90E/K91E
R252A R211E/K213E (a) K90E/K91E
R252A R211E/K213E (a) none
H249E R211E/K213E (a) K90E/K91E
H249N R211E (a) K90E/K91E
H249N R211E/K213E (a) K90E/K91E
32 Å interaction
R252A/D12A R211E/K213E (a) K90E/K91E
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FIGURE 3-7  Fru-6-P saturation profiles for wild-type BsPFK (l) and the active
site mutants proteins R252A (n) and R252E (Í).  MgATP concentration was 3
mM, the buffer component was MOPS-KOH (pH 7.0) and the assay temperature
was 25°C.  Other conditions were as described in Chapter II (Materials and
methods).  Curves represent the best fit to Eq. 2-1 as described in the text.
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allosteric site would have to be mutated.  Thus, from examining the crystal
structure, an arginine at position 25 was found and mutated to a glutamate to
discourage PEP binding.  The effects of this mutation are summarized in Fig. 3-
8.  Due to the difficulties in assessing the direct binding affinity of PEP to BsPFK,
an indirect method was used to elucidate the ability of PEP to inhibit the
binding of Fru-6-P for both the wild-type and R25E mutant enzymes.  The
resulting data were fit to Eq. 2-4 in order to determine the dissociation constant
of PEP for BsPFK (  
† 
Kiyo ).  As Fig. 3-8 shows, it requires approximately 100 mM
PEP to increase the   
† 
K1 /2  for Fru-6-P as compared to 0.023 mM PEP for the wild-
type enzyme indicating a substantial decrease in PEP affinity. However, an
increase in the   
† 
K1 /2  for Fru-6-P is still observed at high concentrations of PEP,
suggesting that the allosteric communication has not been destroyed by the
mutation, and that binding eventually occurs.  These results are analogous to the
previous R211E/K213E allosteric site mutations (a-side) (Kimmel and Reinhart,
2001).
Equipped with the aforementioned active site (b-side) and allosteric site
mutations (b-side), a BsPFK variant was made to isolate the 30 Å interaction that
contained the following mutations: R252A, R25E and K90E/K91E, in which the
surface charge tag (K90E/K91E) was added to facilitate separation of the various
hybrid species via anion exchange chromatography.  When this mutant protein
was used to make hybrids with wild-type BsPFK, the 1:3 hybrid, as well as
others, were unable to form.  An example of this phenomenon can be seen in
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FIGURE 3-8  Dependence of the apparent   
† 
K1 /2  for Fru-6-P on increasing
concentrations of the inhibitor PEP for wild-type BsPFK (l) and the allosteric
site mutant protein R25E (°).  The   
† 
K1 /2  values were obtained from individual
Fru-6-P saturation profiles (performed at pH 7.0 and 25°C; data not shown but
similar to Fig. 3-7) at increasing concentrations of PEP.  The curves correspond
to the best fit of these data to Eq. 2-4 as described in the text.  Error bars
represent ± the standard error and are smaller than the symbol when not
evident.
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lanes 2 and 3 of Fig. 3-9 where only 2 bands are observed probably
corresponding to wild-type BsPFK and the 3:1 hybrid.
In an attempt to make the elusive 1:3 hybrid, the conditions used in
making the hybrids were varied.  Some of these variations included the
following: changing the ratios of the two parent proteins used (1:1 to 50:1),
altering the total protein concentration (0.5 mg/mL to 5 mg/mL) and the
amount of KSCN used in making the hybrids (0.2 to 4 M), varying the time the
proteins were exposed to the denaturant (seconds to hours) and the pH of the
hybrid mix (pH 6.0 to pH 8.0) and using urea, guanidinium hydrochloride,
and/or heat to try to dissociate the proteins.  Unfortunately, none of these
alterations in the hybrid making protocol produced the 1:3 hybrid.
Since this phenomenon did not occur when using the R162E mutation at
the active site, it appeared that the R252A mutation was causing an unfavorable
interaction at the interface not found within the native enzyme.  Thus, other
active site mutations on the b-side of the active site were investigated.  A
histidine at position 249 is adjacent to R252 and within hydrogen bonding
distance of the bound Fru-6-P molecule, thus it was mutated to an alanine, an
asparagine and a glutamate.  The effect of each active site mutation upon the
  
† 
K1 /2  for Fru-6-P is shown in Fig. 3-10, (all data fit to the Eq. 2-1) and based upon
the results, the H249E and H249N mutations were incorporated into the hybrid-
making mutant protein(s).  Unfortunately, the H249 mutants did not make the
1:3 hybrid and the same effects were observed as before (Fig. 3-11).
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              1        2        3         4         5        6        7
FIGURE 3-9  A 10% native PAGE gel showing the inability to form hybrids
between wild-type and the R252A/R25E/K90E/K91E mutant.  Lanes 1 and 5
show the wild-type protein.  Lanes 2 and 3 show the results of using 1 M KSCN
and 2 M KSCN to try to make hybrids between wild-type BsPFK and the
R252A/R25E/K90E/K91E mutant, respectively where only 2 of the 5 hybrid
species are observed.  Lane 4 shows the R252A/D12A/K90E/K91E mutant
protein.  Lane 6 shows the result of using 2 M KSCN to make hybrids between
wild-type BsPFK and the R252A/D12A/R25E/K90E/K91E mutant.  All five
hybrid species form as a result of incorporating the D12A mutation into the
mutant protein.  Lane 7 shows the R252A/D12A/R25E/K90E/K91E mutant
protein.  For lanes 2, 3 and 6, the samples were taken from after the dialysis step,
and prior to loading unto the anion exchange column in the hybrid-making
procedure.  The conditions of how the gel was run were as described in Chapter
II (Materials and methods).
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FIGURE 3-10  Fru-6-P saturation profiles for wild-type BsPFK (l) and the active
site mutants proteins H249A (n ), H249E (Í ) and H249N (u ).  MgATP
concentration was 3 mM, the buffer component was MOPS-KOH (pH 7.0) and
the assay temperature was 25°C.  Other conditions were as described in Chapter
II (Materials and methods).  Curves represent the best fit to Eq. 2-1 as described
in the text.
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A          1     2    3     4     5
B 1       2        3        4       5        6        7        8
C         1         2        3       4         5         6
FIGURE 3-11  10% native PAGE gels showing the inability to form the 1:3 hybrid and sometimes
other hybrids regardless of the conditions assayed and mutant constructs used.  (A) Hybrids
between wild-type and the R252A/R211E/K213E/K90E/K91E mutant protein.  Lane 1 shows
wild-type BsPFK.  Lanes 2-4 show hybrids between wild-type and the
R252A/R211E/K213E/K90E/K91E mutant protein varying the relative ratios of wild-type to
mutant from a 2:1, 4:1 and 10:1.  Lane 5 shows the R252A/R211E/K213E/K90E/K91E mutant
protein.  (B)  Hybrids between wild-type and the H249N/R211E/K90E/K91E mutant protein.
Lane 1 shows wild-type BsPFK.  Lanes 2-7 show hybrids between wild-type and the
H249N/R211E/K90E/K91E mutant protein at increasing concentrations of KSCN starting at 1 M
in lane 2 and ending at 2 M in Lane 7 (0.2 M increments).  Lane 8 shows the
H249N/R211E/K90E/K91E mutant protein.  (C )  Hybrids between wild-type and the
R252A/R25A/K90E/K91E mutant protein.  Lane 1 shows wild-type BsPFK.  Lanes 2-5 show
hybrids between wild-type and the R252A/R25A/K90E/K91E mutant protein at increasing
concentrations of KSCN starting at 1 M in lane 2 and ending at 4 M in lane 5 (1 M increments).
Lane 6 shows the R252A/R25A/K90E/K91E mutant protein.
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Thus, the crystal structure was examined again, but this time, instead of looking
for a different b-side residue to mutate to discourage Fru-6-P binding, we looked
for an amino acid that might be the cause of the unfavorable interaction when
the R252(X) or H249(X) mutants were used.  In the crystal structure, adjacent to
the other side of R252 (outside the binding pocket) is an aspartic acid at position
12 that interacts via a hydrogen bond (inferred from the crystal structure) with
R252 (Fig. 3-12).  More importantly however, D12 is located at the interface of
the protein across from a histidine at position 160 (within hydrogen bonding
distance).  Thus, we suspect that upon mutating R252 or H249, the structural
integrity of the Fru-6-P binding pocket is altered in such a way that D12
interferes with the essential interfacial contacts found in the native enzyme.
Consequently, D12 was mutated to an alanine in hopes of restoring the
appropriate interfacial interactions when either R252 or H249 was mutated.  Fig.
3-12 shows this region of interest highlighting the positions of the R252, D12 and
H160 residues.
The D12A mutation was successful, as all five hybrid species formed
when D12A was combined with the R252A, R25E and K90E/K91E mutations
(lane 5 of Fig. 3-9).  Although the entire effect of D12A is not yet fully
understood, it is likely due to an enhanced quaternary stability for the
aforementioned mutant proteins, which is evident when comparing lanes 4 and
7 of Fig. 3-9.  In lane 4, a banding pattern is seen for the mutant protein in the
absence of the D12A mutation, while in the presence of the D12A mutation a
single band is observed (lane 7).
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FIGURE 3-12  The x-ray crystal structure of the active site region highlighting
the location of the R252, D12, and H160 residues.  D12 is shown in orange (b-
side of the active site), R252 and H249 are shown in blue, H160 and T156 are
shown in green (from the a-side of the active site) and the Fru-6-P molecule
bound in the active site is shown in red (Schirmer and Evans, 1990).  It is
inferred from the crystal structure that D12 makes a hydrogen bond with R252
and H160 across the interface.
101
To ensure the binding affinity for Fru-6-P is diminished enough in the
R252A/D12A mutated protein, a Fru-6-P saturation profile was performed and
Fig. 3-13 illustrates the result of incorporating these mutations at the active site.
Equation 2-1 was used to fit both the wild-type and R252A/D12A mutant data,
although the Hill coefficient did not vary significantly from 1.  As desired, the
affinity for Fru-6-P (  
† 
K1 /2) is diminished by approximately 240-fold relative to
that of wild-type.  Moreover, the specific activity of the mutant is unaffected
indicating no mechanistically significant structural perturbation of the active
site.  Table 3-1, described earlier, lists all of the mutant proteins constructed in
trying to obtain the 1:3 hybrid and Table 3-2 summarizes all the kinetic and
allosteric properties of the wild-type enzyme, the individual active site mutants,
and the individual allosteric site mutants used in making the mutant proteins.
Protein stability.  To further address the added stability associated with
the D12A mutation as described earlier, KSCN denaturation profiles were
performed in an attempt to determine which of the mutations was the cause of
the inherent instability.  At each KSCN concentration, BsPFK activity was
measured and normalized to the percent of total activity to make it easier in
comparing the various denaturation curves.  Figure 3-14 summarizes the effects
of various mutations on the stability, and hence the activity, of each protein.
Not surprisingly, the denaturation curve for the D12A/K90E/K91E
mutant protein is virtually identical to that of wild-type, so although the D12A
mutation provides an added stability in the mutant proteins, it does not provide
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FIGURE 3-13  Fru-6-P saturation profiles for wild-type BsPFK (l) and the active
site mutant protein R252A/D12A (°).  MgATP concentration was 3 mM, the
buffer component was MOPS-KOH (pH 7.0) and the assay temperature was
25°C.  Other conditions were as described in Chapter II (Materials and
methods).  Curves represent the best fit to Eq. 2-1 as described in the text.
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TABLE 3-2  Steady-state kinetic and thermodynamic parameters for wild-
type BsPFK and the individual active site and allosteric site mutants used
in constructing the mutant parent protein(s).  Performed at 25°C and pH
7.0 with [MgATP] = 3 mM
Enzyme
Vmax
(Units/mg)a
K1/2 (mM)a nHa   
† 
Kiyo  (mM)b
wild-type 125 ± 2 0.021 ± 0.001 1.30 ± 0.09 0.023 ± 0.002
R252E ND >100 ND ND
R252A 114 ± 1 26.3 ± 0.5 2.11 ± 0.08 ND
H249A 134 ± 2 0.13 ± 0.01 0.98 ± 0.04 ND
H249E 51 ± 1 5.1 ± 0.3 1.02 ± 0.04 ND
H249N 52 ± 3 1.4 ± 0.3 1.00 ± 0.17 ND
R252A/
D12A
122 ± 3 5.0 ± 0.3 1.17 ± 0.05 ND
R25E 91 ± 1 0.047 ± 0.002 1.27 ± 0.05 ~100
R211E/
K213Ec
109 ± 1 0.058 ± 0.001 1.12 ± 0.08 ~20
aPertaining to Fru-6-P saturation profiles at 0 mM PEP and parameters
obtained from fitting to Eq. 2-1.
bObtained by fitting to Eq. 2-4 as described in Chapter II.
cExperiment performed under identical conditions except at pH 8.0 (Kimmel
and Reinhart 2001).
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FIGURE 3-14  KSCN denaturation profiles for wild-type BsPFK and several
mutant proteins.  The relative activities for wild-type BsPFK (l ), the
D12A/K90E/K91E mutant (s ), the D12A/R25E mutant (® ), the
D12A/R25E/K90E/K91E mutant (Í), the R252A/D12A/R25E/K90E/K91E
mutant (t), the R25E mutant (n) and the R252A/R25E/K90E/K91E mutant (—)
were determined as a function of KSCN concentration to assay protein stability.
Activity measurements were performed using 20 mM Fru-6-P and as described
in Chapter II at pH 7.0 and 25°C.  The data pertaining to each protein were
normalized to percent total activity because the differences in the specific
activity of each protein made it difficult to compare the various denaturation
curves.
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any additional stability for the wild-type protein when using KSCN.  Upon
introducing the R25E allosteric site mutation to either the D12A mutant or the
D12A/K90E/K91E mutant, an obvious decrease in stability is observed.  The
midpoint of stability, or the concentration of KSCN that eliminates 50% of the
total activity, for both the D12A/R25E and D12A/R25E/K90E/K91E mutant
proteins was reduced from 1.0 M (wild-type) to about 0.65 M.  Notably, the
presence of the K90E/K91E mutation does not change the stability of any of the
mutant proteins.
However, the D12A mutation does provide some added stability for the
R25E mutant as the R25E mutant protein alone has a midpoint of stability of
approximately 0.5 M.  The value of the D12A mutation is not truly evident
however until comparing the R252A/R25E/K90E/K91E mutant protein to the
R252A/D12A/R25E/K90E/K91E mutant protein, recalling that the former
protein cannot form the 1:3 hybrid while the latter can.  The midpoint of stability
in the absence and presence of the D12A mutation changes from 0.18 M to 0.65
M respectively.  It is this added stability that may aid in hybrid formation.  As
for the active site mutation R252A, it appears to have no effect upon protein
stability as the midpoint value does not change when comparing the
R252A/D12A/R25E/K90E/K91E mutant and the D12A/R25E/K90E/K91E.
Thus, the allosteric site mutation(s) appears to be the main culprit of the protein
instability, but how an active site mutation (D12A) can add stability at the
allosteric site or it’s interface is unknown.  Table 3-3 summarizes the mutants
investigated for this stability study and the midpoint values obtained for each
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protein.
TABLE 3-3  Values obtained for the midpoint of stability in the
KSCN denaturation profiles for several mutant proteins
Mutant Protein Midpoint of Stability (M)a
wild-type BsPFK 1.02
D12A/K90E/K91E 0.97
R25E/D12A/K90E/K91E 0.65
R25E/D12A 0.65
R25E 0.50
R252A/D12A/R25E/K90E/K91E 0.65
R252A/R25E/K90E/K91E 0.18
aBest estimate obtained by examining each profile, therefore, there
are no error values.
Isolating the two individual heterotropic interactions.  Having
identified the appropriate mutations (R252A/D12A on the b-side of the active
site and R25E on the b-side of the allosteric site), and in conjunction with the
previous allosteric site mutations (R211E/K213E on the a-side) discovered by
Kimmel and Reinhart (2001), the 30 Å and 32 Å heterotropic interactions can be
isolated via their respective 1:3 hybrids.  As reported earlier, the addition of the
surface charge-tag, K90E/K91E, to each of the mutant parent proteins allows for
the isolation of the 1:3 hybrid from the other 6 enzyme species via anion
exchange chromatography (Kimmel and Reinhart, 2001).  However, the extent of
107
separation of the various hybrid species varied among the mutant construct
used.  It is presumed that this is caused by the variability in the solvent
accessibility of the mutated residues, and in particular R211.  Hence, the charge-
tag charge change was in the same positive to negative direction as the binding
site mutations, so as to not negate the chromatographic effects incurred by the
charge-tag.  Using the R252A/D12A, the R25E and/or the R211E/K213E
mutations, the 1:3 hybrid containing either the 30 Å interaction or the 32 Å
interaction was formed, isolated and identified as described earlier in Chapter II.
All 1:3 hybrids were stored at 4°C and no re-hybridization between subunits
was observed for at least 4 weeks as confirmed by native PAGE analysis (data
not shown).
Functional properties of the 1:3 hybrid enzymes.  The dependence of
enzyme activity as a function of Fru-6-P concentration was determined for the
wild-type enzyme, as well as the individual 1:3 hybrid enzymes at pH 6.0, 6.5,
7.0, 7.5 and 8.0.  As expected, the Fru-6-P saturation profiles for the 1:3 hybrids
exhibited the saturation of two different types of binding sites, corresponding to
the high affinity and low affinity active sites respectively.  An example of a
typical saturation profile for the 1:3 hybrids containing the 30 Å interaction and
32 Å interaction at pH 7.0 is shown in Fig. 3-15.  Data obtained from the Fru-6-P
saturation profiles for the wild-type enzyme were fit to Eq. 2-1, while data for
the 1:3 hybrids were fit to Eq. 2-2, in which two Michaelis-Menten equations are
summed together.
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FIGURE 3-15  Fru-6-P saturation profiles for the 1:3 hybrids that isolate the 30 Å
interaction (l) and 32 Å interaction (°) at pH 7.0, 25°C and in the absence of
PEP.  The first phase corresponds to Fru-6-P binding at the lone native active
site, while the second phase corresponds to Fru-6-P binding at the mutated
active sites.  Activity assays were performed as described in Chapter II with the
MgATP concentration equal to 3 mM.  The curve represents the best fit of the
data to Eq. 2-2.  Similar plots were observed for either of the 1:3 hybrids at pH
6.0, 6.5, 7.5 and 8.0.
109
Table 3-4 summarizes the kinetic parameters obtained from these fits for
wild-type BsPFK and both the high affinity (native) and low affinity (mutated)
Fru-6-P binding sites found in the 1:3 hybrids.  At all pH values, the maximal
specific activity for the high affinity interaction (  
† 
Vmax ) is approximately one-
fourth that of wild-type.  This result was expected, as each 1:3 hybrid contains
one-fourth the number of native active sites found within the BsPFK tetramer.
Also, the maximal specific activity for each of the 1:3 hybrids increases with an
increase in pH, a behavior consistent with the wild-type enzyme (Tlapak-
Simmons and Reinhart, 1998).  Moreover, the values obtained for the   
† 
K1 /2  for
Fru-6-P for the high affinity active site agree, within error, with the   
† 
K1 /2  values
for the wild-type enzyme with the exception of the 32 Å interaction at pH 8.0.
The invariability in   
† 
K1 /2  was expected as little to no cooperativity between active
sites in the absence of effector has been reported for the native BsPFK enzyme
(Evans and Hudson, 1979).
The values obtained for the low affinity active sites also conform to
expected results.  The maximal specific activities for the three low affinity active
sites (  
† 
Vmax' ) is approximately three-fourths the   
† 
Vmax  value for the mutant
tetramer, which is comparable to three-fourths the   
† 
Vmax  value for the wild-type
enzyme since the active site mutations do not alter the enzymatic turnover of
BsPFK.  Furthermore, the low affinity   
† 
K1 /2  values are comparable to the
measured   
† 
K1 /2  values for their respective active site mutant enzymes.
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TABLE 3-4  Steady-state kinetic parameters for wild-type BsPFK and the
two 1:3 hybrids which isolate the 30 Å interaction and the 32 Å interaction
at 25°C, pH 6.0, 6.5, 7.0, 7.5 and 8.0, [MgATP] = 3 mM and [PEP] = 0 mM
Enzyme or
Interaction
Isolated
  
† 
Vmax
(Units/mg)
high affinity
  
† 
K1/2  (mM)
high affinity
  
† 
Vmax'
(Units/mg)
low affinity
  
† 
K1/2'  (mM)
low affinity
pH 6.0
wild-type 67.1 ± 1.1 0.032 ± 0.001 n/a n/a
30 Å 15.4  ± 0.4 0.035 ± 0.003 36 ± 1 8.0 ± 0.3
32 Å 14.5 ± 0.5 0.031 ± 0.003 46 ± 2 10.0 ± 0.8
pH 6.5
wild-type ND ND n/a n/a
30 Å 21.0 ± 0.6 0.022 ± 0.002 59.0 ± 1.5 7.9 ± 0.3
32 Å 22.0 ± 1.1 0.026 ± 0.004 71.0 ± 3.2 8.0 ± 0.6
pH 7.0
wild-type 125 ± 2 0.021 ± 0.001 n/a n/a
30 Å 26.7 ± 0.7 0.020 ± 0.002 96 ± 3 12.1 ± 0.7
32 Å 30.9 ± 1.1 0.047 ± 0.005 94 ± 3 9.6 ± 0.5
pH 7.5
wild-type ND ND n/a n/a
30 Å 40.4 ± 0.9 0.027 ± 0.002 128 ± 4 24.5 ± 2.2
32 Å 32.5 ± 1.1 0.078 ± 0.008 109 ± 5 16.6 ± 1.0
pH 8.0
wild-type 153 ± 3 0.034 ± 0.001 n/a n/a
30 Å 37 ± 2 0.079 ± 0.008 UD UD
32 Å 38 ± 2 0.310 ± 0.035 UD UD
n/a = not applicable
ND = Not Determined
UD = Undeterminable
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In order to measure the allosteric effect associated with each heterotropic
interaction, the   
† 
K1/2  for Fru-6-P was determined as a function of PEP
concentration for each of the two 1:3 hybrids at varying pH.  Ideally, this
measured allosteric effect would correspond to the interaction of only the native
active site and native allosteric site.  However, it was previously found that the
three mutated allosteric sites still have the ability to influence the measured
allosteric effect for the 1:3 hybrid at high concentrations of PEP (Kimmel and
Reinhart 2001), thus a control hybrid for each 1:3 hybrid was made.  This control
hybrid consists of one native active site, three mutated active sites and four
mutated allosteric sites and is depicted schematically in Fig. 3-16 using the 30 Å
interaction as an example.  Using the notation introduced by Fenton and
Reinhart (2002), this control hybrid is designated 1|0, where 1 equals the
number of native Fru-6-P binding sites and 0 equals the number of native
allosteric sites in the tetramer.  Thus, the 1:3 hybrids are designated 1|1 whereas
wild-type BsPFK is designated 4|4.  Each of the two control hybrids were
constructed in the same manner as the 1|1 hybrids except the appropriate
allosteric site mutant was substituted for the wild-type parental protein.  Fru-6-P
titrations at pH 6.0, 6.5, 7.0, 7.5 and 8.0 were performed for each 1:3 hybrid and
its corresponding control hybrid at increasing concentrations of PEP.  In all
cases, the measured coupling for each 1:3 hybrid was corrected for by using the
following equation:
  
† 
K1 /2 (corrected) =
K1 /2 (1 | 1)
K1 /2 (1 | 0)
(3-1)
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30 Å
A
B C
DA
A,B and C subunits =
R252A/D12A/R25E/K90,91E mutant protein
D subunit =
wild-type BsPFK
A
B C
DB
A,B and C subunits =
R252A/D12A/R25E/K90,91E mutant protein
D subunit =
R25E mutant (b-side) mutant protein
FIGURE 3-16  Two-dimensional schematics of the 1:3 hybrids corresponding to
the 1|1 hybrid and 1|0 hybrid for the 30 Å interaction.  (A)  The 1:3 hybrid (1|1)
used to obtain data corresponding to the magnitude of the 30 Å interaction.  (B)
The 1:3 hybrid (1|0) used to “control-subtract” the 1|1 hybrid data for the
effects from PEP binding to the mutated allosteric sites.
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An example of the change in Fru-6-P affinity as a function of PEP
concentration for the 32 Å 1:3 hybrid (1|1) and its control hybrid (1|0) is shown
in Fig. 3-17 at pH 7.0 and 25°C.  The subsequent control subtracted data using
Eq. 3-1 is also shown and fit to Eq. 2-4.  The gray shaded region of the plot
indicates the region at which the mutated allosteric sites begin to bind the
inhibitor PEP, thus influencing the affinity the native active site has for Fru-6-P
(occurs at around 10 mM PEP) for both the 1|1 hybrid and the 1|0 hybrid.  This
influence from the mutated allosteric sites results in two phases for the data
corresponding to the 32 Å 1:3 hybrid (1|1), and this second phase is suitably
corrected for by the control hybrid (1|0) data as seen in the plot.  This control
subtraction procedure was performed at all five pH values and for both of the
1:3 hybrids (1|1).
Figures 3-18 A and B show the results for the corrected apparent   
† 
K1/2  for
Fru-6-P as a function of increasing concentrations of PEP for both the 30 Å and
32 Å interactions at pH 6.0, 6.5, 7.0, 7.5 and 8.0.  From fitting the data to Eq. 2-4,
the value of   
† 
Kiao  can be obtained which is the dissociation constant for Fru-6-P in
the absence of PEP.  For the 30 Å interaction, the   
† 
Kiao  is identical to wild-type
and remains the same from pH 6.0 to 7.5, and increases approximately 2-fold at
pH 8.0.  The   
† 
Kiao  obtained for the 32 Å interaction on the other hand is affected a
bit more by pH.  The   
† 
Kiao  value remains like wild-type from pH 6.0 to 7.0,
increases 2-fold at pH 7.5 and an additional 5-fold at pH 8.0.  A minimal increase
in the   
† 
Kiao  as a function of pH (less than 2-fold) has been previously reported for
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FIGURE 3-17  Dependence on the apparent   
† 
K1/2  for Fru-6-P on increasing
concentrations of the inhibitor PEP for the 1|1 hybrid (l), the 1|0 control hybrid
(°), and the corrected 32 Å allosteric interaction (®).  The data relating to the
1|1 hybrid displays two phases where the first phase indicates the extent to
which PEP binding at the native allosteric sites are influencing substrate binding
at the native active sites.  The second phase corresponds to the point at which
PEP binding at the mutated allosteric sites influences substrate binding at the
native active sites.  Data for the corrected 32 Å interaction were obtained using
Eq. 3-1 and Eq. 2-4 was used to generate the curve representing the best fit of
those data.  The shaded gray region corresponds to the point at which PEP
begins binding to the mutated allosteric sites and influencing the apparent   
† 
K1/2
for Fru-6-P of the native active site in both the 1|1 and 1|0 hybrids.  Error bars
represent ± the standard error and are smaller than the symbol when not
evident.
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FIGURE 3-18  Dependence of the corrected apparent   
† 
K1/2  for Fru-6-P on
increasing concentrations of the inhibitor PEP for the 30 Å interaction and the 32
Å interaction at pH 6.0 (l), pH 6.5 (°), pH 7.0 (n), pH 7.5 (o), and pH 8.0 (t).
The data for pH 6.0 were performed in buffer containing 50 mM MES-KOH, the
data for pH 6.5. 7.0 and 7.5 were performed in buffer containing 50 mM MOPS-
KOH, and the data for pH 8.0 were obtained using buffer containing 50 mM
EPPS-KOH.  All the curves correspond to the best fit of these data to Eq. 2-4 as
described in the text.  (A)  Data corresponding to the 30 Å interaction.  (B)  Data
corresponding to the 32 Å interaction.
A
B
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wild-type BsPFK, but seems to be magnified inexplicably in the 30 Å and 32 Å
interactions (Tlapak-Simmons and Reinhart, 1998).  The dissociation constant for
PEP in the absence of Fru-6-P (  
† 
Kiyo ) for the 30 Å and 32 Å interactions can also be
obtained from fitting the data in Figs. 3-18 A and B to Eq. 2-4.  The   
† 
Kiyo  values for
the both the 30 Å and 32 Å interactions were found to be significantly tighter
than that of wild-type BsPFK (wild-type ~ 0.030 mM) by one to two orders of
magnitude with no obvious trend in the data.
The coupling constant,   
† 
Qay , or the extent to which PEP inhibits the
binding of Fru-6-P and vice versa, is also obtained from the data in Figs. 3-18 A
and B.  Fig. 3-18 A shows the corrected values for the   
† 
K1/2  for Fru-6-P plotted as
a function of PEP concentration at the five pH values investigated for the 30 Å
interaction.  At pH 6.0 and 6.5, no coupling is measured (  
† 
Qay ) resulting in a
coupling free energy of 0.00 ± 0.06 kcal/mol at either pH.  Thus, the 30 Å
interaction is “allosterically silent” at low pH.  Interestingly, at pH 7.0, PEP
begins to inhibit the 30 Å interaction, and this extent of inhibition increases with
increasing pH (within error), a phenomenon consistent with wild-type BsPFK.
At pH 7.0, 7.5 and 8.0, the measured coupling free energy (∆Gay) in kcal/mol is
0.31 ± 0.11, 0.71 ± 0.11 and 0.49 ± 0.11 respectively.
Figure 3-18 B shows the analogous data for the 32 Å interaction.  Unlike
the 30 Å interaction, the 32 Å interaction never becomes “allosterically silent” at
low pH, although the extent of PEP inhibition does not change between pH 6.0
and 6.5, as seen with the 30 Å interaction.  Using Eq. 2-6 to convert   
† 
Qay  into
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coupling free energy (∆Gay), pH 6.0 and pH 6.5 have a measured coupling in
kcal/mol of 0.34 ± 0.10 and 0.27 ± 0.13 respectively.  The increase in inhibition
arises at pH 7.0 and continues to increase with increasing pH as the couplings
measured in kcal/mol proceed from 0.57 ± 0.10 at pH 7.0 to 0.71 ± 0.14 at pH 7.5
and finally to 0.82 ± 0.12 at pH 8.0.  A summary of all of the thermodynamic
parameters can be found in Table 3-5.
In comparing the values obtained for the coupling free energies (∆Gay) for
the 30 Å and 32 Å interactions, a major similarity is evident when plotting the
values obtained for ∆Gay as a function of pH (Fig. 3-19).  Even though the 30 Å
interaction is “allosterically silent” at low pH and the 32 Å interaction has an
overall greater measured allosteric effect by PEP, both interactions have an
approximately identical overall change in ∆Gay across the pH values
investigated.  This change has been denoted ∆∆GpH and is the difference
between the ∆Gay measured at low pH and the ∆Gay measured at high pH.  Thus,
from Figs. 3-19 A  and B , the value of ∆∆GpH can be estimated to be
approximately 0.6 kcal/mol for both the 30 Å and 32 Å heterotropic interactions.
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TABLE 3-5  Thermodynamic parameters for wild-type and the two
individual allosteric interactions (control subtracted) at 25°C, pH 6.0, 6.5,
7.0, 7.5 and 8.0 and [MgATP] = 3 mM
Enzyme or
Interaction
Isolated
  
† 
Kiao  (mM)   
† 
Kiyo  (mM)   
† 
Qay
∆Gay
(kcal/mol)
pH 6.0
wild-type 0.032 ± 0.001 0.026 ± 0.002 0.041 ± 0.002 1.89 ± 0.03
30 Å 0.030 ± 0.002 ND 1.00 ± 0.10 0.0 ± 0.06
32 Å 0.029 ± 0.005 0.0045 ± 0.0061 0.56 ± 0.10 0.34 ± 0.10
pH 6.5
wild-type ND ND ND ND
30 Å 0.020 ± 0.001 ND 1.00 ± 0.10 0.00 ± 0.06
32 Å 0.025 ± 0.005 0.0007 ± 0.0001 0.63 ± 0.13 0.27 ± 0.13
pH 7.0
wild-type 0.030 ± 0.002 0.023 ± 0.002 0.0085 ± 0.0004 2.82 ± 0.03
30 Å 0.019 ± 0.004 0.0003 ± 0.0007 0.59 ± 0.11 0.31 ± 0.11
32 Å 0.035 ± 0.006 0.003 ± 0.002 0.38 ± 0.07 0.57 ± 0.10
pH 7.5
wild-type ND ND ND ND
30 Å 0.025 ± 0.004 0.0013 ± 0.0007 0.30 ± 0.05 0.71 ± 0.10
32 Å 0.073 ± 0.015 0.0020 ± 0.0017 0.30 ± 0.07 0.71 ± 0.14
pH 8.0
wild-type 0.027 ± 0.001 0.039 ± 0.001 0.0020 ± 0.0001 3.58 ± 0.02
30 Å 0.074 ± 0.014 0.002 ± 0.001 0.44 ± 0.08 0.49 ± 0.11
32 Å 0.31 ± 0.06 0.0004 ± 0.0003 0.25 ± 0.05 0.82 ± 0.12
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FIGURE 3-19  Determining the extent to which ∆Gay changes as a function of pH
for the 30 Å and 32 Å interactions.  (A)  Data pertaining to the 30 Å interaction
(l).  (B)  Data pertaining to the 32 Å interaction (°).
A
B
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Discussion
Phosphofructokinase from Bacillus stearothermophilus is a homotetramer
containing four active sites and four allosteric sites, all of which are located on
respective dimer-dimer interfaces within the protein.  This oligomeric feature, a
property common to most allosteric enzymes (Kurganov, 1982), provides many
advantages to the regulatory properties of BsPFK, but it also increases the
overall allosteric complexity possible between the various binding sites.  For
example, in BsPFK, 16 total pair-wise heterotropic interactions exist between the
8 binding sites, representing 4 occurrences each of 4 unique interactions.  If our
ultimate goal is to better understand the mechanism of allosteric regulation, this
“web” of allosteric communication presents an interesting challenge in
achieving this goal.  However, when the number of native binding sites is
decreased, the allosteric complexity is also decreased, eventually permitting
characterization of the four heterotropic interactions individually when a
particular native active site and native allosteric site remain.  Moreover, by
taking this divide-and-conquer approach in assessing the allosteric contributions
of each of the four heterotropic interactions, we are able to better understand the
allosteric properties of the enzyme as a whole.  This reduction in allosteric
complexity for a homotetramer, like BsPFK, containing one active site and one
allosteric site per subunit is summarized in Table 3-6.
The fact that the binding sites of BsPFK are located at the interfaces of the
protein is not surprising, as many allosteric enzymes possess this feature;
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TABLE 3-6  Reduction in the allosteric complexity of a homotetramer
containing one active site and one allosteric site per subunit upon reducing
the number of wild-type subunits successively by one
Hybrid
Number
of Wild-
Type
Subunits
Number
of Native
Active
Sites
Number
of Native
Allosteric
Sites
Number of
Heterotropic
Interactions
(Unique)
Number of
total
Interactions
(Unique)a
4:0 (WT) 4 4 4 16 (4) 28 (10)
3:1 3 3 3 9 (4) 15 (10)
2:2 2 2 2 4 (2) 6 (4)
1:3 1 1 1 1 (1) 1 (1)
0:4 (mutant) 0 0 0 0 (0) 0 (0)
aIncludes the possible homotropic interactions between active sites and between
allosteric sites.
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however, it is this aspect that allows for the individual isolation of each of the
four unique heterotropic interactions.  In order to isolate a given interaction, a
particular “side” of the active sites and allosteric sites has to be mutated to
discourage both Fru-6-P and PEP binding.  It was previously shown that the a-
side of the active site (R162E) and the a-side of the allosteric site (R211E/K213E)
could be successfully mutated to achieve these results (Kimmel and Reinhart,
2001), and we have now shown here that the b-side of the active site
(R252A/D12A) and the b-side of the allosteric site (R25E) can also be mutated to
substantially decrease the binding affinity for both Fru-6-P and PEP.  Thus, as
outlined in the strategy earlier in the chapter, mutating the b-side of the active
site and the b-side of the allosteric site isolates the 30 Å interaction via it’s 1:3
hybrid (1|1), and by mutating the b-side of the active site and the a-side of the
allosteric site, the 32 Å interaction is isolated via it’s 1:3 hybrid (1|1).
Unfortunately, a problem arose in forming hybrids when mutating the b-
side of the active site, thus requiring the addition of the D12A mutation to form
all the hybrid species.  We surmised that the D12A mutation provides some
kind of compensatory effect at the interface of the protein (possibly involving
H160 across the interface) resulting in an increase in the overall quaternary
stability of the tetramer as seen in both native PAGE analysis and KSCN
denaturation profiles.  The entire effect of the D12A mutation is not entirely
understood, but is further complicated by the fact that the D12A mutation not
only affects the active site, but also appears to affect the allosteric site(s).  This
long-range effect is evident from the KSCN denaturation profiles, which
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indicates that the D12A mutation alleviates a majority of the decreased stability
associated with the R25E allosteric site mutation.  Furthermore, the binding
affinity for the inhibitor PEP for the D12A/K90E/K91E mutant protein is at least
an order of magnitude tighter as compared to wild-type as seen in Fig. 3-20.
This long-range phenomenon has precedence as Valdez et al. (1989) reported a
68-fold increase in binding affinity for PEP in the R252A protein (BsPFK) relative
to wild-type, while Fenton and Reinhart (2003) have also reported similar long-
range effects of mutations at the active site influencing binding at the allosteric
site in the E. coli form of the enzyme.  Since an analogous mutation is not
necessary when using mutations on the a-side of the active site (R162E), we
believe that the R162E mutation does not create the same interfacial problems
observed with mutations on the b-side of the active site.
In order to isolate the 1:3 hybrid from the other six possible enzyme
species, the K90E/K91E charge tag was added to the mutated subunits (Kimmel
and Reinhart, 2001).  Based upon the allosteric site mutant used (R25E for the 30
Å interaction or R211E/K213E for the 32 Å interaction), the extent of separation
of the seven hybrid species via anion exchange chromatography varied.  This
behavior is believed to be due to the solvent accessibility of R211 and this
possibility will be further addressed in Chapter V.  However, isolation of the 1:3
hybrid from the other enzyme species was never problematic.
With the ability to isolate the 30 Å and 32 Å interactions via the 1|1
hybrids, the couplings were determined by monitoring the apparent   
† 
K1/2  for
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FIGURE 3-20  Comparison of the relative binding affinities for the allosteric
inhibitor PEP of wild-type BsPFK (l) and the D12A/K90E/K91E mutant protein
(°).  The curves represent the best fit of these data to Eq. 2-4 as described in the
text.  The vertical lines correspond to the point at which PEP begins binding and
influencing the binding of the substrate Fru-6-P for wild-type (æ) and the
D12A/K90E/K91E (----) proteins.  Error bars represent ± the standard error and
are smaller than the symbol when not evident.
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Fru-6-P at increasing concentrations of the inhibitor PEP.  Not surprisingly, the
individual Fru-6-P saturation profiles adhered to almost every expectation.  The
  
† 
K1/2  for Fru-6-P at the native active site in the absence of PEP is identical to
wild-type for both interactions and at all five pH values except for some minor
changes at pH 8.0 that is most likely due to the ionization of a His residue near
the active site binding pocket.  As for the mutated active sites, the   
† 
K1/2  for Fru-6-
P is equivalent to the   
† 
K1/2  for Fru-6-P determined for their active site mutant
counterparts.  The   
† 
Vmax  and   
† 
Vmax'  values also obtained from the individual Fru-
6-P saturation profiles followed expectations by equaling 25% and 75% of wild-
type activity respectively.
In plotting the apparent   
† 
K1/2  for Fru-6-P against increasing
concentrations of PEP, two phases are observed for both the 30 Å interaction
and the 32 Å interaction, with the first phase containing the desired information
regarding the interaction between the two native binding sites.  The second
phase, on the other hand, corresponds to the influence upon Fru-6-P affinity
from the three mutated allosteric sites (see (l) data in Fig. 3-17).  This second
phase is easily corrected for by obtaining the analogous data with a control
hybrid that contains only one native active site, three mutated active sites and
four mutated allosteric sites (1|0 hybrid).  The 1|1 data is then corrected for by
using Eq. 3-1, and the resulting data corresponds to the influence of a particular
allosteric site upon a particular active site and vice versa.
The individual couplings (  
† 
Qay ) obtained for the 30 Å and 32 Å
interactions are quite different from one another.  Interestingly, the 30 Å
126
interaction is “allosterically silent” at pH 6.0 and 6.5, meaning that PEP binding
has no inhibitory effect upon the binding of Fru-6-P at that particular active site
or vice versa.  It is not until pH 7.0 that an allosteric effect is observed.  As for the
32 Å interaction, an allosteric effect is measured at pH 6.0, however, it also does
not change until pH 7.0.  Both interactions from pH 7.0 and above behave like
the wild-type enzyme in that with increasing pH, PEP became a better inhibitor
for both interactions (Tlapak-Simmons and Reinhart, 1998).
Of the two interactions studied, the 32 Å interaction contributes more to
the allosteric response (inhibition) as its coupling free energy (∆Gay) is 0.34 ± 0.10
kcal/mol at pH 6.0 and increases to a value of 0.82 ± 0.12 kcal/mol at pH 8.0.
Whereas, the 30 Å interaction has a smaller yet significant role as it begins at a
coupling free energy of 0.00 ± 0.06 and increases to a value of 0.49 ± 0.11
kcal/mol.  Unexpectedly, both interactions have an almost identical overall net
change in coupling free energy over the pH range examined (∆∆GpH ~ 0.6
kcal/mol) indicating that pH affects the two interactions equally, possibly
suggesting that they share some of the same “communication pathway” within
the protein.
Comparing the values for the 30 Å and 32 Å interactions to the values
predicted for the concerted and sequential models, several conclusions can be
made.  First, the concerted model is incompatible with our data because the
couplings of the 30 Å and 32 Å interactions are different at all the pH values
investigated.  Secondly, the sequential model is not in agreement with our data
either at pH 7.0 and above because the two interactions are unique in their
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relative magnitudes and are always greater than zero.  However, the sequential
model does hold true at pH 6.0 and 6.5 because the coupling for the 30 Å
interaction is zero at those pH values.  Nevertheless, the third model, the
“conformational free/linkage” model described in the introduction, is consistent
with the data at all pH values because the couplings are unique in magnitude
regardless of the pH.  However, we cannot dismiss the fact that we have
introduced mutations throughout the enzyme in order to isolate each
interaction, and that the mutations may be the cause of the variability in the
couplings measured for the two interactions.  This possibility will be addressed
in the following chapter when we show how the entire allosteric effect incurred
by PEP is accounted for in the native enzyme (in the absence of PEP
cooperativity) by using the couplings determined here and those determined for
the 22 Å and 45 Å heterotropic interactions as well.
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CHAPTER IV
COMPARING THE RELATIVE ALLOSTERIC CONTRIBUTIONS OF THE
FOUR UNIQUE HETEROTROPIC INTERACTIONS FOUND WITHIN
PHOSPHOFRUCTOKINASE FROM Bacillus stearothermophilus TO THE
NATIVE HOMOTETRAMER 
Introduction
The basis for allosteric communication within oligomeric proteins for the
most part remains an enigma.  In part this is due to the inherent complications
associated with the multiplicity of ligand binding sites usually present in an
oligomer.  Even in the simplest homotetramer containing a single active site and
single allosteric site per subunit, no fewer than four possible heterotropic
interactions, and six possible homotropic interactions exist by which the binding
of one ligand can influence the binding of another.  To illustrate the point, one
might consider the question, how does the binding of an allosteric ligand at each
of the four allosteric sites influence the binding of the substrate at a single active
site?  The popular simplifying models of allosterism, namely the concerted
model of Monod, et al. (1965) and the sequential model described by Koshland,
et al. (1966), provide answers to this question that represent opposite extremes
(Fig. 4-1).
As discussed in Chapter III, the concerted model suggests that the initial
binding of one equivalent of an allosteric inhibitor to any of the four allosteric
                                                 
Portions of this text comprise an article that has been submitted for publication
by A. Ortigosa, J. Kimmel and G. Reinhart.
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FIGURE 4-1  Contrasting predictions of the concerted and sequential models
regarding the influence of the binding of a single allosteric ligand to the binding
of substrate at a single active site associated with the shaded subunit.  In the
concerted model, binding of the allosteric ligand, X, to any site influences the
binding to the active site to the same degree as commonly denoted by the
change in shape from circle to square.  In the sequential model, binding to only
one site influences the binding of substrate at the shaded site.
130
sites will influence a particular active site to the same degree.  The sequential
model, on the other hand, suggests that the occupancy of only one of the four
allosteric sites will perturb the binding of a particular active site, whereas
binding to the remaining sites would have no effect.  Reality, of course, may lie
somewhere in between these two extremes, with the binding of an allosteric
ligand to each site exerting a unique and varying influence on the binding to a
particular active site.  Such a circumstance would suggest that multiple allosteric
routes of communications might exist.
To address this question of how enzymes are allosterically regulated, we
have chosen to study phosphofructokinase from Bacillus stearothermophilus
(BsPFK).  BsPFK is a homotetramer containing on average, one active site and
one allosteric site per subunit, and a schematic of how the four individual
subunits and their binding sites are organized is shown in Fig. 4-2.  Besides
elucidating the subunit organization found within BsPFK, Fig. 4-2 also
emphasizes the positively charged residues that line each of the ligand binding
sites as well as the nomenclature used in identifying the individual “sides” of
the active sites and allosteric sites (Schirmer and Evans, 1990).  Moreover, since
BsPFK contains four active sites and four allosteric sites, 16 possible heterotropic
interactions exist with four of those interactions being unique.  We have
identified the 16 allosteric interactions in Fig. 4-2 as well as the four unique
allosteric interactions, which we have designated as the 22 Å, 30 Å, 32 Å or 45 Å
heterotropic interactions.
In order to determine if each heterotropic interaction plays a unique role
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FIGURE 4-2  The subunit and binding site organization of BsPFK and the heterotropic interactions
possible between the eight binding sites.  (A)  The active sites are located along one dimer-dimer interface
while the allosteric sites are located along the other.  Moreover, the “sides” of the binding sites have been
designated as either the a-side or b-side for the active sites or the a-side or b-side for the allosteric sites.
(B)  Sixteen total pair-wise heterotropic interactions are possible between the four active sites and four
allosteric sites.  (C)  Of the 16 interactions, four are unique and have been designated as the 22 Å (blue),
30 Å (red), 32 Å (green) and 45 Å (magenta) interactions.  These designations correspond to the measured
distances between the phosphorous atom of the Fru-6-P molecule bound in the active site to the terminal
b-phosphorous atom of the ADP molecule bound in each of the four allosteric sites (Schirmer and Evans,
1990).
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in the observed allosteric behavior found in the native tetramer, we needed a
method for isolating each of the four heterotropic interactions so that we could
quantify the allosteric effect associated with each interaction.  To accomplish this
we created heterotetramers of BsPFK to contain only one native active site and
one native allosteric site, thus eliminating 15 of the 16 total heterotropic
interactions and permitting characterization.  Furthermore, by simply
manipulating the particular native active site and native allosteric site that
remain within a given heterotetramer, all four heterotropic interactions can be
successfully isolated and characterized.
This chapter summarizes our efforts to measure the four potentially
unique heterotropic allosteric interactions that exist in BsPFK, and our results
suggest, perhaps not surprisingly, that neither the concerted nor the sequential
models properly describe the network of allosteric communication in this
enzyme.  Rather, the occupancy of each allosteric site by the inhibitor introduces
a unique effect on the binding of the substrate to a particular active site.
Materials and methods
The materials and methods used for the experiments described in this
chapter are the same as described in Chapter II.  Site-directed mutagenesis,
protein purification, hybrid formation via monomer exchange and their
subsequent isolation, enzymatic activity measurements at varying pH, and data
analysis were performed as described in Chapter II.  Preparation, isolation and
data analysis pertaining to the 22 Å interaction at pH 7.0 and 8.0 and the 45 Å
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interaction utilizing the R162E active site mutation at pH 6.0, 7.0 and 8.0 were
performed by Kimmel (2001).
Data analysis.  As mentioned in Chapter II,   
† 
Qay  is determined by
measuring the   
† 
K1 /2  for Fru-6-P at increasing concentrations of PEP and the
subsequent data fit to Eq. 2-4.  In order to make things easier, Eq. 2-4 has been
repeated here:
  
† 
K1 /2 = Kiao
Kiyo + [Y]
Kiyo + Qay[Y]
Ê 
Ë 
Á Á 
ˆ 
¯ 
˜ ˜ (4-1)
Data pertaining to both the native tetramer and the 1:3 hybrids (1|1) have been
fit with Eq. 4-1, and for either case, the single substrate, single modifier model
sufficiently fits the data (Tlapak-Simmons and Reinhart, 1994, 1998; Johnson and
Reinhart, 1994, 1997; Kimmel and Reinhart, 2001; Fenton and Reinhart, 2002).
The legitimacy however in using Eq. 4-1 becomes questionable when the
number of native active sites is not equivalent to the number of native allosteric
sites.  This situation arises later in the chapter when a wild-type control hybrid
is constructed to address the effects of the homotropic interactions between the
allosteric sites upon the observed allosteric effect in the native tetramer.
For the wild-type control hybrid (4|1), three of the allosteric sites have
been mutated, eliminating the four-fold redundancy found in the native
tetramer and abolishing the homotropic interactions between the allosteric sites.
In order to address this discrepancy in the number of binding sites and its
subsequent effect upon   
† 
Qay , we can consider an analogous situation occurring in
a symmetrical dimer containing two native active sites and one native allosteric
134
site which can be derived from the two active sites and two allosteric sites case
considered by Reinhart (1988) (Weber 1972 and 1975).  In this case, Eq. 4-1
becomes the following:
  
† 
K1 /2 = Kiao
Kiyo + [Y]
Kiyo + Qay
2[Y]
Ê 
Ë 
Á Á 
ˆ 
¯ 
˜ ˜ 
1 /2
(4-2)
The apparent coupling for the dimer,   
† 
Qapp , can then be estimated when
considering the two concentration extremes for Y, zero and infinity:
  
† 
Qapp =
lim
YÆ0
K1/2
lim
YÆ•
K1/2
(4-3)
substituting Eq. 4-2 into Eq. 4-3 yields:
  
† 
Qapp =
Kiao
Kiao
1
Qay
2
Ê 
Ë 
Á Á 
ˆ 
¯ 
˜ ˜ 
1/ 2 (4-4)
which in turn implies:
  
† 
Qapp = Qay (4-5)
Using Eq. 2-6 to convert the couplings into free energy terms, Eq. 4-5 becomes:
  
† 
DGapp = DGay (4-6)
Thus, the measured coupling is equal to an average of the two heterotropic
couplings that exist in the dimer in the absence of homotropic effects between
the allosteric sites.  Applying this result to our symmetrical tetramer, we would
then assume the same phenomenon would occur leading to the measured
coupling in the wild-type control hybrid (4|1) equaling an average of the four
heterotropic couplings that exist in the tetramer.  Thus, for the coupling free
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energy determined for the wild-type control hybrid to be equivalent to the
coupling free energy determined for the native tetramer in the absence of
homotropic effects between the allosteric sites, the coupling free energy for the
wild-type control hybrid needs to be multiplied by 4.
  
† 
DGtetramer = 4 ⋅ DG(4 |1 )hybrid (4-7)
Results
Isolation of the four heterotropic interactions via their respective 1:3
hybrids.  As was previously shown by Kimmel and Reinhart (2001) and in
Chapter III, the positively charged residues that make-up either the a-side or the
b-side of the active site or the a-side or b-side of the allosteric site can be
successfully mutated to discourage Fru-6-P and PEP binding by more than two
orders of magnitude as compared to wild-type.  Furthermore, by simply
manipulating the “sides” of the active sites and allosteric sites that are mutated,
four mutant proteins result which have been designated as the [a,a], [a,b], [b,a]
and [b,b] mutants proteins where the first letter refers to the “side” of the active
that is mutated while the second letter refers to the “side” of the allosteric site
that is mutated.  Table 4-1 summarizes the active site and allosteric site
mutations that are used in this investigation to create the four mutant proteins
and the heterotropic interaction that is isolated in the 1:3 hybrid (hybridization
with the wild-type enzyme).  The four different 1:3 hybrids are shown
schematically in Fig. 4-3 indicating the “sides” of the binding sites that are
mutated, and the heterotropic interaction that is isolated.
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TABLE 4-1  List of the active site and allosteric site mutations used in the
isolation of the four individual allosteric heterotropic interactions
Mutant
Proteina
Active Site
Mutation
(a or b-side)
Allosteric Site
Mutation
(a or b-side)
Heterotropic
Interaction Isolated
via the 1|1 Hybrid
[a,a] R162E (a) R211E/K213E (a) 22 Å
[b,a] R252A/D12A (b) R25E (b) 30 Å
[b,b] R252A/D12A (b) R211E/K213E (a) 32 Å
[a,b] R162E or R243E (a) R25E (b) 45 Å
aAll four mutant proteins also contain the K90E/K91E charge tag on the surface
of the protein to permit isolation of the 1:3 hybrid from the other hybrid species.
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FIGURE 4-3  The two-dimensional schematics of the four possible 1:3 hybrids
highlighting the binding site mutations used to isolate each of the four
heterotropic interactions.  (A)  The 1:3 hybrid (1 wild-type subunit: 3 [a,a]
mutant subunits) that isolates the 22 Å heterotropic interaction.  The R162E
mutation was used in the active site, and the R211E/K213E mutations were used
in the allosteric site.  (B)  The 1:3 hybrid (1 wild-type subunit: 3 [b,b] mutant
subunits) that isolates the 30 Å heterotropic interaction.  The R252A/D12A
mutations were used in the active site, and the R25E mutation was used in the
allosteric site.  (C)  The 1:3 hybrid (1 wild-type subunit: 3 [b,a] mutant subunits)
that isolates the 32 Å heterotropic interaction.  The R252A/D12A mutations
were used in the active site, and the R211E/K213E mutations were used in the
allosteric site.  (D)  The 1:3 hybrid (1 wild-type subunit: 3 [a,b] mutant subunits)
that isolates the 45 Å heterotropic interaction.  Either the R162E mutation or the
R243E mutation was used in the active site, and the R25E mutation was used in
the allosteric site.
138
30 Å
A
B C
D
B
32 Å
A
B C
D
C
b-side of the active site mutated (R252A/D12A)
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22 Å
D
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A
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D
a-side of the allosteric site mutated (R211E/K213E)
a-side of the active site mutated (R162E)
b-side of the allosteric site mutated (R25E)
a-side of the active site mutated (R162E or R243E)
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A unique case arose when investigating the allosteric properties of the 45
Å heterotropic interaction requiring an additional [a,b] mutant protein to be
constructed.  Instead of using the R162E mutation, R243E was used as the a-side
active site mutation.  R243 is adjacent to R162 and is seen in the crystal structure
within hydrogen bonding distance of the bound Fru-6-P molecule at the active
site (Schirmer and Evans, 1990).  Characterization of the R243E active site
mutation alone yielded results similar to its R162E counterpart (Kimmel,
unpublished), in that it diminished Fru-6-P binding by more than two orders of
magnitude compared to wild-type.  A summary of the R243E steady-state
kinetic data along with the data for the other active site and allosteric site
mutations utilized for this investigation are found in Table 4-2.
In addition to the active site and allosteric site mutations necessary to
isolate a particular interaction, a surface charge tag mutation (K90E/K91E) has
also been added to the mutant subunits to facilitate separation of the 1:3 hybrid
from the other six enzyme species.  The charge tag is designated schematically in
Fig. 4-3 as the “lolli-pop” structure on the surface of the mutant subunits.
Moreover, it was also previously shown that the K90E/K91E mutations have no
adverse affects upon the kinetic or allosteric properties of BsPFK and the
mutations solely provide a charge differential amongst the different hybrid
species to permit separation of the various enzyme species (Kimmel and
Reinhart, 2001).
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TABLE 4-2  Steady-state kinetic and thermodynamic coupling parameters
for the wild-type, the active site mutants and the allosteric site mutants at
25°C and pH 7.0 with [MgATP] = 3 mM
Enzyme   
† 
Vmax
(Units/mg)a   
† 
K1/2  (mM)a   
† 
nHa   
† 
Kiyo  (mM)b   
† 
Qay b
wild-
type
125 ± 2 0.021 ± 0.001 1.30 ± 0.09
0.023 ±
0.002
0.0085 ±
0.0004
R252A/
D12A
122 ± 3 5.0 ± 0.3 1.17 ± 0.05 ND ND
R162Ec 146 ± 6 21.2 ± 1.9 1.15 ± 0.06 ND ND
R243Ec,d 132 ± 4 7.3 ± 0.8 0.90 ± 0.06 ND ND
R25E 91 ± 1 0.047 ± 0.002 1.27 ± 0.05 ~100 UD
R211E/
K213Ec
109 ± 1 0.058 ± 0.001 1.12 ± 0.08 ~20 UD
ND = Not Determined
UD = Undetermined
aPertaining to Fru-6-P saturation profiles at 0 mM PEP.  Parameters determined
from fitting data to Eq. 2-1.
bParameters obtained by fitting to Eq. 2-4.
cExperiment performed under identical conditions except at pH 8.0 and utilizing
EPPS buffer instead of MOPS buffer (Kimmel and Reinhart 2001).
dParameters determined by Kimmel (unpublished).
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Each of the four possible 1:3 hybrids shown in Fig. 4-3 were constructed
and isolated in the same manner as described in Chapter II and Chapter III,
utilizing the method that was originally designed for the isolation of the 22 Å
interaction (Kimmel and Reinhart, 2001).  All five of the isolated 1:3 hybrids
(two 1:3 hybrids for isolating the 45 Å interaction) were stored at 4°C and no re-
hybridization between subunits was observed for at least four weeks as
confirmed by native PAGE analysis (data not shown).
Isolation of the control hybrids (1|0).  As was discussed in Chapter III
for the 1:3 hybrids that isolate the 30 Å and 32 Å interactions, control hybrids are
necessary to correct for the influence PEP binding at the three mutated allosteric
site has upon the measured allosteric effect at the lone native active site.
Although the effect is minimal, it was previously shown by Kimmel and
Reinhart (2001) and in Chapter III, that this correction is not only necessary, but
also significant.  Each control hybrid consists of one native active site, three
mutated active sites and four mutated allosteric sites (1|0), and were
constructed just like the 1:3 hybrids, except the appropriate allosteric site mutant
was substituted for the wild-type parental protein.  For the [a,a ] and [b,a]
mutant proteins, the R211E/K213E allosteric site mutant protein was used,
whereas for the [a,b] and [b,b] mutant proteins, the R25E allosteric site mutant
was used.  The four different control hybrids are shown schematically in Fig. 4-4
(two control hybrids for the 45 Å interaction).  All five of the isolated control
hybrids were stored at 4°C and no re-hybridization between the subunits was
observed for at least 4 weeks as confirmed by native PAGE analysis (data not
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FIGURE 4-4  The two-dimensional schematics of the four control hybrids (1|0)
constructed in order to correct for the allosteric effect incurred upon the native
active site by PEP binding to the mutated allosteric sites.  In all four cases, the
wild-type subunit is replaced with the corresponding allosteric site mutant
protein resulting in only one native active site and no native allosteric sites.  (A)
The 1:3 control hybrid (1 R211E/K213E subunit: 3 [a,a] mutant subunits) for
correcting the data pertaining to the 22 Å interaction.  (B)  The 1:3 control hybrid
(1 R25E subunit: 3 [b,b] mutant subunits) for correcting the data pertaining to
the 30 Å interaction.  (C)  The 1:3 control hybrid (1 R211E/K213E subunit: 3 [b,a]
mutant subunits) for correcting the data pertaining to the 32 Å interaction.  (D)
The 1:3 control hybrid (1 R25E subunit: 3 [a,b] mutant subunits – using either the
R162E or R423E mutation in the active site) for correcting the data pertaining to
the 45 Å interaction.
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shown).
Functional properties of the five 1:3 hybrid (1|1) enzymes in the
absence of PEP.  The dependence of enzyme activity as a function of Fru-6-P
concentration was determined for the wild-type enzyme, as well as the five 1:3
hybrids at pH 6.0, 7.0 and 8.0.  The Fru-6-P saturation profiles for each of the 1:3
hybrids exhibited the saturation of two different types of binding sites,
corresponding to the high affinity and low affinity active sites respectively as
shown in Chapter III for the 30 Å and 32 Å interactions.  Data obtained from the
Fru-6-P saturation profiles for the wild-type enzyme were fit to Eq. 2-1 (Hill
equation), whereas the data for the 1:3 hybrids were fit to Eq. 2-2, in which two
Michaelis-Menten equations are summed together.
Table 4-3 summarizes the kinetic parameters obtained from these fits for
wild-type enzyme and both the high affinity (native) and low affinity (mutated)
Fru-6-P binding sites found in the five 1:3 hybrids.  All four parameters
calculated for the five hybrids (  
† 
Vmax ,   
† 
K1/2  for Fru-6-P,   
† 
Vmax'  and   
† 
K1/2'  for Fru-6-P)
agree primarily with one another, and more importantly, conform to expected
results.  At all pH values, the maximal specific activity for the high affinity
interaction (  
† 
Vmax ) for all five 1:3 hybrids is approximately one-fourth that of
wild-type.  Moreover, the maximal specific activity for each of the 1:3 hybrids
increases with an increase in pH, a behavior consistent with the wild-type
enzyme (Tlapak-Simmons and Reinhart, 1998).  The values obtained for the   
† 
K1 /2
for Fru-6-P agree, within error, with the   
† 
K1 /2  values for the wild-type enzyme
with the exception of the 32 Å interaction at pH 8.0.
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TABLE 4-3  Steady-state kinetic parameters for wild-type BsPFK and the
four 1:3 hybrids containing the four individual allosteric interactions
within BsPFK at 25°C, pH 6.0, 7.0 and 8.0, [MgATP] = 3 mM and [PEP] = 0
mM
Enzyme
  
† 
Vmax
(Units/mg)
high affinity
  
† 
K1/2
(mM)
high affinity
  
† 
Vmax'
(Units/mg)
low affinity
  
† 
K1/2'
(mM)
low affinity
pH 6.0
wild-type 67.1 ± 1.1 0.032 ± 0.001 n/a n/a
22 Å interaction 22.5 ± 0.5 0.028 ± 0.002 85 ± 1 3.6 ± 0.1
30 Å interaction 15.4  ± 0.4 0.035 ± 0.003 36 ± 1 8.0 ± 0.3
32 Å interaction 14.5 ± 0.5 0.031 ± 0.003 46 ± 2 10.0 ± 0.8
45 Å interaction
(R162E) 19.4 ± 1.1 0.039 ± 0.007 85 ± 1 6.2 ± 0.3
45 Å interaction
(R243E) 17.6 ± 0.8 0.028 ± 0.004 50 ± 1 5.7 ± 0.5
pH 7.0
wild-type 125 ± 2 0.021 ± 0.001 n/a n/a
22 Å interaction 28.0 ± 1.0 0.029 ± 0.004 113 ± 2 8.6 ± 0.5
30 Å interaction 26.7 ± 0.7 0.020 ± 0.002 96 ± 3 12.1 ± 0.7
32 Å interaction 30.9 ± 1.1 0.047 ± 0.005 94 ± 3 9.6 ± 0.5
45 Å interaction
(R162E) 29.2 ± 0.8 0.024 ± 0.002 114 ± 1 9.3 ± 0.4
45 Å interaction
(R243E) 28.0 ± 1.3 0.017 ± 0.003 95 ± 2 6.3 ± 0.5
pH 8.0
wild-type 153 ± 3 0.034 ± 0.001 n/a n/a
22 Å interaction 36 ± 1 0.034 ± 0.004 90 ± 3 25 ± 2
30 Å interaction 37 ± 2 0.079 ± 0.008 UD UD
32 Å interaction 38 ± 2 0.310 ± 0.035 UD UD
45 Å interaction
(R162E) 39 ± 1 0.038 ± 0.003 123 ±10 42 ± 6
45 Å interaction
(R243E) 39 ± 2 0.024 ± 0.004 117 ± 3 8.3 ± 0.9
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As for the low affinity active sites, the maximal specific activities (  
† 
Vmax' )
are approximately three-fourths the   
† 
Vmax  value obtained for the mutant
tetramer, which is comparable to three-fourths the   
† 
Vmax  value obtained for the
wild-type enzyme.  Furthermore, the values obtained for the   
† 
K1/2'  for Fru-6-P are
comparable to the measured   
† 
K1 /2  for Fru-6-P values for their respective active
site mutant enzymes alone.
Measuring the allosteric effect for each of the heterotropic interactions.
In order to measure the allosteric effect for each of the four heterotropic
interactions, the   
† 
K1 /2  for Fru-6-P was determined as a function of increasing PEP
concentration for each of the five 1:3 hybrids and their corresponding control
hybrids at pH 6, 7 and 8.  Fru-6-P titrations at pH 6.0, 7.0 and 8.0 were
performed for each 1:3 hybrid and its corresponding control hybrid at increasing
concentrations of PEP.  In all cases, the measured coupling for each 1:3 hybrid
was corrected for by using the following equation:
  
† 
K1 /2 (corrected) =
K1 /2 (1 | 1)
K1 /2 (1 | 0)
(4-8)
Figure 4-5 shows the corrected values for the   
† 
K1 /2  for Fru-6-P plotted as a
function of PEP concentration at the three pH values investigated.  With the
exception of the 30 Å interaction at pH 6.0 and the 45 Å interaction at all pH
values, the high affinity binding site of each of the 1:3 hybrids was found to
behave like the wild-type enzyme in that the addition of PEP increased the   
† 
K1 /2
for Fru-6-P in a saturable manner.
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FIGURE 4-5  The dependence of the corrected apparent   
† 
K1/2  for Fru-6-P on
increasing concentrations of the inhibitor PEP for the 22 Å interaction (l), the 30
Å interaction (n), the 32 Å interaction (°) and the 45 Å interaction (o).  The
data shown for the 45 Å interaction is from using the R243E active site mutation.
The data obtained at pH 6.0 were performed in buffer containing 50 mM MES-
KOH, the data for pH 7.0 were performed in buffer containing 50 mM MOPS-
KOH, and the data for pH 8.0 were obtained using buffer containing 50 mM
EPPS-KOH.  All the curves correspond to the best fit of these data to Eq. 2-4 as
described in the text.  (A )  Data corresponding to pH 6.0.  (B )  Data
corresponding to pH 7.0.  (C)  Data corresponding to pH 8.0.
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A summary of the thermodynamic parameters obtained from fitting these
data to Eq. 2-4 is found in Table 4-4.  The measured coupling,   
† 
Qay , for each of
the 1:3 hybrids was reduced to different extents (one even becoming
allosterically “silent”) relative to the wild-type enzyme.  Moreover, all the
heterotropic interactions, with the exception of the 45Å interaction, display an
increase in coupling with an increase in pH, a phenomenon consistent with the
wild-type enzyme (Tlapak-Simmons and Reinhart, 1998).
Using Eq. 2-6 to convert the calculated   
† 
Qay  to ∆Gay, it was found that the
22 Å heterotropic interaction dominated the allosteric effect incurred by the
binding of PEP at all three pH values.  The 22 Å interaction contributes 22 ± 5%,
23 ± 4% and 41 ± 4% to the overall coupling free energy determined for the wild-
type tetramer at pH 6.0, 7.0 and 8.0 respectively.  The 32 Å interaction also
contributes significantly at all pH values with 18 ± 5%, 20 ± 4% and 23 ± 3% at
pH 6.0, 7.0 and 8.0.  Interestingly, the 30 Å interaction is the only interaction that
becomes allosterically “silent” at pH 6, meaning that the binding of PEP has no
effect upon the binding of Fru-6-P or vice versa.  However, at pH 7.0 and pH 8.0
the 30 Å interaction contributes 11 ± 4% and 14 ± 3% respectively to the overall
observed coupling free energy determined for the wild-type tetramer.  As for
the 45 Å heterotropic interaction, it was initially measured to have a coupling
free energy of 0 kcal/mol at all the pH values examined using the R162E active
site mutation.  To confirm this phenomenon, a second [a,b] mutant protein was
constructed where the active site mutation, R162E, was replaced with the R243E
mutation.  Upon implementing the mutation in making the 1:3 hybrids (both the
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TABLE 4-4  Thermodynamic parameters for wild-type and the four
individual allosteric interactions (control subtracted) at 25°C, pH 6.0, 7.0 and
8.0 and [MgATP] = 3 mM
Enzyme   
† 
Kiao
(mM)
  
† 
Kiyo
(mM)   
† 
Qay   
† 
DGay
(kcal/mol)
% of
WT
pH 6.0
WT 0.032 ± 0.001 0.026 ± 0.002 0.041 ± 0.002 1.89 ± 0.03 -
22 Å 0.026 ± 0.002 0.091 ± 0.086 0.50 ± 0.08 0.41 ± 0.10 22 ± 5
30 Å 0.030 ± 0.002 UD 1.00 ± 0.10 0.00 ± 0.06 0
32 Å 0.029 ± 0.005 0.0045 ± 0.0061 0.56 ± 0.10 0.34 ± 0.10 18 ± 5
45 Å
(R162E) 0.037 ± 0.004 UD 1.00 ± 0.15 0.00 ± 0.09 0
45 Å
(R243E) 0.033 ± 0.006 0.27 ± 0.08 0.68 ± 0.18 0.23 ± 0.14 12 ± 8
pH 7.0
WT 0.030 ± 0.002 0.023 ± 0.002 0.0085 ±0.0004 2.82 ± 0.03 -
22 Å 0.023 ± 0.002 0.079 ± 0.047 0.33 ± 0.05 0.66 ± 0.10 23 ± 4
30 Å 0.019 ± 0.004 0.0003 ± 0.0007 0.59 ± 0.11 0.31 ± 0.11 11 ± 4
32 Å 0.035 ± 0.006 0.003 ± 0.002 0.38 ± 0.07 0.57 ± 0.10 20 ± 4
45 Å
(R162E) 0.024 ± 0.001 UD 1.00 ± 0.06 0.00 ± 0.03 0
45 Å
(R243E) 0.022 ± 0.005 0.04 ± 0.02 0.77 ± 0.18 0.18 ± 0.14 6 ± 5
pH 8.0
WT 0.027 ± 0.001 0.039 ± 0.001 0.0020 ±0.0001 3.58 ± 0.02 -
22 Å 0.031 ± 0.002 0.22 ± 0.07 0.08 ± 0.02 1.48 ± 0.15 41 ± 4
30 Å 0.074 ± 0.014 0.002 ± 0.001 0.44 ± 0.08 0.49 ± 0.11 14 ± 3
32 Å 0.31 ± 0.06 0.0004 ± 0.0003 0.25 ± 0.05 0.82 ± 0.12 23 ± 3
45 Å
(R162E) 0.038 ± 0.001 UD 1.00 ± 0.04 0.00 ± 0.02 0
45 Å
(R243E) 0.026 ± 0.003 2.0 ± 0.9 0.78 ± 0.24 0.17 ± 0.20 5 ± 5
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1|1 hybrid and the 1|0 hybrid), and performing the characterization, a minimal
amount of a coupling free energy was measured for the 45Å interaction at pH
6.0, 7.0 and 8.0 contributing 12 ± 8%, 6 ± 5% and 5 ± 5% to the overall allosteric
effect measured for the tetramer.
Why this discrepancy occurred in analyzing the two different [a,b]
mutant constructs that isolate the 45 Å interaction is not entirely known, but we
speculate it could be due to the manner by which the data for the 1:3 hybrid
(1|1) using the R162E mutant were corrected.  Due to time constraints, the
control hybrid was only analyzed at pH 8.0; consequently, all the data for the 1:3
hybrid (1|1) at pH 6.0, 7.0 and 8.0 were corrected with only the pH 8.0 control
data (Kimmel, 2001).  This differs significantly from the way the other three
interactions and the alternative way to isolate the 45 Å interaction (using R243E)
were characterized.  In those cases, each 1:3 hybrid and its corresponding
control hybrid were individually analyzed at each pH with the same
experimental conditions to ensure the correction was as accurate as possible.
Figure 4-6 shows the variance in the control hybrid data that isolates the 45 Å
interaction using the R243E mutation at pH 6.0, 7.0 and 8.0.  Although there is
not a major difference between the three pH values, there is some variance
between the three data sets validating the necessity to perform the control
hybrid experiments using the identical conditions that were used for the 1:3
hybrid, especially when a minimal amount of coupling may be present.
When summing together all of the coupling free energies for the four
heterotropic interactions at pH 6.0, 7.0 and 8.0, the entire allosteric effect
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FIGURE 4-6  The dependence of the apparent   
† 
K1/2  for Fru-6-P determined for
the 45 Å control hybrid (1|0) on increasing concentrations of the inhibitor PEP.
The data was obtained at 25°C and at pH 6.0 (l) using 50 mM MES-KOH, at pH
7.0 (n) using 50 mM MOPS-KOH and at pH 8.0 (°) using 50 mM EPPS-KOH.
The concentration of MgATP was equal to 3 mM, and the error bars represent ±
the standard error.
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measured for the native tetramer is never entirely accounted for by the four
individual heterotropic interactions as shown in Fig. 4-7.  At first we thought
this was due to the mutations we had introduced throughout the binding sites
and the surface of the protein in order isolate a given interaction; however, the
presence of homotropic effects between the allosteric sites seemed like a more
plausible explanation.  This hypothesis was supported by the fact that Riley-
Lovingshimer and Reinhart (2001) had measured a Hill number for PEP binding
of 2.9 ± 0.3 for a tryptophan-shifted mutant of BsPFK (determined by
fluorescence and in the absence of ATP and Fru-6-P).
In order to prove that cooperativity existed in the native enzyme as well
and in the presence of ATP and Fru-6-P, PEP titrations were performed on the
wild-type protein at pH 6.0, 7.0 and 8.0 using steady-state kinetics.  Figure 4-8
summarizes the results, and as expected, a substantial amount of cooperativity
was found between the PEP binding sites at low Fru-6-P (Hill number ~ 3);
however, at high Fru-6-P the cooperativity is diminished greatly to
approximately 1 at pH 6.0 and 7.0 and to about 1.5 at pH 8.0.  With the presence
of cooperativity confirmed within the native enzyme, a control hybrid was
constructed to contain four native active sites, and one native allosteric site,
eliminating the homotropic interactions between the allosteric sites (4|1).  A
schematic of this wild-type control hybrid is shown in Fig. 4-9.  The control
hybrid was constructed and isolated in the same manner as the other 1:3
hybrids, except the two parental proteins were wild-type BsPFK and the
R211E/K213E/K90E/K91E allosteric site mutant protein.  Steady-state kinetic
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FIGURE 4-7  Comparison of the sum of the individual coupling free energies
determined for the four heterotropic interactions to the coupling free energy
determined for the native tetramer at pH 6.0, 7.0 and 8.0.  The bar on the left at
each pH corresponds to the sum of the coupling free energies determined for the
22 Å interaction (white), the 30 Å interaction (light gray), the 32 Å interaction
(dark gray) and the 45 Å interaction (black), while the bar on the right at each
pH corresponds to the coupling free energy determined for the wild-type
enzyme (polka-dotted).
155
0
0.5
1
1.5
2
2.5
3
3.5
4
10-2 10-1 100 101 102
Hi
ll 
Nu
m
be
r
[Fru-6-P] mM 
FIGURE 4-8  The dependence upon the Hill number (  
† 
nH) determined for PEP
binding as a function of increasing concentrations of Fru-6-P for the wild-type
enzyme.  The data was obtained at 25°C and at pH 6.0 (l) using 50 mM MES-
KOH, at pH 7.0 (n) using 50 mM MOPS-KOH and at pH 8.0 (°) using 50 mM
EPPS-KOH.  The concentration of MgATP was equal to 3 mM, and the error bars
represent ± the standard error.
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FIGURE 4-9  A two-dimensional schematic of the wild-type control hybrid (4|1)
and the steady-state characterization of its allosteric properties at pH 6.0 (l), 7.0
(n) and 8.0 (°). The data was obtained at 25°C and using 50 mM MES-KOH at
pH 6.0, 50 mM MOPS-KOH at pH 7.0 and 50 mM EPPS-KOH at pH 8.0.  The
concentration of MgATP was equal to 3 mM, and the error bars represent ± the
standard error.
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analysis was performed to measure the effect of PEP binding upon Fru-6-P
binding and the data are shown in Fig. 4-9.  The parameters obtained from the
analysis are summarized in Table 4-5.
As was discussed earlier, Eq. 4-7 is used to equate the coupling free
energy determined for the wild-type control hybrid to the coupling free energy
determined for the wild-type enzyme in the absence of homotropic effects
between the allosteric sites.  Amazingly, the sum of the coupling free energies
determined for the individual heterotropic interactions equals, within error, the
coupling free energy determined (x4) for the wild-type control hybrid as seen in
Fig. 4-10.
Discussion
The agreement of the sum of the measured individual couplings with the
4|1 control provides strong evidence that the individual interactions isolated in
the respective 1:3 hybrids can be related directly to the corresponding
interaction as it exists in the native tetramer.  It is significant, therefore, that at
each pH examined, the value of each of the couplings is different, indicating that
the binding of a single Fru-6-P equivalent is influenced to a unique extent
depending on which of the four allosteric sites is occupied by PEP.  We note that
our data do not indicate how a second equivalent of bound PEP might further
influence the binding of that first Fru-6-P equivalent.  Nonetheless, this result
clearly lies in between the predictions made by either the concerted MWC
model or the sequential KNF model as summarized in Fig. 4-1.  It is also
unlikely, given the modest magnitudes of the individual couplings even at pH 8,
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TABLE 4-5  Thermodynamic parameters determined for the wild-type
control hybrid (4|1) at 25°C, pH 6.0, 7.0 and 8.0 and [MgATP] = 3 mM
  
† 
Kiao
(mM)
  
† 
Kiyo
(mM)   
† 
Qay 
∆Gay
(kcal/mol)
∆Gay x 4
(kcal/mol)
pH 6.0
WT
control
(4|1)
0.043 ±
0.001
1.4 ± 0.9 0.57 ± 0.07 0.33 ± 0.08 1.32 ± 0.32
pH 7.0
WT
control
(4|1)
0.021 ±
0.001
0.34 ± 0.10 0.50 ± 0.04 0.41 ± 0.05 1.64 ± 0.20
pH 8.0
WT
control
(4|1)
0.043 ±
0.001
0.15 ± 0.01 0.29 ± 0.01 0.73 ± 0.02 2.92 ± 0.08
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FIGURE 4-10  Comparison of the sum of the individual coupling free energies
determined for the four heterotropic interactions to the coupling free energy
determined for the wild-type control hybrid (4|1) and the wild-type enzyme
(4|4) at pH 6.0, 7.0 and 8.0.  The bar on the left at each pH corresponds to the
sum of the coupling free energies determined for the 22 Å interaction (white),
the 30 Å interaction (light gray), the 32 Å interaction (dark gray) and the 45 Å
interaction (black).  The bar in the middle at each pH corresponds to the
coupling free energy determined for the wild-type control hybrid (striped), and
the bar on the right at each pH corresponds to the coupling free energy
determined for the wild-type enzyme (polka-dotted).
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that a single species containing one bound PEP and one bound Fru-6-P would
be formed in a suitable titration experiment.  Although one would clearly expect
the concentration of the species with Fru-6-P and PEP 45 Å apart to dominate
(except at pH 6), the other species would be populated to lesser, but nonzero,
extents at ambient temperatures, especially at the lower pH values.  Thus a two-
state view of the structural response of BsPFK to ligand binding becomes far too
limiting a way of modeling its functional behavior, even in the seemingly simple
case of the binding of a single equivalent of each ligand.
These results also suggest that allosteric interactions proceed by different
pathways when considering how different sites are coupled.  Stated another
way, it is now reasonable to attempt to define the residues that are responsible
for transmitting the influence between the various pairs of active and allosteric
sites.  Furthermore, it is unlikely that the same residues will be important for
establishing the allosteric conduit in each case, although some residues may be
shared.  Since the hybrids isolate each individual interaction, determination of
the residues that participate in the transmission of the allosteric influence would
now seem to be possible, and these investigations are ongoing.
In order to isolate the 30 Å and 32 Å heterotropic interactions, the D12A
mutation on the outside of the b-side binding pocket was required as discussed
in Chapter III.  The entire effect of D12A is still unknown however from the
results presented here, we now feel confident that the mutation is not affecting
the allosteric coupling between the native active site and native allosteric site
because the sum of the coupling free energies of the individual heterotropic
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interactions is equal to the measured allosteric coupling for the 4|1 wild-type
control hybrid.  However, since the binding affinity for PEP is so different
between the interactions isolated in absence and presence of D12A, we do think
the D12A mutation influences the binding of PEP at both the native and mutated
allosteric sites.  However, this long-range effect has precedence as others have
also noted the same effects of mutations at the active site influencing binding at
the allosteric site in both BsPFK and EcPFK (Valdez et al., 1989, Fenton and
Reinhart, 2003).
With the four heterotropic interactions now isolated and characterized,
almost half of the allosteric interactions found in the native tetramer have now
been quantified.  Thus, the six homotropic interactions remain, and it is their
pair-wise isolations and characterizations that are the subjects of Chapters V and
VI.
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CHAPTER V
FORMATION AND ISOLATION OF THE 2:2 HYBRIDS
Introduction
Within BsPFK, the potential for twenty-eight pair-wise allosteric
interactions exist between the four active sites and four allosteric sites.  Of those
28 allosteric interactions, ten are unique and consist of four heterotropic
interactions and six homotropic interactions.  Up to this point, only the four
heterotropic interactions have been individually isolated and characterized
(Chapters III and IV); thus, the six homotropic interactions remain: three
homotropic interactions between active sites (28 Å, 47 Å and 45 Å) and three
homotropic interactions between allosteric sites (23 Å, 40 Å and 39.9 Å).  As the
name implies, the homotropic interactions involve the allosteric communication
between like binding sites, and in order to tell them apart, a distance has been
assigned to each one which corresponds to the distance measured between the
relevant binding sites within the crystal structure (Schirmer and Evans, 1990).
More specifically, the active site homotropic interactions are differentiated by
the distances measured in between the phosphorous atoms of the Fru-6-P
molecules bound in the active sites, while the allosteric site homotropic
interactions are differentiated by the distances measured between the b-
phosphorous atoms of the ADP molecules bound in the allosteric sites.  Of the
28 possible pair-wise allosteric interactions found within BsPFK, 12 are
homotropic interactions, and of those 12, 6 are unique, all of which are shown
schematically in Fig. 5-1.
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FIGURE 5-1  Three schematics depicting the pair-wise allosteric interactions
possible within BsPFK.  (A)  28 total pair-wise allosteric interactions are possible
between the four active sites and four allosteric sites.  (B)  Of those 28, 12 are
homotropic interactions (the interaction between like binding sites).  (C)  Of the
12 homotropic interactions, 6 are unique and have been assigned a different
color and distance, which corresponds to the distance measured between the
relevant binding sites within the crystal structure (Schirmer and Evans, 1990).
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If our ultimate goal is to better understand the mechanism of allosteric
regulation, and more specifically inhibition, then the allosteric contributions of
the remaining six homotropic interactions need to be determined.  However,
within the native tetramer, two copies of each of the six homotropic interactions
exist; thus, a reduction in the number of native binding sites, and hence the
allosteric complexity is required.  Utilizing the same hybrid-forming technique
and mutant proteins described in Chapters III and IV, we show here the
formation and isolation of the 2:2 hybrids and the ultimate characterizations of
the six homotropic interactions (see Chapter VI).  Two subunits of wild-type
BsPFK and two subunits of either the [a,a], [a,b], [b,a] or [b,b] mutant proteins
(recalling that specific “sides” of the binding sites have been mutated to
discourage both Fru-6-P and PEP binding) form twelve different 2:2 hybrids, six
of which are unique because of the pair-wise allosteric interactions they isolate.
Each 2:2 hybrid contains two copies of two different heterotropic interactions,
one copy of one homotropic interaction between active sites and one copy of one
homotropic interaction between allosteric sites.  A schematic of all twelve 2:2
hybrids is shown in Fig. 5-2 highlighting the interactions each 2:2 hybrid isolates
and the mutant protein used to form each one.
As Fig. 5-2 shows, each of the six unique 2:2 hybrids has been designated
as either the 2:2V(30&32), 2:2V(22&45), 2:2D(32&45), 2:2D(22&30), 2:2H(22&32)
or 2:2H(30&45) hybrids.  This notation was introduced in order to tell each of
the six 2:2 hybrids apart, and utilizes two distinguishing characteristics inherent
to each 2:2 hybrid.  First, the letter in each “name” refers to the relative
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The 2:2D(32&45) Hybrids The 2:2D(22&30) Hybrids
The 2:2H(22&32) Hybrids The 2:2H(30&45) Hybrids
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FIGURE 5-2  A schematic of the twelve 2:2 hybrids.  Of the twelve 2:2 hybrids,
six are unique, meaning there are two ways to form every 2:2 hybrid as shown
above, with each unique pair having a specific “name” as described in the text.
Furthermore, each 2:2 hybrid isolates six specific pair-wise allosteric interactions
consisting of the two copies of two heterotropic interactions, a homotropic
interaction between the active sites and a homotropic interaction between the
allosteric sites.  The “closed” symbols imply the presence of a mutation and
hence the inability to bind either Fru-6-P or PEP at that particular site, while the
“open” symbols are those “sides” of the binding sites that are not mutated (two
paired “open” symbols are required to constitute a native binding site, while
only one “closed” symbol is required to almost eliminate ligand binding as
shown in Chapters III and IV).
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orientations of the wild-type and mutant subunits in the two-dimensional
schematic we use to depict the tetramer.  Thus, the “D” refers to diagonally
oriented subunits, the “H” to horizontally oriented subunits and the “V” to
vertically oriented subunits.  Second, the two different heterotropic interactions
isolated in each 2:2 hybrid are listed in parentheses, since each of the six unique
2:2 hybrids isolates a different pair of heterotropic interactions.  Hence, the
2:2V(30&32) hybrid corresponds to the 2:2 hybrid that has the wild-type and
mutant subunits vertically oriented and also contains two copies each of the 30
Å and 32 Å heterotropic interactions.
Also shown in Fig. 5-2 is the fact that two different mutant proteins can
be used to generate each of the six unique 2:2 hybrids, and this observation is
related to the specific heterotropic interactions isolated in each 2:2 hybrid.
Using the 2:2V(30&32) hybrid as an example, either the [b,b] or [b,a] mutant
proteins can be used to form the 2:2V(30&32) hybrid because those two mutant
proteins isolate the 30 Å and 32 Å heterotropic interactions via their individual
1:3 hybrids (1|1) respectively.  Thus, if a problem arises so that a specific 2:2
hybrid cannot be formed or isolated, the alternative mutant protein can be used
to possibly circumvent these difficulties.
Since the relative contributions of the four individual heterotropic
interactions have already been determined (Chapters III and IV), we can then
characterize the various 2:2 hybrids and in principle determine the roles played
by the individual homotropic interactions in the inhibition process.  However,
before we are able to characterize the 2:2 hybrids, we need to devise a method
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for isolating each of the 2:2 hybrids, and that is the topic of this chapter.  The
functional characterizations of the isolated 2:2 hybrids will be described in
Chapter VI.
As discussed in Chapters III and IV, the K90E/K91E charge tag was
added to the mutated subunits in order to separate the 1:3 hybrid from the other
six enzyme species that form during the monomer exchange process.  However,
besides just separating the 1:3 hybrid, we discovered that the K90E/K91E charge
tag also caused one of the three 2:2 isomers to be retarded in its elution off the
Mono-Q anion exchange column relative to the other 2:2 isomers.  Upon
examining the crystal structure, we inferred that this separation was the result of
the different distances between the K90E/K91E charge tags on each of the three
2:2 isomers.  The lysines that are mutated for the K90E/K91E charge tag are
relatively close together on the 2:2D isomer, only about 50 Å apart, while on the
other two isomers the lysines that are mutated are on opposite ends of the
protein and are approximately 82 Å and 90 Å apart (Schirmer and Evans, 1990).
These distances were determined by averaging the two distances measured
within the crystal structure between the four mutated residues.  For example,
the 50 Å distance determined for the 2:2D isomer was determined by measuring
the distance between the two K90 residues and averaging that value with the
distance measured between the two K91 residues.  Thus, we propose that the
2:2D isomer would be retained longer on the Mono-Q anion exchange column
because all four lysine to glutamate mutations could be presented more easily to
the same face of an individual Mono-Q bead (particle size ~10 mM) resulting in a
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stronger affinity for the resin as opposed to the other two isomers.  Based on this
idea, we designed two more charge tags to individually isolate the 2:2H and
2:2V isomers.  Moreover, we also developed conditions that allowed dimer
exchange to occur across the active site dimer-dimer interface between wild-
type and the [b,a] mutant protein as an alternative means of isolating the
2:2V(30&32) hybrid.
Materials and methods
The materials and methods used for the experiments described in this
chapter are as described in Chapter II.  In particular, site-directed mutagenesis,
protein purification, 2:2 hybrid formation via the monomer exchange procedure,
enzymatic activity measurements, and data analysis were performed as
described in Chapter II.
Hybrid formation, isolation and identification via dimer exchange
across the active site interface.  Unlike EcPFK, BsPFK does not undergo dimer
exchange at room temperature (Fenton and Reinhart, 2002), thus special
conditions were devised to promote exchange of the BsPFK subunits at the
dimer level.  Deville-Bonne et al. (1989) showed in EcPFK that the active site
dimer-dimer interface was the weaker of the two interfaces, and that the
addition of Fru-6-P would eliminate dimer exchange.  Thus, due to the dramatic
similarities between the two bacterial enzymes, we postulated that the active site
dimer-dimer interface would also be the weaker of the two interfaces in BsPFK,
particularly in the presence of PEP.
With this in mind, equal amounts of wild-type (1 mg/mL) and the [b,a]
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mutant protein (1 mg/mL) were mixed together in the presence of 20 mM Tris-
HCl (pH 8.5), 0.4 M KSCN and 4 mM PEP and incubated for 30 minutes at room
temperature.  A low concentration of KSCN and the addition of PEP were used
to ensure subunit exchange occurred only at the dimer level and across the
active site dimer-dimer interface, resulting in only one 2:2 hybrid forming, the
2:2V(30&32) hybrid.
To remove the KSCN and PEP, the hybrid mixture was dialyzed at room
temperature into 20 mM Tris-HCl (pH 8.5) for 4 1/2 hours replacing the buffer
every 90 minutes.  The sample was then passed through a 0.22 mm membrane
filter and applied onto a Mono Q HR 10/10 anion exchange column (Pharmacia)
previously equilibrated with 20 mM Tris-HCl (pH 8.5).  After washing the
column with 3-5 bed volumes, a linear NaCl gradient (1.77 mM NaCl/mL) was
used to elute the proteins.  1.5 mL fractions were collected and their absorbances
at 280 nm determined.  Figure 5-3 shows an elution profile for hybrids between
wild-type and a mutant form of BsPFK.  Three peaks are observed
corresponding to wild-type BsPFK, the 2:2V(30&32) hybrid and the [b,a] mutant
protein.
Native polyacrylamide gel electrophoresis analysis was used (as
described in Chapter II for the monomer exchange procedure) to confirm the
identity of the protein peaks and the results are shown in Fig. 5-4.  The fractions
exhibiting the greatest absorbance at 280 nm corresponding to the 2:2 hybrid
were then pooled and stored at 4°C to prohibit any re-hybridization from
occurring.
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FIGURE 5-3  Elution profile for BsPFK hybrids made via dimer exchange from
the Mono-Q column.  Equal amounts of wild-type BsPFK and the [b,a] mutant
were mixed together with 0.4 M KSCN and 4 mM PEP, and incubated for 30
minutes.  The proteins were then dialyzed and loaded onto the Mono-Q column.
A linear salt gradient was used to elute the proteins (1.77 mM NaCl/mL) and 1.5
mL fractions collected.  Since the mutant has more net negative charge at pH 8.5,
it stays on the column longer, and the wild-type protein elutes first.  Absorbance
at 280 nm (l) is plotted versus fraction number, and the dashed line (---)
corresponds to the salt gradient used to elute the hybrid proteins from the
column.  Three peaks are observed with the wild-type enzyme eluting first, the
2:2V(30&32) hybrid next followed by the [b,a] mutant protein.
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                                            1      2     3      4      5     6       7     8
FIGURE 5-4  10% native polyacrylamide gel identifying the hybrids obtained via
dimer exchange and isolated from the Mono-Q column.  Samples were taken
from the three peaks (Fig. 5-3) and the lanes correspond to the following: Lane 1
shows the hybrid mix prior to separation.  Lanes 2 and 3 show peak 1
corresponding to wild-type BsPFK (4:0).  Lanes 4, 5 and 6 show peak 2
corresponding to the 2:2V(30&32) hybrid.  Lanes 7 and 8 show peak 3
corresponding to the [b,a] mutant protein (0:4).
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Re-hybridization experiment.  In order to confirm the identity of the
isolated 2:2H(30&45) hybrid (isolated via monomer exchange and utilizing the
R232E/Q233E charge tag), a subsequent re-hybridization experiment was
performed between the wild-type enzyme and the 2:2H(30&45) hybrid.  The two
proteins were incubated in equal amounts (0.025 mg of each for a final protein
concentration of 0.4 mg/mL) in 50 mM MOPS-KOH (pH 7.0) buffer containing
100 mM KCl, 5 mM MgCl2, 0.1 mM EDTA and 2 mM DTT.  Moreover, 30 mM
PEP was also added to stabilize the allosteric site interface, and the mixture was
then heated for 2 hours at 50°C.  Furthermore, two experimental controls were
also made, and contained the identical components as listed above except one
did not contain PEP and the other was not heated.  Dialysis was used to remove
the PEP from the pertinent samples and then all of the samples were run on a
10% native PAGE gel using the protocol described in Chapter II.
Results
Using monomer exchange for 2:2 hybrid formation.  Monomer exchange
is one way to form the 2:2 hybrids (procedure outlined in Chapter II), and when
this technique is utilized, three 2:2 isomers form, all of which differ in their
relative orientations of the wild-type and mutant subunits and the allosteric
interactions isolated.  The wild-type and mutant subunits can be oriented either
vertically (2:2V), diagonally (2:2D) or horizontally (2:2H), and the six pair-wise
allosteric interactions that are isolated in the three 2:2 isomers vary based upon
the mutant protein used.  Moreover, the only interaction common to all three
isomers is the heterotropic interaction that is isolated via the mutant protein’s
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respective 1:3 hybrid with the wild-type enzyme.  Figure 5-5 illustrates
schematically the three 2:2 isomers that can form when using monomer
exchange to make hybrids between wild-type and either the [b,b] mutant
protein or the [b,a] mutant protein, recalling that both mutant proteins produce
the 2:2V(30&32) hybrid as mentioned above.  Thus, in order to make any of the
twelve 2:2 hybrids shown in Fig. 5-2, the same four mutant constructs ([a,a].
[a,b], [b,a] and [b.b]) used in Chapters III and IV are utilized.
Strategy for isolating the 2:2D isomer when using monomer exchange
and the K90E/K91E charge tag.  In order to individually characterize the 2:2
hybrids, we needed to design a method for separating the 2:2 isomers that form
when using the monomer exchange procedure outlined in Chapter II.  The
approach we took for separating the 2:2 isomers was actually based upon our
results involving the isolation of the 30 Å and 45 Å heterotropic interactions (via
the 1:3 hybrids) using the K90E/K91E charge tag and either the [b,b] or [a,b]
mutant proteins respectively (Chapters III and IV).  Besides separating the 1:3
hybrid from the other six hybrid species, the K90E/K91E charge tag was also
successful in separating the three 2:2 isomers as evidenced by seven peaks in the
elution profile.  Figure 5-6 shows an example of this separation for hybrids
between wild-type and the [b,b] mutant protein.  First, two separate peaks are
observed corresponding to the wild-type enzyme and the 3:1 hybrid.  Next, a
doublet and a single peak are observed which were all proven to be 2:2 isomers
by native PAGE analysis (data not shown).  The elution profile then concludes
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The 2:2 Hybrids that Form when
Using the [b,b] Mutant Protein
The 2:2 Hybrids that Form when
Using the [b,a] Mutant Protein
2:2V(30&32) 2:2V(30&32)
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FIGURE 5-5  The three 2:2 isomers that form between wild-type BsPFK and
either the [b,b] or [b,a] mutant proteins when using monomer exchange.  Note
that the 30 Å heterotropic interaction (red) is found in all three 2:2 isomers when
using the [b,b] mutant protein, and the 32 Å interaction (bright green) is found
in all three 2:2 isomers when using the [b,a] mutant protein.
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FIGURE 5-6  The elution profile for hybrids between wild-type and the [b,b]
mutant protein (R252A/D12A/R25E/K90E/K91E) from the Mono-Q anion
exchange column.  The volume collected (each fraction contained 1.5 ml) is
plotted versus absorbance at 280 nm (—) as well as percent 1 M NaCl (---).  The
gray region indicates the region of 2:2 separation.  The doublet contains the 2:2H
and 2:2V hybrids while the single 2:2 peak contains the 2:2D hybrid as
determined from the distances between the K90E/K91E charge tag on the three
isomers.  The identity of the peaks (4:0, 3:1, 2:2, 1:3 or 0:4) was confirmed via
native PAGE analysis (data not shown).
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with individual peaks for the 1:3 hybrid (isolating the 30 Å heterotropic
interaction) and the [b,b] mutant protein.
Since the three 2:2 isomers are undistinguishable from one another via
native PAGE analysis, we examined the crystal structure to see where K90 and
K91 were located on each of the three isomers in hopes of assigning the 2:2
isomer peaks (Schirmer and Evans, 1990).  Since K90 and K91 are located on the
ends of the large domain, the K90E/K91E mutations would be closest in the
2:2D isomer (~50 Å apart) and much farther away from one another in the 2:2V
and 2:2H isomers (~82 Å and 90 Å respectively).  Thus, we propose that the 2:2D
hybrid is retained longer on the Mono-Q anion exchange column (the single
peak in the gray region of Fig. 5-6), than the 2:2V or 2:2H hybrids (the doublet in
the gray region of Fig. 5-6) because the negative charge tags are more likely to be
presented simultaneously to the same face of an individual Mono-Q bead
(particle size ~ 10 mm).  This explanation has also been used to explain the
separation of the 2:2 isomers for lactate dehydrogenase hybrids (Fushinobu et
al., 1996) and fructose-1,6-bisphosphatase hybrids (Nelson et al., 2001), both of
which are homotetrameric enzymes of approximately the same molecular
weight as BsPFK.  Furthermore, the functional behavior of the isolated 2:2D
hybrid is also consistent with this explanation (see Chapter VI).  Thus, the
K90E/K91E charge tag was used to separate the 2:2D isomer from the 2:2V and
2:2H isomers, and more specifically to isolate the two 2:2D(32&45) hybrids via
the [b,a] and [a,b(K213E)] mutant proteins and the 2:2D(22&30) hybrid via the
[b,b] mutant protein.
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The adverse chromatographic effects of the R211E mutation.  Although
separation of the 2:2 isomers was observed when making hybrids between wild-
type and either the [a,b] or [b,b] mutant proteins, no separation of the 2:2
isomers was seen when using the [a,a] or [b,a] mutant proteins despite the
K90E/K91E charge tag.  Figure 5-7 A shows the elution profile for hybrids
b e t w e e n  w i l d - t y p e  a n d  t h e  [a,a]  m u t a n t  p r o t e i n
(R162E/R211E/K213E/K90E/K91E), and five peaks, rather than seven are
observed.  This difference in hybrid separation is likely the result of the
R211E/K213E (a-side) mutations in the allosteric site.  It is believed that one or
both of the allosteric site mutations might be solvent exposed thus interfering
with the efficiency of the K90E/K91E charge tag.  To provide evidence that this
was in fact the case, hybrids between the R211E/K213E mutant protein and the
[a,a] mutant protein (R162E/R211E/K213E/K90E/K91E) were made (Fig. 5-7
B).  Since the R211E/K213E mutations are present in all four subunits, the effect
of the K90E/K91E charge tag was not counteracted, and some separation of the
2:2 isomers is observed (two peaks) as shown in Fig. 5-7 B.
Next, to determine if only one of the allosteric site mutations (either
R211E or K213E) was responsible for this inability to separate the 2:2 isomers,
the crystal structure was examined and showed that only the side chain of R211
was exposed at the surface of the protein (Schirmer and Evans, 1990).  Thus, to
circumvent the adverse chromatographic effects of the R211E mutation, the
K213E mutation was used instead of the R211E/K213E double mutation when
necessary.  Luckily, all of the other binding site residues that are mutated are
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FIGURE 5-7  Two elution profiles demonstrating the influence of the
R211E/K213E mutations upon resolution of the 2:2 isomers (gray region).  A
shoulder on the right side of every peak is observed and is thought to be a result
of the column performance and not hybrid separation. The volume collected
(each fraction contained 1.5 ml) is plotted versus absorbance at 280 nm (—) as
well as percent 1 M NaCl (---).  The same salt gradient is used in both
experiments.  (A)  Hybrids between wild-type and the [a,a] mutant protein
(R162E/R211E/K213E/K90E/K91E).  No resolution of the 2:2 isomers is seen.
(B)  Hybrids between the R211E/K213E mutant protein and the [a,a] mutant
protein (R162E/R211E/K213E/K90E/K91E).  The 2:2D isomer is separated from
the 2:2V and 2:2H isomers as evidenced by two peaks.  Identification of all the
peaks shown above was confirmed via native PAGE analysis.
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located deep in the binding pockets prohibiting any interference with the
effectiveness of the surface charge tags (Schirmer and Evans, 1990).
Characterization of the K213E allosteric site mutation.  Like the
R211E/K213E mutation, the K213E mutation alone needed to prohibit PEP
binding by at least two orders of magnitude, thus before utilizing the K213E
mutation in forming hybrids and isolating specific allosteric interactions, the
mutation needed to be characterized.  Using the R162E/K213E mutant protein,
the effects of the K213E mutation were determined and the results shown in Fig.
5-8.  Over the PEP concentrations assayed, the R162E/K213E mutant protein is
essentially unresponsive to PEP, thus the K213E mutation was found to be
suitable to use instead of the R211E/K213E mutations (the effects of the R162E
mutation are also seen as the decreased binding affinity for Fru-6-P as compared
to wild-type).
Unfortunately, when the K213E mutation was implemented for use in
making hybrids, we discovered that all seven hybrid species were not able to
form whenever K213E was used in conjunction with the R162E mutation (the
[a,a] mutant protein) and the K90E/K91E charge tag.  This phenomenon was
reminiscent of the earlier problems encountered when making hybrids between
wild-type and the [b,a] and [b,b] mutant proteins in the absence of the D12A
mutation (Chapter III).  Unfortunately, since D12 is located on the b-side of the
active site and the R162E mutation is located on the a-side of the active site, we
were unable to use the D12A mutation to circumvent this problem.  Table 5-1
summarizes the mutant proteins that were unable to be used in forming three of
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FIGURE 5-8  The dependence of the apparent   
† 
K1 /2  for Fru-6-P on increasing
concentrations of the inhibitor PEP for wild-type BsPFK (l ) and the
R162E/K213E mutant protein (° ).  The   
† 
K1 /2  values were obtained from
individual Fru-6-P saturation profiles (performed at pH 7.0 and 25°C; data not
shown) at increasing concentrations of PEP.  The curves correspond to the best
fit of these data to Eq. 2-4 as described in the text.  Error bars represent ± the
standard error and are smaller than the symbol when not evident.
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TABLE 5-1  The 2:2 hybrids that were unable to be formed utilizing the
[a,a] mutant protein with the K213E mutation in the allosteric site
Mutant
Protein
Active Site
Mutation
Allosteric Site
Mutationa
Charge Tag
2:2 Hybrid It
Would Form
[a,a] R162E
R211E/K213E
(K213E)
N303E/K304E 2:2V(22&45)
[a,a] R162E
R211E/K213E
(K213E)
K90E/K91E 2:2D(22&30)
[a,a] R162E
R211E/K213E
(K213E)
R232E/Q233E 2:2H(22&32)
aThe R11E/K213E mutations were unable to be used because of the location of
R211 on the surface of the protein, thus the K213E mutation was used as an
alternative.
the twelve possible 2:2 hybrids.  Fortunately however, the redundant proteins
were used in isolating those three 2:2 hybrids.
Strategy for isolating the 2:2H and 2:2V isomers when using monomer
exchange utilizing the R232,233E and N303E/K304E charge tags.  Using the
same approach of separating one of the 2:2 isomers from the remaining two
isomers, we set out to find two more charge tags; one to separate the 2:2H
hybrid from the 2:2D and 2:2V isomers, and the other to separate the 2:2V
isomer from the 2:2D and 2:2H isomers.  Upon gazing at the crystal structure,
we discovered that there were no pairs of positively charged residues that
exhibited the same biased distance distribution as was observed for the
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K90E/K91E mutations; thus, we chose one positively charged residue and one
neutral residue to mutate to two glutamates for the remaining two charge tags.
The R232E/Q233E charge tag was found to be an excellent candidate for
separating the 2:2H isomer from the 2:2D and 2:2V isomers because the average
distance between the two R232 residues and the two Q233 residues on the 2:2H
isomer was approximately 29 Å, while the average distances for the same
residues on the 2:2D and 2:2V isomers were approximately 68 Å  and 69 Å apart,
respectively.  On the other hand, to separate the 2:2V isomer from the 2:2D and
2:2H isomers, the N303E/K304E charge tag was chosen because it also met our
distance criteria.  The average distance between the two N303 residues and the
two K304 residues on the 2:2V isomer was about 40 Å, while the average
distances were approximately 64 Å and 74 Å for the 2:2H and 2:2D isomers.
Figures 5-9, 5-10 and 5-11 illustrate the locations of the residues that are mutated
for the three different charge tags (recalling that the K90E/K91E charge tag
isolates the 2:2D isomer, the R232E/Q233E charge tag isolates the 2:2H isomer
and the N303E/K304E charge tag isolates the 2:2V isomer) in the 2:2D, 2:2H and
2:V isomers respectively (Schirmer and Evans, 1990).
Implementing these two new charge tags to accomplish our goal of
separating either the 2:2H or 2:2V isomers was next, and Fig. 5-12 shows the
chromatographic results for utilizing either the R232E/Q233E charge tag or the
N303E/K304E charge tag in the [b,b] mutant protein (R252A/D12A/R25E +
Charge Tag).  For the R232E/Q233E charge tagged protein, we observe a similar
elution pattern to what was observed for the K90E/K91E charge tagged protein
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FIGURE 5-9  The positions of K90 and K91 in the 2:2D, 2:2H and 2:2V isomers in
either the two-dimensional schematic or crystal structure.  In the crystal
structure, K90 and K91 are colored orange.  (A)  The 2:2D isomer with a black
dashed line indicating a distance of 50 Å between the charge tags.  (B)  The 2:2H
isomer with a black dashed line indicating a distance of 90 Å between the charge
tags.  (C)  The 2:2V isomer with a black dashed line indicating a distance of 82 Å
between the charge tags.
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FIGURE 5-10  The positions of R232 and Q233 in the 2:2D, 2:2H and 2:2V
isomers in either the two-dimensional schematic or crystal structure.  In the
crystal structure, R232 and Q233 are colored magenta.  (A)  The 2:2D isomer
with a black dashed line indicating a distance of 68 Å between the charge tags.
(B)  The 2:2H isomer with a black dashed line indicating a distance of 29 Å
between the charge tags.  (C)  The 2:2V isomer with a black dashed line
indicating a distance of 69 Å between the charge tags.
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FIGURE 5-11  The positions of N303 and K304 in the 2:2D, 2:2H and 2:2V
isomers in either the two-dimensional schematic or crystal structure.  In the
crystal structure, N303 and K304 are colored cyan.  (A)  The 2:2D isomer with a
black dashed line indicating a distance of 74 Å between the charge tags.  (B)  The
2:2H isomer with a black dashed line indicating a distance of 64 Å between the
charge tags.  (C)  The 2:2V isomer with a black dashed line indicating a distance
of 40 Å between the charge tags.
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FIGURE 5-12  Two elution profiles demonstrating the influence of the
R232E/Q233E and N303E/K304E charge tags upon the resolution of the 2:2
isomers (gray region).  The volume collected (each fraction contained 1.5 ml) is
plotted versus absorbance at 280 nm (—) as well as percent 1 M NaCl (---).  (A)
Hybrids between wild-type and the [b,b ] mutant protein
(R252A/D12A/R25E/R232E/Q233E).  The 2:2 isomers separate as a doublet
(2:2V and 2:2D) followed by a single peak containing the 2:2H hybrid.  (B)
Hybrids between wild-type and the [b,b ] mutant protein
(R252A/D12A/R25E/N303E/K304E).  The 2:2 isomers are seen as a triplet peak
because the charge tag distances are more similar for the three isomers (40 Å
(2:2V), 64 Å (2:2H) and 74 Å (2:2D)).  Identification of all the peaks shown above
was confirmed via native PAGE analysis.
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(compare to Fig. 5-6).  For the R232E/Q233E charge tagged protein, the 2:2
isomers separate first as a doublet, followed by a single peak containing the
2:2H isomer.  Thus, the R232,233E charge tag effectively isolates the 2:2H isomer
from the 2:2D and 2:2V isomers and is utilized in isolating the 2:2H(22&32)
hybrid utilizing the [b,b(K213E)] mutant protein and the 2:2H(30&45) hybrid
using either the [b,b] or [a,b] mutant proteins.
The elution profile for the N303E/K304E charge tagged protein is also
shown in Fig. 5-12 B, however it displays an entirely new profile.  Since the
relative distances between the charge tag pairs for the three 2:2 isomers are not
as different as the previous two charge tags, a triplet peak is observed.
Although an isolated peak is preferred, we were able to successfully obtain the
2:2V isomer by re-running the far right shoulder of the triplet peak over the
Mono-Q anion exchange column again to obtain a pure peak.  Figure 5-13 shows
the results of this added purification.  A major peak is observed with a minor
contamination shoulder on the left side of the peak probably containing the 2:2H
hybrid.  However, to ensure the isolated 2:2 hybrid was not contaminated, only
the extreme right side of the major peak was used for characterization. Thus, the
N303E/K304E charge tag was successful in isolating the 2:2V isomer from the
2:2D and 2:2H isomers, and more specifically in isolating the 2:2V(30&32) hybrid
via the [b,b] mutant protein, and the 2:2V(22&45) hybrid via the [a,b] mutant
protein.
Isolation of the 2:2V(30&32) hybrid via dimer exchange.  Besides using
the monomer exchange procedure to form the 2:2 hybrids, dimer exchange
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FIGURE 5-13  The elution profile for the 2:2V hybrid (with some 2:2H
contamination) from the Mono-Q anion exchange column.  The volume
collected (each fraction contained 1.5 ml) is plotted versus absorbance at 280 nm
(—) as well as percent 1 M NaCl (---).  A doublet peak is observed, where the
bigger peak is the 2:2V isomer and the left shoulder is probably the 2:2H isomer.
The right side of the doublet peak was used for characterization to ensure there
was no contamination from the 2:2H isomer.  Identification of the 2:2 peak was
confirmed via native PAGE analysis.
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could also be used providing the advantage of forming only one specific 2:2
hybrid rather than three, eliminating the requirement for separating the 2:2
isomers.  Unlike EcPFK, BsPFK does not undergo dimer exchange at room
temperature (data not shown) thus special conditions were devised to promote
exchange of BsPFK dimers.  Deville-Bonne et al. (1989) showed in EcPFK that
the active site dimer-dimer interface was the weaker of the two interfaces, and
that the addition of Fru-6-P would eliminate dimer exchange.  Thus, due to the
sequence and structural similarities between the two bacterial enzymes (French
and Chang, 1987), we postulated that the active site dimer-dimer interface
would also be the weaker of the two interfaces in BsPFK, particularly in the
presence of saturating PEP.  Consequently, dimer exchange could only be used
to form the 2:2V hybrids.
Exchange was attempted between wild-type and all four mutant proteins
containing the K90E/K91E charge tag and surprisingly, dimer exchange only
occurred between wild-type and the [b,a ] mutant protein
(R252A/D12A/R211E/K213E/K90E/K91E) as proven by native PAGE analysis.
Since dimer exchange was successful between wild-type and the [b,a] mutant
protein, the hybrid mixture was applied to the Mono-Q anion exchange column,
and the elution profile shown in Fig. 5-3.  As expected, three peaks are observed
and native PAGE analysis confirmed the identity of all three peaks (see
Materials and methods Fig. 5-4).
Furthermore, dimer exchange only occurred between wild-type and the
[b,a] mutant protein in the presence of PEP as shown in Fig. 5-14.  In the absence
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FIGURE 5-14  A 10% native PAGE gel illustrating the importance of PEP in the
dimer exchange procedure.  Lane 1 shows wild-type BsPFK.  Lane 2 shows
dimer exchange performed in the presence of 0.4 M KSCN and 5 mM PEP.  Lane
3 shows dimer exchange performed only in the presence of 0.4 M KSCN.  Lane 4
shows the [b,a] mutant protein.
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of PEP, only the parent proteins are observed (lane 3, 2 major bands), while in
the presence of PEP (5 mM PEP), dimer exchange is successful between wild-
type and the [b,a] mutant protein (lane 2, 3 major bands).  Some residual
monomer exchange is observed with either condition, but in negligible amounts
when compared to the amount of the parent proteins or the 2:2V(30&32) hybrid
visualized in the gel.  Thus, PEP not only potentially stabilizes the allosteric site
interface, but it also seems to destabilize the allosteric site interface.  This
phenomenon will be revisited later, but more importantly, dimer exchange was
successful in the presence of PEP and a low concentration of KSCN in producing
and isolating the 2:2V(30&32) hybrid.
Interestingly, dimer exchange did not occur with the other three mutant
proteins.  Temperature, the concentrations of KSCN and PEP, as well as the
incubation time were all varied, but with no success.  Either no exchange or
varying degrees of monomer exchange was always observed (data not shown).
Why dimer exchange did not occur for the [a,a], [a,b] and [b,b] mutant proteins
is unknown, however we believe that it is a result of the several binding site
mutations introduced at the interfaces of the protein which results in an overall
decrease in the quaternary stability of the protein (as shown in Chapter III for
the [b,b] mutant protein in the absence of D12A).  Fortunately, we were able to
use monomer exchange to isolate a majority of the 2:2 hybrids.  Figure 5-15
summarizes the conditions and the mutant proteins used to successfully isolate
nine of the possible twelve 2:2 hybrids.
Kinetic characterization of the three charge tags.  The three charge tags
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FIGURE 5-15  The nine of the twelve 2:2 hybrids that were able to be formed and
isolated using strategically placed charge tags and either monomer exchange or
dimer exchange with the wild-type enzyme.
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were chosen primarily because of their utility in isolating either the 1:3 or 2:2
hybrids, but they were also chosen because the residues that are mutated for
these surface charge tags are far removed from both the active sites and the
allosteric sites.  They were chosen in this manner to reduce the risk of the charge
change mutations altering the binding or allosteric properties of the enzyme.  To
ensure this was the case, steady-state kinetic characterization was performed for
each of the charge tags at pH 7.0.  Kimmel and Reinhart (2001) have previously
shown that the K90E/K91E charge tag has no effect upon the behavior of the
enzyme.  However, that characterization was performed at pH 8.0, therefore it
was repeated here at pH 7.0 to be consistent with the other data.
Figure 5-16 shows the results of the allosteric characterization for the
three charge tags and the wild-type enzyme at pH 7.0.  Of the three charge tags,
the R232E/Q233E charge tag is the only one that deviates somewhat from wild-
type behavior.  The binding affinity for PEP (  
† 
Kiyo ) is an order of magnitude
tighter than wild-type and the coupling for the R232E/Q233E mutant,   
† 
Qay , is
somewhat diminished.  Thus, although the R232E/Q233E charge tag is
approximately 26 Å and 21 Å from the two closest active sites and about 21 Å
and 51 Å away from the two closest allosteric sites, it still has some effect upon
the allosteric behavior of the enzyme (Schirmer and Evans, 1990).  However, this
is not consequential because the charge tag is on the mutated subunits, and the
allosteric behavior is measured for the wild-type subunits.  A summary of all the
kinetic and thermodynamic parameters obtained from the analysis is found in
Table 5-2.
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FIGURE 5-16  The dependence of the apparent   
† 
K1 /2  for Fru-6-P upon increasing
concentrations of the inhibitor PEP for wild-type BsPFK (l), the K90E/K91E
charge tag mutant (° ), the R232E/Q233E charge tag mutant (n ) and the
N303E/K304E charge tag mutant (o) at pH 7.0.  The   
† 
K1 /2  values were obtained
from individual Fru-6-P saturation profiles (performed at pH 7.0 and 25°C; data
not shown) at increasing concentrations of PEP.  The curves correspond to the
best fit of these data to Eq. 2-4 as described in the text.  Error bars represent ± the
standard error and are smaller than the symbol when not evident.
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TABLE 5-2  Kinetic and thermodynamic parameters determined for the
wild-type enzyme and the three charge tag proteins at 25°C, pH 7.0 and the
[MgATP] = 3 mM
Protein   
† 
Kiao  (mM)   
† 
Kiyo  (mM)   
† 
Qay
∆Gay
(kcal/mol)
wild-type 0.030 ± 0.002 0.023 ± 0.002
0.0085 ±
0.0004
2.82 ± 0.03
K90E/K91E 0.024 ± 0.002 0.019 ± 0.002
0.0068 ±
0.0007
2.95 ± 0.07
R232E/Q233E 0.025 ± 0.002
0.00088 ±
0.00001
0.019 ± 0.001 2.34 ± 0.04
N303E/K304E 0.013 ± 0.001 0.011 ± 0.001
0.0056 ±
0.0002
3.06 ± 0.03
 Utilizing dimer exchange to verify the identity of the isolated 2:2H
isomer.  Using the [a,b] mutant protein and the R232E/Q233E charge tag, the
2:2H(30&45) hybrid is presumed to be separated away from the 2:2V and 2:2D
isomers based upon the proximity of the added negative charges between the
subunits described earlier.  Since all three 2:2 isomers migrate identically on a
native PAGE gel, a subsequent re-hybridization experiment was performed in
hopes of confirming the identity of the 2:2H(30&45) hybrid.  Hybrids between
the wild-type enzyme and the 2:2H isomer were attempted using conditions that
allowed subunit exchange to occur only across the active site dimer-dimer
interface.  If the isolated 2:2 isomer is truly the 2:2H(30&45) isomer, then upon
199
re-hybridization, four proteins should form: the wild-type protein, the 3:1
hybrid, and the 2:2D and 2:2H isomers as shown in Fig. 5-17 A.  On the other
hand, if the hybrid was in the 2:2V orientation re-hybridization would not
produce any additional species.  Upon performing this experiment, and the
controls, we observed three bands on a native PAGE gel verifying the identity of
the 2:2 isomer as being either the 2:2H or 2:2D isomer (Fig. 5-17 B), as the 2:2D
isomer would produce the same results.  Although this procedure does not
provide definitive results, it does provide further support to our distance
dependence argument made earlier regarding the identification of the isolated
2:2 isomers.
Furthermore, only two bands were observed for the experimental control
that was heated in the absence of PEP (lane 2 of Fig. 5-17 B).  This is the second
occasion in which PEP seems to not only stabilize the allosteric site dimer-dimer
interface, but also destabilize the active site dimer-dimer interface.  A
destabilization of the active site interface has also been reported for a BsPFK
tryptophan-shifted mutant, W179Y/Y164W.  (Riley-Lovingshimer and Reinhart,
2002).  It was shown in that case that upon the addition of PEP, the mutant
enzyme dissociated into inactive dimers, a result consistent with our previous
observations in the two preceding dimer exchange experiments.  Furthermore,
Schirmer and Evans (1990) have also noted a 7° shift or rotation of the active site
dimer-dimer interface in a crystal structure solved with only 2-phosphoglycolate
(PEP analog) bound in the allosteric sites.  This conformational change at the
active site dimer-dimer interface is also consistent with our data, but whether
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FIGURE 5-17  A schematic showing the possible proteins that can form when
performing dimer exchange between wild-type and the 2:2H(30&45) hybrid, and
a 10% native PAGE gel verifying the expected results.  (A)  A schematic
illustrating the dimer exchange procedure as well as the expected outcome if the
starting proteins are wild-type and the 2:2H(30&45) hybrid.  (B)  A 10% native
PAGE gel confirming the expected results shown in A.  Three bands are only
observed when performing dimer exchange between wild-type and the
2:2H(30&45) hybrid when both PEP and heat are used.  Lane 1 shows monomer
exchange of wild-type and the [a,b] mutant protein.  Lane 2 shows dimer
exchange between wild-type and the 2:2H(30&45) hybrid in the absence of PEP,
but in the presence of heat.  Lane 3 shows dimer exchange between wild-type
and the 2:2H(30&45) hybrid in the presence of both PEP and heat.  Lane 4 shows
dimer exchange between wild-type and the 2:2H(30&45) hybrid in the presence
of PEP, but in the absence of heat.
A
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this “destabilization” may be involved in the transmission of the allosteric signal
is not evident.
Characterization of the two 2:2V(30&32) hybrids.  As was previously
shown, the 2:2V(30&32) hybrid can be formed and isolated with using either
monomer exchange between the wild-type protein and the [b,b] mutant protein
(R252A/D12A/R25E/N303E/K304E) or by using dimer exchange between the
w i l d - t y p e  p r o t e i n  a n d  t h e  [ b , a ]  m u t a n t  p r o t e i n
(R252A/D12A/R211E/K213E/K90E/K91E).  Either way, the same six pair-wise
allosteric interactions are isolated (refer to either Figs. 5-2 or 5-13).  Thus, if our
distance dependence hypothesis is correct regarding the relative separations and
subsequent identification of the 2:2 isomers via monomer exchange, then the
allosteric couplings (  
† 
Qay or ∆Gay) determined at pH 6.0, 7.0 and 8.0 for both of
the aforementioned 2:2V(30&32) hybrids should be identical, thus supporting
our theory.
Figures 5-18 A, B and C show the results for this characterization, and the
measured couplings for both the dimer exchanged and monomer exchanged
2:2V hybrids are identical, within error, at pH 6.0, 7.0 and 8.0.  Some minor
differences are evident regarding the binding affinities of both Fru-6-P and PEP
(  
† 
Kiao and  
† 
Kiyo ) at pH 6.0 and 8.0, but more importantly, the overall measured
couplings are the same.  Thus, the charge tag rationale used for isolating eight of
the 2:2 hybrids has been further validated.  Table 5-3 summarizes the
parameters obtained from the above characterization.
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FIGURE 5-18  The dependence of the apparent   
† 
K1 /2  for Fru-6-P upon increasing
concentrations of the inhibitor PEP for the 2:2V(30&32) hybrid obtained by
monomer exchange utilizing the N303E/K304E charge tag (l ) and the
2:2V(30&32) hybrid obtained by dimer exchange utilizing the K90E/K91E
charge tag (° ) at pH 6.0, 7.0 and 8.0.  The   
† 
K1 /2  values were obtained from
individual Fru-6-P saturation profiles (at 25°C and the concentration of MgATP
equal to 3 mM; data not shown) at increasing concentrations of PEP.  The curves
correspond to the best fit of these data to Eq. 2-4 as described in the text.  Error
bars represent ± the standard error and are smaller than the symbol when not
evident.  (A)  pH 6.0.  (B)  pH 7.0.  (C)  pH 8.0.
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TABLE 5-3  Kinetic and thermodynamic parameters determined for the
two 2:2V(30&32) hybrids isolated via the [b,b] or [b,a] mutant proteins at
25°C, pH 6.0, 7.0, 8.0 and [MgATP] = 3 mM
Mutant
Protein Useda   
† 
Kiao  (mM)   
† 
Kiyo  (mM)   
† 
Qay
∆Gay
(kcal/mol)
pH 6.0
[b,b] 0.031 ± 0.001 0.13 ± 0.06 0.62 ± 0.04 0.28 ± 0.04
[b,a] 0.044 ± 0.003 0.036 ± 0.02 0.57 ± 0.05 0.33 ± 0.05
pH 7.0
[b,b] 0.022 ± 0.001 0.007 ± 0.001 0.22 ± 0.01 0.90 ± 0.03
[b,a] 0.021 ± 0.002 0.005 ± 0.001 0.21 ± 0.02 0.92 ± 0.06
pH 8.0
[b,b] 0.032 ± 0.002 0.004 ± 0.001 0.098 ± 0.01 1.37 ± 0.01
[b,a] 0.12 ± 0.01 0.005 ± 0.001 0.085 ± 0.005 1.46 ± 0.04
aMonomer exchange was used for the [b,b] mutant protein utilizing the
N303E/K304E charge tag.  Dimer exchange was used for the [b,a] mutant
protein utilizing the K90E/K91E charge tag.
Discussion
Often bacterial enzymes are chosen over their eukaryotic counterparts to
study because they are less complex structurally, and in the realm of allosterism,
are often regulated by fewer molecules.  This is the case for phosphofructokinase
(Bloxham and Lardy, 1973; Blangy et al., 1968), however even the bacterial form
of the enzyme from Bacillus stearothermophilus still has the potential for 28 total
pair-wise allosteric interactions (10 of which are unique) between its four active
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sites and four allosteric sites.  Thus, the allosteric complexity of even this simple
homotetramer had to be reduced in order to address the question of how
allosteric regulation occurs in proteins, and more specifically, what the roles of
each of the 10 unique allosteric interactions are in the inhibitory response of
BsPFK.
In order to characterize four of the ten allosteric interactions, 1:3 hybrids
(1|1) were previously constructed to contain only one native active site and one
native allosteric site.  By doing this and alternating which active site and
allosteric site remained native, we were able to successfully isolate the four
heterotropic interactions found in the tetramer and determine their relative
contributions to the inhibitory process (Chapters III and IV).  Thus, to address
the roles of the six remaining homotropic interactions, the same approach is
taken, however instead of using the 1:3 hybrids, the 2:2 hybrids (2|2) are used
which contain two native active sites and two native allosteric sites.  Again, by
alternating which two active sites and which two allosteric sites remain native,
six unique 2:2 hybrids can form, with each 2:2 hybrid isolating a different set of
six pair-wise allosteric interactions.  Two of these six isolated interactions are
two of the six pair-wise homotropic interactions found in the tetramer (one for
each ligand), and by isolating two at a time via the 2:2 hybrids, we are able to
characterize their individual roles in the inhibitory response (see Chapter VI).
Moreover, two different mutant proteins (either [a,a], [a,b], [b,a], or the [b,b]
mutant protein) can be used to form each 2:2 hybrid, resulting in a total of
twelve possible 2:2 hybrids, all of which were shown in Fig. 5-2.  Thus, it was the
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goal of this chapter to describe how we formed and isolated these twelve 2:2
hybrids, and the subsequent chapter summarizes their allosteric
characterizations (Chapter VI).
Just like the 1:3 hybrids, a charge tag (either K90E/K91E, R232E/Q233E
or N303E/K304E) was added to the surface of the mutant subunits to isolate the
2:2 hybrids; however, an important determinant in the efficiency of the charge
tag in separating the three 2:2 isomers that form when using the monomer
exchange procedure was the solvent accessibility of the R211E/K213E mutations
in the allosteric site (a-side).  We arrived at this conclusion because separation of
the 2:2 isomers was only observed when making hybrids between wild-type and
the [a,b] or [b,b] mutant proteins, and not with the [a,a] or [b,a] mutant proteins.
However, separation was observed for the latter two mutant proteins when the
R211E/K213E mutations were added to the wild-type subunits.  Thus, we
determined that the 2:2 isomers separated because of the differences in the
overall distances between each pair of charge tags on the three 2:2 isomers.
Furthermore, since 2:2 isomer separation was not observed when using either
the [a,a] or [b,a] mutant proteins, we determined that the solvent accessibility of
the R211E/K213E mutations on the a-side of the allosteric sites were interfering
with the landscape of charges on the surface of the protein, and prohibiting
separation of the three 2:2 isomers.
The crystal structure was then examined to determine if the
R211E/K213E mutations were near the surface of the protein, and upon
inspection, the side-chain of the R211 residue is in fact at the edge of the binding
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pocket and at the surface of the protein (Schirmer and Evans, 1990).  Thus, we
surmised that the R211E mutation was interfering with the effectiveness of the
charge tag.  Therefore, we used the K213E mutation alone instead of the
R211E/K213E double mutation eliminating the adverse effects previously
encountered with the double mutation.
Using steady-state kinetics, the K213E mutation was shown to be suitable
in deterring PEP binding by over two orders of magnitude when compared to
wild-type, thus it was utilized in making hybrids.  Unfortunately, the 2:2
hybrids (and others) were unable to form when the K213E mutation was used in
conjunction with the R162E mutation in the active site (the [a,a] mutant protein),
a problem reminiscent to the one encountered in forming hybrids between wild-
type and the [b,a] or [b,b] mutant proteins in the absence of the D12A mutation.
Since D12 is located on the b-side of the active site and R162 is located on the a-
side of the active site, the D12A mutation was unable to be used because it
would have been in the wild-type subunits, complicating the allosteric
characterizations.  Thus, because each 2:2 hybrid can be formed two different
ways, we were able to form the three relevant 2:2 hybrids by using the other
mutant protein, and we just disregarded the problems encountered in forming
hybrids with the K213E/R162E mutant protein.
With nine of the twelve possible the 2:2 hybrids now successfully formed,
including at least one of each of the six unique 2:2 hybrids, the next formidable
task was figuring out a way to separate each one of them individually so that we
could characterize the homotropic interactions.  From previous results using the
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K90E/K91E charge tag to isolate the 1:3 hybrids, we found that the K90E/K91E
charge tag successfully separated the 2:2D isomer away from the 2:2H and 2:2V
isomers because of the relative positions of the lysine to glutamate mutations on
the three different 2:2 isomers.  As the crystal structure revealed (Schirmer and
Evans, 1990), the positions of the lysines that were mutated for the K90E/K91E
charge tag were on the same ends of the protein in the 2:2D isomer,
approximately 50 Å apart, allowing all four lysine to glutamate mutations to
present their negative charges to the positively charged Mono-Q bead at the
same time.  The 2:2H and 2:2V isomers on the other hand, have the lysine to
glutamate mutations on the opposite ends of the protein allowing only two of
the four negative charges to be presented to any given positively charged Mono-
Q bead.  Thus, the 2:2D isomer was retained longer on the column because of
the shorter distance between it’s pair of charge tags, providing the necessary
separation and subsequent isolation of the 2:2D(32&45) and 2:2D(22&30)
hybrids.
Using this same rationale, we constructed two additional charge tags, the
R232E/Q233E charge tag and the N303E/K304E charge tag, to separate the 2:2H
and 2:2V isomers respectively.  The R232E/Q233E charge tag performed
similarly to that of the K90E/K91E charge tag in producing a doublet and a
single peak in the elution profile for separating the 2:2 isomers.  More
importantly however, the R232E/Q233E charge tag was shown to be successful
in isolating the 2:2H isomer.   More specifically, the R232E/Q233E charge tag
isolated the 2:2H(22&32) and 2:2H(30&45) hybrids.
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The 2:2V isomer was isolated using the N303E/K304E charge tag.
However, since the distances between each pair of N303E/K304E charge tags on
the three isomers are not as different from one another like they are for the
K90E/K91E and R232E/Q233E charge tagged proteins, the separation is
reduced, and an additional purification step was required to ensure no
contamination of the other isomers occurred in isolating the 2:2V isomer.  With
the N303E/K304E charge tag, we were able to isolate both the 2:2V(30&32)
hybrid and the 2:2V(22&45) hybrid.  In summary, by using the monomer
exchange procedure and the three different strategically placed charge tags
(K90E/K91E, R232E/Q233E and N303E/K304E), we were able to successfully
isolate and identify all six of the unique 2:2 hybrids, plus two additional 2:2
hybrids for a total of eight.
In order to further support our charge tag distance-dependence theory,
we devised an additional exchange procedure that exchanged dimers instead of
monomers. Unfortunately, due to the decreased quaternary stability of the
mutant proteins and other unknown factors, the dimer exchange procedure was
only successful when applied to the wild-type enzyme and the [b,a] mutant
protein.  With the addition of saturating PEP during the exchange process,
exchange occurred only across the active site dimer-dimer interface, thus the
2:2V isomer was the only 2:2 hybrid that could form.  Furthermore, we
specifically formed the 2:2V(30&32) hybrid, a hybrid we had also obtained using
the monomer exchange procedure with the [b,b] mutant protein and the
N303E/K304E charge tag.  The fact that the functionalities of both of these
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hybrids are nearly identical helps to validate the rationale we have used for the
separation and identification of the other 2:2 hybrids.
An additional experiment was performed to further corroborate these
results and involved using a dimer exchange re-hybridization experiment of the
2:2H(30&45) hybrid and the wild-type enzyme.  Three bands were observed on
a native PAGE gel after the re-hybridization which corresponded to the wild-
type enzyme, the 3:1 hybrid and a mixture of the 2:2D(32&45) and 2:2V(30&45)
hybrids.  Although the 2:2D(32&45) hybrid would produce the identical results,
the experiment only substantiates our earlier conclusions regarding the identity
of our isolated 2:2 hybrids using the monomer exchange process and the
distance-dependence theory regarding the strategic placement of the three
different charge tags.  Thus, with nine of the 2:2 hybrids now isolated and their
identities known, the allosteric characterizations of the six homotropic
interactions can now be performed and the roles of the six homotropic
interactions in the inhibition process determined.
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CHAPTER VI
THE ALLOSTERIC CHARACTERIZATIONS OF THE 2:2 HYBRIDS
Introduction
Phosphofructokinase from Bacillus stearothermophilus (BsPFK) is a
homotetramer containing four active sites and four allosteric sites, all of which
are located along respective dimer-dimer interfaces of the protein (Schirmer and
Evans, 1990).  Due to this composition, twenty-eight pair-wise allosteric
interactions are possible, ten of which are unique.  There are four heterotropic
interactions (22 Å, 30 Å, 32 Å and 45Å – 4 copies of each), three homotropic
interactions between active sites (47 Å, 45 Å and 28 Å – 2 copies of each), and
three more homotropic interactions between allosteric sites (39.9 Å, 23 Å and 40
Å – 2 copies of each).  With this allosteric complexity it is impossible to define
the role each of these allosteric interactions plays in the inhibitory response
within the native tetramer.  To begin to dissect these roles, we previously
created and isolated BsPFK heterotetramers (1:3 hybrids) in which only one
active site and one allosteric site possess high affinity for both substrate and
inhibitor.  This allowed us to quantify the allosteric effect associated with each of
the four unique heterotropic interactions individually (Chapters III and IV).
However, the 1:3 hybrids did not provide any direct information regarding the
six remaining homotropic interactions found in the tetramer or how multiple
allosteric interactions combine and influence one another in an oligomeric
protein.
In this chapter we again use heterotetramers, however this time they
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contain two native active sites and two native allosteric sites (2:2 hybrids).  By
increasing the number of native active sites and allosteric sites by one, we have
increased the allosteric complexity to that of a dimer, requiring the analysis of
six allosteric interactions at a time: one homotropic interaction between active
sites, one homotropic interaction between allosteric sites and two copies of two
different heterotropic interactions.  We report here the allosteric
characterizations of nine of the twelve possible 2:2 hybrids; those that form
between the wild-type enzyme and three mutant proteins ([a,b], [b,a] or [b,b]),
all of which have been previously formed, isolated and identified in Chapter V.
Deciphering the role of the homotropic interactions.  From the allosteric
characterizations of these nine 2:2 hybrids, we will be able to address a number
of issues, the first of which being the role each of the six unique homotropic
interactions play in the inhibition process.  This is achieved by measuring the
Hill numbers for both Fru-6-P binding and PEP binding in the absence and
saturating presence of the heterotropic ligand, and using these values to
calculate the allosteric couplings for the homotropic interactions in both the
absence and saturating presence of the heterotropic ligand (  
† 
Qaa ,   
† 
Qaa/yy ,   
† 
Qyy  and
  
† 
Qyy/aa ) with the following equation:
  
† 
Qhomo =
nH
2 - nH
È 
Î 
Í 
˘ 
˚ 
˙ 
 2
(6-1)
where   
† 
Qhomo  is either   
† 
Qaa  (coupling between Fru-6-P binding sites in the absence
of PEP),   
† 
Qaa/yy  (coupling between Fru-6-P binding sites in the saturating
presence of PEP),   
† 
Qyy  (coupling between PEP binding sites in the absence of
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Fru-6-P) or   
† 
Qyy/aa  (coupling between PEP binding sites in the saturating
presence of Fru-6-P) and   
† 
nH is equal to the Hill number measured for either Fru-
6-P or PEP binding at the appropriate heterotropic ligand concentration.
Finally, the couplings are substituted appropriately into Eq. 6-2 to determine the
contributions of the homotropic interactions to the measured coupling
determined for the 2:2 hybrid (Reinhart, 1988).
  
† 
Q2:2 hybrid = Qay1 ⋅ Qay2 ⋅
Qyy /aa
Qyy
È 
Î 
Í 
Í 
˘ 
˚ 
˙ 
˙ 
1 /2
⋅
Qaa / yy
Qaa
È 
Î 
Í 
˘ 
˚ 
˙ 
1 /2
(6-2)
where   
† 
Q2:2 hybrid  is equal to the measured coupling (  
† 
Qay ) for the 2:2 hybrid of
interest,   
† 
Qay1  and   
† 
Qay2  are the couplings measured for the two heterotropic
interactions isolated within that particular 2:2 hybrid (measured previously via
the 1:3 hybrids), and   
† 
Qaa ,   
† 
Qaa/yy ,   
† 
Qyy  and   
† 
Qyy/aa  are the couplings calculated for
the two homotropic interactions isolated within that particular 2:2 hybrid in the
absence and saturating presence of the heterotropic ligand.  Equation 6-2 can
also be considered in coupling free energy terms by simply using the Gibbs free
energy equation to convert all of the allosteric couplings into coupling free
energies (Eq. 2-6).
  
† 
DG2:2 hybrid = DGay1 + DGay2 + DGhomo-allos + DGhomo-active (6-3)
where   
† 
DG2:2 hybrid  is equal to the measured coupling free energy for the 2:2 hybrid
of interest,   
† 
DGay1  and   
† 
DGay2  are the coupling free energies measured for the two
heterotropic interactions isolated within that particular 2:2 hybrid,   
† 
DGhomo-allos  is
the coupling free energy contribution measured for the homotropic interaction
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between allosteric sites and   
† 
DGhomo-active  is the coupling free energy contribution
measured for the homotropic interaction between active sites.  Moreover,
  
† 
DGhomo-allos  and   
† 
DGhomo-active  are further defined to be equal to the following:
  
† 
DGhomo-allos =
DGyy /aa ⋅ DGyy
2
(6-4)
  
† 
DGhomo-active =
DGaa/yy ⋅ DGaa
2
(6-5)
Thus, in order for the homotropic interactions to augment the inhibitory
effect (  
† 
DGhomo-allos  and   
† 
DGhomo-active > 0), the homotropic couplings in the absence
of the heterotropic ligand (  
† 
Qyy  and   
† 
Qaa) must be greater than the homotropic
couplings in the saturating presence of the heterotropic ligand (  
† 
Qyy/aa  and
  
† 
Qaa/yy ).  However, if   
† 
Qyy  and   
† 
Qaa  are less than   
† 
Qyy/aa  and   
† 
Qaa/yy  (  
† 
DGhomo-allos  and
  
† 
DGhomo-active < 0), then the homotropic interactions will diminish the inhibitory
effect.  Thus, the net change in the Hill numbers measured for Fru-6-P and PEP
binding must diminish saturation of the other ligand to augment the apparent
heterotropic inhibition.  Conversely, if the Hill numbers increase upon
saturation of the heterotropic ligand, heterotropic inhibition will diminish.
Subsaturating heterotropic cooperativity.  Another issue we will be able
to address from the allosteric characterizations of the 2:2 hybrids is
subsaturating heterotropic cooperativity.  This phenomenon was first noted by
Weber (1972 and 1975) and further developed by Reinhart (1988) to describe the
apparent positive cooperativity measured for ligand binding at subsaturating
concentrations of the heterotropic ligand when the heterotropic couplings of the
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two heterotropic interactions are not equal to 1 (  
† 
Qay1  and   
† 
Qay2 ≠ 1).  However,
before we explain why subsaturating heterotropic cooperativity occurs, one
needs to recall the following: (1) the binding of Fru-6-P influences the binding of
PEP to the same extent as PEP binding influences Fru-6-P binding and (2) Fru-6-
P and PEP antagonize each other’s binding.  Consequently, subsaturating
heterotropic cooperativity occurs because in the presence of a subsaturating
amount of PEP, the binding of the first equivalent of Fru-6-P decreases the
degree of saturation of PEP binding, making it easier for the second equivalent
of Fru-6-P to bind leading to an apparent positive cooperativity in Fru-6-P
binding.  This apparent positive cooperativity will continue to increase until a
maximum Hill number is reached at which point the apparent positive
cooperativity will decrease with increasing concentrations of PEP (Reinhart,
1988).  The concentration of PEP that produces the greatest amount of Fru-6-P
cooperativity is also related to the overall coupling measured for the 2:2 hybrid
(  
† 
Q2:2 hybrid ) as well as the   
† 
Kiyo  (Reinhart, 1988).  Thus, if the   
† 
Kiyo  is relatively high
and the coupling is small, detecting subsaturating heterotropic cooperativity
within our PEP concentration range becomes less feasible.  Moreover, if one of
the heterotropic couplings is equal to 1 (  
† 
Qay1 = 1 or   
† 
Qay2 =1; i.e. the 30 Å
heterotropic interaction at pH 6.0), then no subsaturating heterotropic
cooperativity will occur.   This is because in the absence of one of the
heterotropic couplings, each pair of one active site and one allosteric site
function independently of each other, with the first binding equivalent of Fru-6-
P only affecting one allosteric site instead of two (affects two when   
† 
Qay1  and
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† 
Qay2 ≠ 1), eliminating the possibility of an apparent positive cooperativity at
subsaturating levels of PEP.
How the pair-wise allosteric interactions combine in an oligomer.  The
third and most important issue we will be able to address from characterizing
the 2:2 hybrids is how the six allosteric interactions combine in each of the nine
isolated 2:2 hybrids.  With the contributions of the four heterotropic interactions
previously determined, and after measuring the individual couplings for each of
the 2:2 hybrids and the contributions of the six homotropic interactions, we will
be equipped with the means to determine which allosteric model most
accurately describes the observed allosteric behavior for each of the nine 2:2
hybrids.  Therefore, we will be able to establish the validity of not only the most
popular models used to describe allosteric behavior, but also to determine for
the first time experimentally if the predictions made by Reinhart (1988)
regarding the allosteric response of a symmetrical dimer (analogous to the 2:2
hybrid) are accurate.
The two most widely accepted models used to describe an allosteric effect
are the concerted (Monod et al., 1965) and sequential models (Koshland et al.,
1966).  The concerted or MWC model assumes that the conformation of all the
subunits in an oligomer are identical and are subject to a concerted
conformational change upon the binding of an allosteric ligand.  Thus, when
invoking the concerted model, an oligomeric protein at no time can contain two
or more conformationally distinct subunits.  The sequential or KNF model on
the other hand, does allow for multiple conformational states within an
217
oligomer.  Furthermore, as the name implies, the sequential model assumes that
the binding of an allosteric ligand to an oligomer induces a conformational
change localized mainly to that ligand-bound subunit, and subsequent binding
events are necessary to complete the entire allosteric transition.
Applying these models to a dimeric enzyme, we can make several
predictions regarding the observed allosteric effect as shown in Fig. 6-1.  If the
dimer contains one active site and one allosteric site per subunit (the two active
sites are denoted A and B while the two allosteric sites are denoted X and Y,
with A and X on one subunit and B and Y on the other), and one equivalent of
PEP binds to either X or Y, then the concerted model would predict an
equivalent influence upon Fru-6-P binding at A regardless of the location of PEP
binding.  Furthermore, the second equivalent of PEP binding to the enzyme
would provide no additional allosteric effect on Fru-6-P binding to A because
the entire allosteric effect was already realized upon the first binding equivalent
of PEP.  However, the average measured allosteric effect of both binding events
would be equivalent to the measured allosteric effect for the first binding event.
The sequential model would predict that only binding PEP to X would
incur an allosteric effect on Fru-6-P binding to A, while no allosteric effect
would be measured for Fru-6-P binding to A if PEP was bound to Y.  Moreover,
if the latter case occurred, then the second equivalent of PEP binding to X would
produce the entire allosteric effect upon binding Fru-6-P to A, and would be
equivalent to the allosteric effect measured for Fru-6-P binding to A if the first
equivalent of PEP bound to X.  Thus, the average allosteric effect measured for
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FIGURE 6-1  A schematic depicting the predictions regarding the observed
allosteric effect in either the concerted or sequential models on the binding of
one equivalent of Fru-6-P to the A site.
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both binding events is equivalent, regardless of the pathway of binding, to the
measured allosteric effect that occurred if PEP initially bound to X.
Taking it one step further and applying these predictions to the 1:3 and
2:2 hybrids and more specifically the case of the 2:2V(30&32) hybrid, the
concerted model would predict that the coupling free energies measured for the
30 Å and 32 Å heterotropic interactions would be equivalent (first binding event
measured via the 1:3 hybrids), and that the coupling free energy measured for
the 2:2V(30&32) hybrid would not be any different than the couplings measured
for the heterotropic interactions (  
† 
DG30 = DG32 = DG2:2V(30&32 )).  The sequential
model on the other hand would predict that the coupling free energy of one of
the two heterotropic interactions would be zero, while the other coupling free
energy would be equivalent to the coupling free energy measured for the
2:2V(30&32) hybrid (  
† 
DG30 = 0;   
† 
DG32 = DG2:2V(30&32 ) or   
† 
DG32 = 0;   
† 
DG30 = DG2:2V(30&32 )).
These scenarios regarding the expected data are shown in Fig. 6-2 A.
The biggest advantage for both of these models is their simplistic nature
in describing the allosteric effect, however it is this advantage that is also their
downfall.  In considering only a finite number of conformationally active or
inactive states, and hence an “all-or-none” type of allosteric effect, the overall
allosteric freedom allowed for an oligomeric protein is constrained and
oversimplified.  A more suitable model would consider any number of ligand-
bound states with the potential for each of those states to be distinct both in their
overall conformation and in their allosteric properties.  These objectives are
achieved when using a linked function approach in analyzing the allosteric
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FIGURE 6-2  The data predictions for the concerted, sequential and
conformational free/linkage models as they pertain to the 2:2V(30&32) hybrid.
The light gray bar represents the expected measured coupling free energy for
the 1:3 hybrid isolating the 30 Å heterotropic interaction (  
† 
DG30 ).  The dark gray
bar represents the expected measured coupling free energy for the 1:3 hybrid
isolating the 32 Å heterotropic interaction (  
† 
DG32 ).  The polka-dotted bar
represents the expected measured coupling free energy for the 2:2V(30&32)
hybrid (  
† 
DG2:2V(30&32) ).  (A)  Far left: The predictions of the concerted model
(  
† 
DG30 = DG32 = DG2:2V(30&32 )). Middle and Far Right: The predictions of the
sequential model (  
† 
DG30 = 0;   
† 
DG32 = DG2:2V(30&32 ) or   
† 
DG32 = 0;   
† 
DG30 = DG2:2V(30&32 )).
(B)   The conformational  free/linkage model  predictions
(  
† 
DG30 + DG32 = DG2:2V(30&32 )).
A
B
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effect (the “conformational free/linkage” model), and predicts two major things;
(1) that the coupling free energies are unique in magnitude, and (2) that the sum
of the heterotropic coupling free energies and the coupling free energy
contribution from the homotropic interactions is always equal to the overall
coupling free energy measured for the protein (Eq. 6-3).  Applying these
statements to the same aforementioned 2:2V(30&32) hybrid, the coupling free
energies of the 30 Å and 32 Å heterotropic interactions could be anything (even
zero), but their sum in the absence of any homotropic contributions would be
equal to the coupling free energy measured for the 2:2V(30&32) hybrid
(  
† 
DG30 + DG32 = DG2:2V(30&32 )).   This prediction for the data is shown in Fig. 6-2 B.
From our work regarding the 1:3 hybrids and the wild-type control
hybrid (4|1), we already know that the concerted and sequential models are
insufficient in describing the observed allosteric effect between Fru-6-P and PEP
and vice versa because the coupling free energies measured for each of the four
heterotropic interactions are unique in magnitude (Chapters III and IV).
However, with the information gained from characterizing the 2:2 hybrids, we
will be able to determine what kind of role the homotropic interactions play in
the allosteric response (specifically inhibition) and also show experimentally if
the predictions made by Reinhart (1988) regarding the expected allosteric
behavior of a symmetrical dimer are substantiated.
Materials and methods
The materials and methods used for the experiments described in this
chapter are as described in Chapter II.  The Fru-6-P enzymatic activity
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measurements and data analysis were performed as described in Chapter II.
The formation, isolation and identification of the nine 2:2 hybrids were
performed as described in Chapter V.
Experimental determination of PEP cooperativity.  As previously
mentioned, the relative couplings for the homotropic interactions between both
the active sites and the allosteric sites can be determined from the Hill number
(  
† 
nH) obtained between the pertinent binding sites in both the absence and
saturating presence of the heterotropic ligand.  For determining   
† 
Qaa  and   
† 
Qaa/yy ,
no additional experiments are required as the relevant data are already collected
from determining   
† 
Qay  for each of the nine 2:2 hybrids.  The Hill numbers
obtained from the first phase of the individual Fru-6-P saturation profiles in the
absence and saturating presence of PEP are fit to Eqs. 6-6 and 6-7 to determine
  
† 
Qaa  and   
† 
Qaa/yy  respectively.
  
† 
Qaa =
nH
2 - nH
È 
Î 
Í 
˘ 
˚ 
˙ 
 2
(6-6)
  
† 
Qaa/yy =
nH
2 - nH
È 
Î 
Í 
˘ 
˚ 
˙ 
 2
(6-7)
To determine the cooperativity between the allosteric sites, an additional
experiment is required.  Instead of measuring the   
† 
K1 /2  for Fru-6-P at increasing
concentrations of PEP, the   
† 
K1 /2  for PEP is determined at increasing
concentrations of Fru-6-P.  The same experimental procedure outlined in
Chapter II for assaying enzymatic activity as a function of PEP concentration is
used in determining the   
† 
K1 /2  for PEP, except the Fru-6-P and PEP components
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are switched.  Furthermore, since Fru-6-P is a substrate of PFK, the number of
phases observed in the individual PEP saturation profiles differs upon the
concentration of Fru-6-P used.  At low Fru-6-P only one phase in the data is
observed because a small amount of Fru-6-P is bound to the high affinity active
sites; thus, upon the addition of PEP, only the effect from binding PEP to the
high affinity allosteric sites is observed because there is so little PFK activity to
begin with.  Therefore, to determine the   
† 
K1 /2  for PEP and the Hill number for the
native allosteric sites, these data are fit to the following equation:
  
† 
v = MaxD ⋅ [Y]
n H + Vo ⋅ K1/2
n H + Vo ⋅ [Y]n H
K1/2
n H + [Y]n H
Ê 
Ë 
Á 
ˆ 
¯ 
˜ (6-8)
where v equals the steady-state rate of turnover, Max∆ represents the maximal
change in activity, [Y] equals the concentration of PEP,   
† 
Vo equals the initial rate
of turnover at a particular Fru-6-P concentration,   
† 
K1 /2  is the concentration of
PEP resulting in half maximal activity also at that particular concentration of
Fru-6-P, and   
† 
nH is the Hill coefficient.
At higher Fru-6-P concentrations, the binding of PEP to the mutated
allosteric sites can now be observed, due to the initially greater activity,
resulting in two phases in the data.  The first phase corresponds to the effect on
PFK activity from PEP binding to the high affinity allosteric sites, while the
second phase corresponds to the effect on PFK activity from PEP binding to the
low affinity (mutated) allosteric sites.  These data are fit to the Eq. 6-9 to
determine the binding affinities of both types of allosteric sites, however often,
the second phase is not well defined and the Hill number has to be removed
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from the second half of the equation to obtain a decent fit of all the data.
  
† 
v = MaxD ⋅ [Y]
n H + Vo ⋅ K1/2
n H + Vo ⋅ [Y]n H
K1/2
n H + [Y]n H
Ê 
Ë 
Á 
ˆ 
¯ 
˜ 
  
† 
+
MaxD' ⋅ [Y]n H' + Vo' ⋅ K1/2'
n H' + Vo' ⋅ [Y]n H
'
K1/2'
n H' + [Y]n H'
Ê 
Ë 
Á 
Á 
ˆ 
¯ 
˜ 
˜ 
(6-9)
where Max∆’,   
† 
Vo' ,   
† 
K1/2'  and   
† 
nH'  refer to the maximal change in activity, the initial
rate of turnover, apparent dissociation parameter for PEP and the Hill
coefficient for the low affinity (mutated) allosteric site population, respectively.
At saturating levels of Fru-6-P, the data returns to one phase again
because now the Fru-6-P is bound to more than just the native active sites, thus
more PEP is required to inhibit the enzyme.  Therefore, only inhibition from the
native allosteric sites is observed, not because the mutated allosteric sites are
unable to inhibit the enzyme, but rather due to the inability to use high enough
levels of PEP to observe the allosteric effect.  Thus, in these cases the data are fit
to Eq. 6-8 to determine the binding affinity for PEP at the high affinity allosteric
sites.  Figure 6-3 displays these three trends in the data based upon the
concentration of Fru-6-P used and the necessity to alter the equations used to fit
the resulting data.
The couplings for the homotropic interactions between the allosteric sites,
  
† 
Qyy  and   
† 
Qyy/aa , are determined from the Hill numbers obtained from the
individual PEP saturation profiles in the absence and saturating presence of Fru-
6-P using the following equations:
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FIGURE 6-3  The PEP saturation profiles determined for the 2:2D(22&30) hybrid
at pH 7.0 and increasing concentrations of Fru-6-P.  At low Fru-6-P, only one
phase in the data is observed and these data are fit to Eq. 6-8.  As the
concentration of Fru-6-P increases, and additional phase begins to be seen, thus
these data were fit to Eq. 6-9 to account for the binding affinity of the mutated
allosteric sites.  Finally, at high Fru-6-P, the data returns to one phase because of
the limitations in adding additional PEP to observe the second phase, and these
data are fit once again to Eq. 6-8 as described in the text. The various
concentrations of Fru-6-P are as follows: 0.0023 mM (l), 0.0069 mM (n), 0.0206
mM (s), 0.0617 mM (°), 0.185 mM (o), 0.556 mM (Í), 1.67 mM (l) and 5 mM
(n).
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† 
Qyy =
nH
2 - nH
È 
Î 
Í 
˘ 
˚ 
˙ 
 2
(6-10)
  
† 
Qyy/aa =
nH
2 - nH
È 
Î 
Í 
˘ 
˚ 
˙ 
 2
(6-11)
However,   
† 
Qyy  cannot be determined explicitly because Fru-6-P is one of
the substrates of PFK.  Moreover,   
† 
Qyy/aa  is difficult to measure because at high
Fru-6-P concentration, the binding affinity for PEP is so low that the PEP
saturation profile is unable to reach saturation within the limits of the
experiment.  Thus, the Hill numbers for those two extremes have to be
extrapolated from the data at intermediate concentrations of Fru-6-P.  For those
cases in which the Hill number is at or near 1 at both low Fru-6-P and high Fru-
6-P, a value of 1 is assumed for the Hill numbers in the absence and saturating
presence of Fru-6-P, resulting in a coupling of 1 for both   
† 
Qyy  and   
† 
Qyy/aa
respectively.  Moreover, if the Hill number for PEP binding does not change as a
function of Fru-6-P concentration, then the Hill number is obtained from an
average of all the Hill numbers measured.  However, if the Hill number is at a
value greater than 1 at low Fru-6-P and returns to 1 at high Fru-6-P, the
following equation is used to obtain the Hill number in the absence of Fru-6-P:
  
† 
nH =
MaxD ⋅ [Y]+ (1- MaxD) ⋅ nH1/2 + (1- MaxD) ⋅ [Y]
nH1/2 + [Y]
Ê 
Ë 
Á Á 
ˆ 
¯ 
˜ ˜ (6-12)
where Max∆ now represents the maximal change in the Hill number and (1-
Max∆) is equivalent to the Hill number in the absence of Fru-6-P.  By
substituting the latter parameter into Eq. 6-10,   
† 
Qyy  is determined.  The   
† 
nH1 /2
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parameter found in Eq. 6-12 is the concentration of PEP resulting in half the
maximal Hill number value, which for all intents and purposes is an irrelevant
parameter.  By using Eq. 6-12 to fit the data, the Hill number at saturating Fru-6-
P is always equal to 1, thus the   
† 
Qyy/aa  is always equal to 1.  This constraint
placed upon the data is reasonable because in every case the trend is towards a
final value of 1 as seen in the Results section.
Results
Characterization of the 2:2V hybrids.  As previously described in
Chapter V, the 2:2V(30&32) and 2:2V(22&45) hybrids were formed and isolated
using three different mutant proteins and two different methods.  The two
2:2V(30&32) hybrids were formed and isolated by using either dimer exchange
with the [b,a] mutant protein (R252A/D12A/R211E/K213E/K90E/K91E), or by
using monomer exchange with the [b,b]  mutant protein
(R252A/D12A/R25E/N303E/K304E).  In either case, the same six allosteric
interactions are isolated in each respective 2:2V(30&32) hybrid, four of which are
unique and are as follows: the 30 Å heterotropic interaction, the 32 Å
heterotropic interaction, the 47 Å homotropic interaction between active sites
and the 39.9 Å homotropic interaction between allosteric sites.
The 2:2V(22&45) hybrid also isolates the 47 Å and 39.9 Å homotropic
interactions, but was formed and isolated by using monomer exchange with the
[a,b] mutant protein (R162E/R25E/N303E/K304E).  However, instead of
isolating the 30 Å and 32 Å heterotropic interactions like the aforementioned
2:2V hybrids, the 2:2V(22&45) hybrid isolates two copies of the 22 Å and 45 Å
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heterotropic interactions.  Thus, all three 2:2V hybrids isolate the same
homotropic interactions, but two different pairs of heterotropic interactions
depending upon the mutant protein used.
The allosteric couplings,   
† 
Qay , for the three 2:2V hybrids were determined
at pH 6.0, 7.0 and 8.0 and the results are shown in Figs. 6-4 of A, B and C.  Not
surprisingly, the couplings for the 2:2V(30&32) hybrids are identical within error
(as discussed in Chapter V) since the two 2:2 hybrids contain the same allosteric
interactions.  Moreover, the coupling free energies increase with an increase in
pH, a phenomenon consistent with the wild-type enzyme (Tlapak-Simmons and
Reinhart, 1988).  The only difference between the two 2:2V(30&32) hybrids is the
binding affinity for Fru-6-P at pH 8.0.  The 2:2V(30&32) hybrid obtained using
the [b,a] mutant protein (isolates the 32 Å heterotropic interaction via its 1:3
hybrid) has a lower Fru-6-P binding affinity compared to the 2:2V(30&32)
hybrid obtained using the [b,b] mutant protein (isolates the 30 Å heterotropic
interaction via its 1:3 hybrid).  This result is consistent with the Fru-6-P binding
affinities measured previously for the respective 1:3 hybrids (see Chapter III).
As for the 2:2V(22&45) hybrid, the coupling also increases with an
increase in pH, however, the binding affinity for PEP (  
† 
Kiyo ) is substantially
decreased.  Due to this influence, the upper plateaus at both pH 7.0 and 8.0 are
not as well defined in Fig. 6-4 C as the previous 2:2V hybrids (A and B) and
leads to the possibility of the mutated allosteric sites influencing the measured
coupling for the 2:2V(22&45) hybrid.  In turn, this causes the apparent coupling
to be greater than the actual coupling found between the four native binding
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FIGURE 6-4  The two-dimensional schematics of the three 2:2V hybrids isolated
and the steady-state characterization of their allosteric properties at pH 6.0 (l),
7.0 (o) and 8.0 (s). The data was obtained at 25°C and using 50 mM MES-KOH
at pH 6.0, 50 mM MOPS-KOH at pH 7.0 and 50 mM EPPS-KOH at pH 8.0.  The
concentration of MgATP was equal to 3 mM.  All the curves correspond to the
best fit of these data to Eq. 2-4 and the error bars represent ± the standard error.
(A)  The 2:2V(30&32) hybrid obtained by using the [b,a] mutant protein (via
dimer exchange) and its allosteric characterization.  (B)  The 2:2V(30&32) hybrid
obtained by using the [b,b] mutant protein (via monomer exchange) and its
allosteric characterization.  (C)  The 2:2V(22&45) hybrid and its allosteric
characterization.
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sites.  A summary of all the kinetic and thermodynamic parameters obtained for
the three 2:2V hybrids is found in Table 6-1, and the Gibbs free energy equation
(Eq. 2-6) was used to convert all of the couplings (  
† 
Qay ) into coupling free energy
terms (  
† 
DGay ).
Characterization of the 47 Å homotropic interaction between active sites via the
2:2V hybrids.  In order to determine the allosteric contribution of the 47 Å
homotropic interaction (between active sites) to the measured coupling for each
of the three 2:2V hybrids, the Hill numbers for Fru-6-P binding were determined
at increasing concentrations of PEP for all three 2:2V hybrids at pH 6.0, 7.0 and
8.0.  The results are shown in Fig. 6-5 A, B and C.  For the 2:2V(30&32) hybrid
obtained by dimer exchange (using the [b,a] mutant protein), the Hill number at
pH 6.0 does not change over the course of the PEP concentrations assayed as
seen in Fig. 6-5 A .  This observation can be explained by the fact that the
coupling for the 30 Å heterotropic interaction equals 1 at pH 6.0 (  
† 
Q30Å = 1;
Chapter III).  At pH 7.0, subsaturating heterotropic cooperativity is observed,
but at pH 8.0, no real trend in the Hill numbers is seen.  Interestingly, the Hill
numbers in the absence and saturating presence of PEP increase with increasing
pH.  A somewhat different pattern in Fru-6-P cooperativity is seen for the
2:2V(30&32) hybrid obtained by monomer exchange (using the [b,b] mutant
protein) (Fig. 6-5 B).  At both low and high Fru-6-P, the Hill numbers are
approximately 1 at all three pH values (no pH effect observed like the
other2:2V(30&32) hybrid); however, subsaturating heterotropic cooperativity is
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TABLE 6-1  A summary of the kinetic and thermodynamic parameters
obtained for the 2:2V hybrids at 25°C, pH 6.0, 7.0 and 8.0 and [MgATP] = 3
mM
2:2 Hybrid   
† 
Kiao  (mM)   
† 
Kiyo  (mM)   
† 
Qay   
† 
DGay
(kcal/mol)
pH 6.0
2:2V(30&32)
Dimer X-∆
([b,a])
0.042 ± 0.001 0.031 ± 0.013 0.61 ± 0.03 0.29 ± 0.04
2:2V(30&32)
Monomer X-∆
([b,b])
0.031 ± 0.001 0.13 ± 0.06 0.62 ± 0.04 0.28 ± 0.04
2:2V(22&45) 0.032 ± 0.002 0.44 ± 0.03 0.41 ± 0.03 0.52 ± 0.05
pH 7.0
2:2V(30&32)
Dimer X-∆
([b,a])
0.022 ± 0.001 0.0051 ± 0.0013 0.19 ± 0.02 0.97 ± 0.05
2:2V(30&32)
Monomer X-∆
([b,b])
0.022 ± 0.001 0.0069 ± 0.0012 0.22 ± 0.01 0.90 ± 0.04
2:2V(22&45) 0.016 ± 0.001 0.46 ± 0.07 0.17 ± 0.01 1.03 ± 0.05
pH 8.0
2:2V(30&32)
Dimer X-∆
([b,a])
0.15 ± 0.02 0.0030 ± 0.0008 0.11 ± 0.01 1.33 ± 0.08
2:2V(30&32)
Monomer X-∆
([b,b])
0.032 ± 0.002 0.0039 ± 0.0005 0.098 ± 0.005 1.37 ± 0.03
2:2V(22&45) 0.027 ± 0.001 1.1 ± 0.1 0.033 ± 0.002 2.02 ± 0.04
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FIGURE 6-5  The characterization of the 47 Å homotropic interaction between
active sites by following the dependence of the Hill number (  
† 
nH) determined for
Fru-6-P binding as a function of increasing concentrations of PEP for the 2:2V
hybrids.  The data was obtained at 25°C and at pH 6.0 (l) using 50 mM MES-
KOH, at pH 7.0 (o) using 50 mM MOPS-KOH and at pH 8.0 (s) using 50 mM
EPPS-KOH.  The concentration of MgATP was equal to 3 mM, and the error bars
represent ± the standard error.  (A)  The 2:2V(30&32) hybrid obtained by using
the [b,a] mutant protein (via dimer exchange).  (B)  The 2:2V(30&32) hybrid
obtained by using the [b,b] mutant protein (via monomer exchange).  (C)  The
2:2V(22&45) hybrid.
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apparent at both pH 7.0 and 8.0 and absent from pH 6.0, consistent again with
  
† 
Q30Å = 1.  Furthermore, a greater maximal Hill number is attained at pH 8.0 than
pH 7.0 because of the increased coupling (  
† 
Q2:2V(30&32) ) at pH 8.0 as compared to
pH 7.0 (see Table 6-1).  As for the third 2:2V hybrid (2:2V(22&45)), the Hill
numbers are approximately 1 at all three pH values and at all PEP
concentrations (Fig. 6-5 C).
Since there is no overall net change in the Hill numbers for Fru-6-P
binding in the absence and saturating presence of PEP for any of the 2:2V
hybrids,   
† 
Qaa  is equal to   
† 
Qaa / yy  (according to Eqs. 6-6 and 6-7) for all three 2:2V
hybrids and at all three pH values investigated (Fig. 6-5).  Furthermore, because
  
† 
Qaa = Qaa / yy , the 47 Å homotropic interaction contributes nothing to the overall
allosteric effect measured for the 2:2V hybrids based upon the prediction made
earlier by Eq. 6-2, repeated here for convenience (Reinhart, 1988):
  
† 
Q = Qay1 ⋅ Qay2 ⋅
Qyy /aa
Qyy
È 
Î 
Í 
Í 
˘ 
˚ 
˙ 
˙ 
1 /2
⋅
Qaa / yy
Qaa
È 
Î 
Í 
˘ 
˚ 
˙ 
1 /2
(6-13)
Characterization of the 39.9 Å homotropic interaction between allosteric sites via
the 2:2V hybrids.  Using the same conditions, but determining the binding affinity
for PEP as a function of Fru-6-P concentration enabled us to measure the
cooperativity in PEP binding between the two native allosteric sites and hence
determine the allosteric contribution of the 39.9 Å homotropic interaction to the
overall measured coupling for the 2:2V hybrids.  Figures 6-6 A, B and C
summarize these results.  All three 2:2V hybrids behave similarly, and the Hill
number is always at or near 1 at both low and high Fru-6-P concentration for all
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FIGURE 6-6  The characterization of the 39.9 Å homotropic interaction between
allosteric sites by following the dependence of the Hill number (  
† 
nH) determined
for PEP binding as a function of increasing concentrations of Fru-6-P for the 2:2V
hybrids.  The data was obtained at 25°C and at pH 6.0 (l) using 50 mM MES-
KOH, at pH 7.0 (o) using 50 mM MOPS-KOH and at pH 8.0 (s) using 50 mM
EPPS-KOH.  The concentration of MgATP was equal to 3 mM, and the error bars
represent ± the standard error.  (A)  The 2:2V(30&32) hybrid obtained by using
the [b,a] mutant protein (via dimer exchange).  (B)  The 2:2V(30&32) hybrid
obtained by using the [b,b] mutant protein (via monomer exchange).  (C)  The
2:2V(22&45) hybrid.
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three pH values investigated.  In some instances the Hill number increases
somewhat at subsaturating levels of Fru-6-P (subsaturating heterotropic
cooperativity), but it always returns to 1 at high Fru-6-P.  Unfortunately, a
limited amount of data was collected regarding PEP cooperativity for the
2:2V(30&32) hybrid, thus the number of points is decreased (Fig. 6-6 B).
For all three 2:2V hybrids, a value of 1 was assumed for the Hill numbers
in both the absence and saturating presence of Fru-6-P leading to a coupling of 1
for both   
† 
Qyy  and   
† 
Qyy /aa  (Eqs. 6-10 and 6-11).  Furthermore, since the there is no
net change in PEP cooperativity in the absence and saturating presence of Fru-6-
P, the 39.9Å homotropic interaction contributes nothing to the overall measured
allosteric effect in each of the three 2:2V hybrids.  Thus, both homotropic
interactions in the 2:2V hybrids are not involved in transmitting the allosteric
signal between Fru-6-P and PEP or vice versa.
How the allosteric interactions combine in the 2:2V hybrids.  Next, all the
coupling free energies (  
† 
DGay ) measured for the four individual allosteric
interactions found within each 2:2V hybrid were compared to the coupling free
energy measured for each corresponding 2:2V hybrid (Figs. 6-7, A and B).  Since
both the 47 Å homotropic interaction between active sites (Fru-6-P
cooperativity) and the 39.9 Å homotropic interaction between allosteric sites
(PEP cooperativity) were found to contribute nothing to the measured allosteric
effect of the 2:2V hybrids, they were not included in the analysis.  For both of the
2:2V(30&32) hybrids, the measured coupling free energy for each 2:2 hybrid is
equal to the sum of the individual coupling free energies (within error)
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FIGURE 6-7  The comparison of the sum of the individual coupling free energies determined for
the heterotropic interactions to the coupling free energy determined for the 2:2V hybrids at pH
6.0, 7.0 and 8.0 in the absence of any homotropic contribution.  (A)  The bar on the left at each pH
corresponds to the sum of the coupling free energies determined for the 30 Å interaction (light
gray) and the 32 Å interaction (dark gray), the bar in the middle corresponds to the coupling free
energy determined for the 2:2V(30&32) hybrid obtained by using the [b,a] mutant protein
(stripes), and the bar on the right corresponds to the coupling free energy determined for the
2:2V(30&32) hybrid obtained by using the [b,b] mutant protein (polka-dots).  (B)  The bar on the
left at each pH corresponds to the sum of the coupling free energies determined for the 22 Å
interaction (white) and the 45 Å interaction (black), and the bar on the right corresponds to the
coupling free energy determined for the 2:2V(22&45) hybrid (bricks).
A
2:2V(30&32)
[b,a]
2:2V(30&32)
[b,b]
B
2:2V(22&45)
[a,b]
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calculated for the 30 Å and 32 Å heterotropic interactions respectively at all
three of the pH values investigated (Fig. 6-7 A). Thus, even as the relative
contributions of the 30 Å and 32 Å heterotropic interactions change with pH, the
coupling free energies measured for both of the 2:2V(30&32) hybrids changes as
well to still equal the sum of the individual coupling free energies for the 30 Å
and 32 Å heterotropic interactions.
As for the 2:2V(22&45) hybrid (Fig. 6-7 B), the coupling free energy
measured at pH 6.0 also equals the sum of the coupling free energies (within
error) determined for the 22 Å and 45 Å heterotropic interactions, but is not the
case at pH 7.0 and 8.0.  At pH 7.0 and 8.0 the coupling free energy calculated for
the 2:2V(22&45) hybrid is somewhat greater than the sum of the coupling free
energies measured for the 22 Å and 45 Å heterotropic interactions; this
discrepancy is most likely due to the influence upon the apparent coupling of
PEP binding to the mutated allosteric sites.  Unlike the 1:3 hybrids, a “control”
hybrid was not constructed for each individual 2:2 hybrid and assayed to
determine the point at which the mutated allosteric sites begin to influence the
measured allosteric coupling (see Chapters III and IV).  However, from
experience with the 1:3 control hybrids, the mutated allosteric sites are estimated
to begin binding PEP at around 5 mM PEP.  Thus, if saturation is not reached by
5 mM PEP, as is the case at pH 7.0 and 8.0 (Figs. 6-4, B and C), the measured
coupling will contain partial influence from PEP binding at the two mutated
allosteric sites.  Unfortunately this is difficult to prove since we were unable to
form and characterize the redundant form of the 2:2V(22&45) hybrid utilizing
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the [a,a] mutant protein.
Characterization of the 2:2D hybrids.  The three 2:2D hybrids were all
formed and isolated as described in Chapter V via the monomer exchange
procedure described in Chapter II utilizing the K90E/K91E charge tag and three
different mutant proteins.  The two 2:2D(32&45) hybrids were formed using
either the [b,a] mutant protein (R252A/D12A/K213E/K90E/K91E) or the [a,b]
mutant protein (R162E/R25E/K90E/K91E) respectively, while the 2:2D(22&30)
hybr id  was  formed us ing  the  [b ,b ]  mutant  prote in
(R252A/D12A/R25E/K90E/K91E).  All three 2:2D hybrids isolate the 45 Å
homotropic interaction between active sites and the 23 Å homotropic interaction
between allosteric sites, but as the names describe, the 2:2D(32&45) hybrids also
isolate two copies each of the 32 Å and 45 Å heterotropic interactions (Figs. 6-8,
A and B), whereas the 2:2D(22&30) hybrid isolates two copies each of the 22 Å
and 30 Å heterotropic interactions respectively (Fig. 6-8 C).
The allosteric characterizations of the three 2:2D hybrids at pH 6.0, 7.0
and 8.0 are shown in Figs. 6-8 A, B and C with the parameters derived from this
analysis summarized in Table 6-2.  All three 2:2D hybrids responded to the
change in pH in the expected manner, with the coupling (  
† 
Qay ) increasing with
increasing pH. However, the 2:2D(32&45) hybrid obtained by using the [b,a]
mutant protein (Fig. 6-8 A) displayed a decrease in Fru-6-P affinity with
increasing pH, a phenomenon consistent with the allosteric behavior of the
2:2V(30&32) hybrid obtained using the [b,a] mutant protein discussed earlier,
with the only mutational difference being the addition of the R211E allosteric
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FIGURE 6-8  The two-dimensional schematics of the three 2:2D hybrids isolated
and the steady-state characterization of their allosteric properties at pH 6.0 (l),
7.0 (o) and 8.0 (s). The data was obtained at 25°C and using 50 mM MES-KOH
at pH 6.0, 50 mM MOPS-KOH at pH 7.0 and 50 mM EPPS-KOH at pH 8.0.  The
concentration of MgATP was equal to 3 mM.  All the curves correspond to the
best fit of these data to Eq. 2-4 and the error bars represent ± the standard error.
(A)  The 2:2D(32&45) hybrid obtained by using the [b,a] mutant protein and its
allosteric characterization.  (B)  The 2:2D(32&45) hybrid obtained by using the
[a,b] mutant protein and its allosteric characterization.  (C)  The 2:2D(22&30)
hybrid and its allosteric characterization.
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TABLE 6-2 A summary of the kinetic and thermodynamic parameters
obtained for the 2:2D hybrids at 25°C, pH 6.0, 7.0 and 8.0 and [MgATP] = 3
mM
2:2 Hybrid   
† 
Kiao  (mM)   
† 
Kiyo  (mM)   
† 
Qay   
† 
DGay
(kcal/mol)
pH 6.0
2:2D(32&45)
([b,a])
0.039 ± 0.004 0.0035 ± 0.0025 0.64 ± 0.07 0.26 ± 0.07
2:2D(32&45)
([a,b])
0.023 ± 0.003 1.6 ± 0.7 0.34 ± 0.24 0.64 ± 0.52
2:2D(22&30) 0.044 ± 0.002 0.65 ± 0.07 0.67 ± 0.11 0.24 ± 0.09
pH 7.0
2:2D(32&45)
([b,a])
0.017 ± 0.001 0.0065 ± 0.0025 0.43 ± 0.03 0.50 ± 0.05
2:2D(32&45)
([a,b])
0.023 ± 0.002 3.0 ± 1.3 0.20 ± 0.08 0.96 ± 0.25
2:2D(22&30) 0.024 ± 0.001 0.0091 ± 0.0010 0.097 ± 0.005 1.38 ± 0.03
pH 8.0
2:2D(32&45)
([b,a])
0.085 ± 0.003 0.0022 ± 0.0002 0.20 ± 0.01 0.94 ± 0.02
2:2D(32&45)
([a,b])
0.025 ± 0.001 4.5 ± 0.7 0.054 ± 0.020 1.72 ± 0.23
2:2D(22&30) 0.031 ± 0.001 0.018 ± 0.001 0.012 ± 0.001 2.62 ± 0.05
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site mutation in the latter mutant protein.  The other major difference between
Figs. 6-8 A, B and C is the decreased binding affinity for PEP (  
† 
Kiyo ) measured for
the 2:2D(32&45) hybrid obtained by using the [a,b] mutant protein (Fig. 6-8 B).
Due to this effect, none of the data reaches saturation at pH 6.0, 7.0 or 8.0
potentially allowing PEP to bind at the mutated allosteric sites and influence the
apparent measured coupling.  Interestingly, this observation of decreased PEP
binding affinity was also made and discussed previously regarding the
2:2V(22&45) hybrid, which also used the [a,b] mutant protein (same binding site
mutations but different charge tag).
In order to determine if PEP binding at the mutated allosteric sites was
influencing the measured coupling of the 2:2D(32&45) hybrid obtained by using
the [a,b] mutant protein, we compared the coupling free energies calculated for
the two 2:2D(32&45) hybrids because the same allosteric interactions are isolated
in both hybrids.  The coupling free energy calculated for the 2:2D(32&45) hybrid
with the elevated   
† 
Kiyo  is greater than the other 2:2D(32&45) hybrid by
approximately 2-fold, thus it seems that our argument regarding PEP binding at
the mutated allosteric sites and influencing the measured coupling free energy
for the 2:2D(32&45) hybrid isolated by using the [a,b] mutant protein is
substantiated.
Characterization of the 45 Å homotropic interaction between active sites via the
2:2D hybrids.  To determine the contribution of the 45 Å homotropic interaction
to the measured allosteric effect of the three 2:2D hybrids, the Hill number for
Fru-6-P binding was measured as a function of PEP concentration and the
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results are shown in Figs. 6-9 A, B and C.  The Hill numbers measured for the
2:2D(32&45) hybrid obtained by using the [b,a] mutant protein (Fig. 6-9 A)
behave similarly to the previously mentioned 2:2V(30&32) hybrid obtained by
using the [b,a] mutant protein (the former mutant protein has the K213E
mutation, while the latter has the R211E/K213E double mutation) in that the
Hill numbers themselves increase with increasing pH, but always beginning and
ending at the same value.  Subsaturating heterotropic cooperativity is not
evident at pH 6.0 or 7.0 as the Hill number does not change dramatically over
the course of the PEP concentrations assayed.  At pH 8.0, subsaturating
heterotropic cooperativity may be evident.
The Hill numbers measured for the other 2:2D(32&45) hybrid obtained by
using the [a,b] mutant protein (Fig. 6-9 B), “bounce” around a little with
subsaturating heterotropic cooperativity occurring at the higher concentrations
of PEP for all three pH values which is consistent with the elevated   
† 
Kiyo  value
determined earlier for this particular 2:2 hybrid.  The data regarding pH 6.0
however are somewhat inconsistent because the maximum Hill number
measured at pH 6.0 should not be greater than the maximum Hill number
measured at pH 7.0 and 8.0 because the coupling is lowest at pH 6.0.  More
importantly however, the Hill numbers begin and end at approximately the
same value.  The final 2:2D hybrid, the 2:2D(22&30) hybrid obtained by using
the [b,b] mutant protein (Fig. 6-9 C), also displays subsaturating heterotropic
cooperativity, but only at pH 7.0 and 8.0 (with the maximum Hill number
occurring at pH 8.0) and behaves quite similarly to the 2:2V(30&32) hybrid
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FIGURE 6-9  The characterization of the 45 Å homotropic interaction between
active sites by following the dependence of the Hill number (  
† 
nH) determined for
Fru-6-P binding as a function of increasing concentrations of PEP for the 2:2D
hybrids.  The data was obtained at 25°C and at pH 6.0 (l) using 50 mM MES-
KOH, at pH 7.0 (o) using 50 mM MOPS-KOH and at pH 8.0 (s) using 50 mM
EPPS-KOH.  The concentration of MgATP was equal to 3 mM, and the error bars
represent ± the standard error.  (A)  The 2:2D(32&45) hybrid obtained by using
the [b,a] mutant protein.  (B)  The 2:2D(32&45) hybrid obtained by using the
[a,b ] mutant protein.  (C )  The 2:2D(22&30) hybrid and its allosteric
characterization.
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obtained by using the [b,b] mutant protein (the latter mutant protein uses the
N303E/K304E charge tag instead of the K90E/K91E charge tag).  The lack of
subsaturating heterotropic cooperativity occurring at pH 6.0 is consistent with
  
† 
Q30Å = 1.  More importantly however, the Hill numbers are (within error) the
same value in the limits of low and high concentrations of PEP.  Thus, since
  
† 
Qaa = Qaa / yy , the 45 Å homotropic interaction (between active sites) contributes
nothing to the apparent heterotropic coupling (  
† 
Qay ) measured for each of the
three 2:2D hybrids.
Characterization of the 23 Å homotropic interaction between allosteric sites via
the 2:2D hybrids.  The other homotropic interaction isolated within the 2:2D
hybrids, the 23 Å homotropic interaction between allosteric sites, proved to be
much more challenging to characterize than the previous 39.9 Å homotropic
interaction between allosteric sites.  Of the three 2:2D hybrids, only the Hill
numbers for PEP binding to the 2:2D(22&30) hybrid were measured, but for two
different reasons. Unfortunately, not enough data were collected for the
2:2D(32&45) hybrid obtained by using the [b,a] mutant protein to generate
quality PEP saturation profiles.  Consequently, the Hill numbers for PEP
binding were not measured for that particular 2:2 hybrid.  On the other hand,
accurate Hill numbers for PEP binding to the other 2:2D(32&45) hybrid were
impossible to measure due to the decreased binding affinity for PEP.  Since the
  
† 
Kiyo  is so high for that particular 2:2 hybrid, the individual PEP saturation
profiles could not define the lower plateau preventing any kind of accurate fit to
the data.  Thus, the Hill numbers for PEP binding were undeterminable for the
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2:2D(32&45) hybrid obtained by using the [a,b] mutant protein.
The remaining 2:2D hybrid, the 2:2D(22&30) hybrid, was characterized
and the Hill numbers for PEP binding determined as a function of Fru-6-P
concentration are shown in Fig. 6-10.  Unlike any other homotropic interaction
characterized to this point, the Hill numbers measured for PEP binding to the
2:2D(22&30) hybrid begin at a value greater than 1 at low Fru-6-P and proceed
to a value of 1 at high Fru-6-P.  Moreover, the initial Hill number value at low
Fru-6-P increases with increasing pH.  The data were fit to Eq. 6-12 to
extrapolate the Hill number value in the absence of Fru-6-P at pH 6.0, 7.0 and 8.0
and their values are summarized in Table 6-3.  Furthermore, Eq. 6-10 was used
to calculate   
† 
Qyy  and since the Hill numbers returned to 1 at high Fru6-P,   
† 
Qyy /aa
is equal to 1 at all pH values (Eq. 6-11).
To determine the allosteric contribution of the 23 Å homotropic
interaction to the measured allosteric effect for the 2:2D(22&30) hybrid, the
square root of the ratio of   
† 
Qyy/aa  to   
† 
Qyy  was calculated as called for in Eq. 6-2
and is the ratio presented in Table 6-3.    
† 
Qyy/aa  and   
† 
Qyy  were determined from
the respective Hill coefficients at high and low concentrations of Fru-6-P using
Eqs. 6-12 and 6-1.  Moreover, this ratio can also be expressed as a coupling free
energy, as indicated in Table 6-3.  Thus, of the two homotropic interactions
isolated by the 2:2D hybrids, the 23 Å homotropic interaction plays a significant
role in the inhibition process, with the 45 Å homotropic interaction between
active sites contributing nothing to the allosteric effect.
251
0.5
1
1.5
2
2.5
10-3 10-2 10-1 100 101 102
Hi
ll 
Nu
m
be
r 
(P
EP
 C
oo
pe
ra
tiv
ity
)
[Fru-6-P] mM
FIGURE 6-10  The characterization of the 23 Å homotropic interaction between
active sites by following the dependence of the Hill number (  
† 
nH) determined for
PEP binding as a function of increasing concentrations of Fru-6-P for the
2:2D(22&30) hybrid.  The data was obtained at 25°C and at pH 6.0 (l) using 50
mM MES-KOH, at pH 7.0 (o) using 50 mM MOPS-KOH and at pH 8.0 (s) using
50 mM EPPS-KOH.  The concentration of MgATP was equal to 3 mM, and the
error bars represent ± the standard error.
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TABLE 6-3  A summary of the kinetic and thermodynamic parameters
obtained in characterizing the 23 Å homotropic interaction between
allosteric sites
pH   
† 
nH   
† 
Qyy
  
† 
Qyy /aa
Qyy
È 
Î 
Í 
Í 
˘ 
˚ 
˙ 
˙ 
 1 /2
  
† 
DG23 Å *
(kcal/mol)
6.0 1.29 ± 0.11 3.30 ± 1.17 0.55 ± 0.10 0.35 ± 0.10
7.0 1.48 ± 0.04 8.10 ± 1.32 0.35 ± 0.03 0.62 ± 0.05
8.0 1.55 ± 0.05 11.86 ± 2.74 0.29 ± 0.03 0.73 ± 0.06
*
  
† 
DG23 Å =
1
2
DGyy /aa - DGyy( ) = -RT
Qyy /aa
Qyy
È 
Î 
Í 
Í 
˘ 
˚ 
˙ 
˙ 
1 /2
How the allosteric interactions combine in the 2:2D hybrids.  Figures 6-11 A, B
and C  compare the sum of the coupling free energies measured for the
individual heterotropic interactions found within a particular 2:2D hybrid and
the coupling free energy contribution of the 23 Å allosteric site homotropic
interaction to the coupling free energy calculated for each of the three 2:2D
hybrids.  For the 2:2D(32&45) hybrid obtained by using the [b,a] mutant protein
(Fig. 6-11 A), the coupling free energy measured for the 2:2 hybrid (third bar) is
substantially less than the sum of the individual 32 Å and 45 Å heterotropic
interactions plus the contribution measured for the 23 Å homotropic interaction
determined via the 2:2D(22&30) hybrid (first bar) at pH 6.0, 7.0 and 8.0.
However, the coupling free energy for the 2:2D(22&30) hybrid is equivalent
within error, except at pH 6.0, to the sum of the individual heterotropic
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FIGURE 6-11  The comparison of the sum of the individual coupling free
energies determined for the heterotropic interactions and the 23 Å homotropic
contribution to the coupling free energy determined for the 2:2D hybrids at pH
6.0, 7.0 and 8.0.  (A)  The bar on the left at each pH corresponds to the sum of the
coupling free energies determined for the 32 Å interaction (dark gray), the 45 Å
interaction (black), and the 23 Å homotropic interaction measured via the
2:2D(22&30) hybrid (*hatches).  The bar in the middle corresponds to the sum of
the coupling free energies determined for only the 32 Å interaction (dark gray)
and the 45 Å interaction (black).  The bar on the right corresponds to the
coupling free energy measured for the 2:2D(32&45) hybrid obtained by using
the [b,a] mutant protein (stripes).  (B )  The bar on the left at each pH
corresponds to the sum of the coupling free energies determined for the 32 Å
interaction (dark gray), the 45 Å interaction (black), and the 23 Å homotropic
interaction measured via the 2:2D(22&30) hybrid (*hatches) and the bar on the
right corresponds to the coupling free energy measured for the 2:2D(32&45)
hybrid obtained by using the [a,b] mutant protein (polka-dots).  (C)  The bar on
the left at each pH corresponds to the sum of the coupling free energies
determined for the 22 Å interaction (white), the 30 Å interaction (light gray), and
the 23 Å homotropic interaction (hatched), while the bar on the right
corresponds to the coupling free energy determined for the 2:2D(22&30) hybrid
(bricks).
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interactions in the absence of any homotropic contribution.  Thus, it seems that
one or more of the binding site or charge tag mutations introduced in the [b,a]
mutant protein (R252A/D12A/K213E/K90E/K91E) is potentially interfering
with the transmission of the 23 Å homotropic signal.  The discrepancy at pH 6.0
also occurs for several other 2:2 hybrids (always with the coupling free energy
measured for the 2:2 hybrid less than the sum), and is a phenomenon that
cannot be explained.
On the other hand, the coupling free energy calculated for the
2:2D(32&45) hybrid obtained by using the [a,b ] mutant protein
(R162E/R25E/K90E/K91E – Fig. 6-11 B) is equivalent within error to the sum of
the individual 32 Å and 45 Å heterotropic interactions plus the 23 Å homotropic
component determined in the 2:2D(22&30) hybrid.  Thus, it seems the reason
why the coupling free energies for the two 2:2D(32&45) hybrids are different is
because of the absence and presence of the 23 Å homotropic component
(comparing Figs. 6-11, A and B).
The coupling free energy calculated for the third 2:2D hybrid, the
2:2D(22&30) hybrid, is found to be equivalent at pH 7.0 and 8.0 to the sum of the
coupling free energies determined for the 22 Å and 30 Å heterotropic
interactions plus the contribution from the 23 Å homotropic interaction as seen
in Fig. 6-11 C.  However, at pH 6.0, the coupling free energy measured for the
2:2D(22&30) hybrid is less than the sum, and at this point we have no
explanation for this discrepancy except that this phenomenon also occurs for
some of the other 2:2 hybrids as well (i.e. the 2:2D(32&45) – Fig. 6-11 A).  Thus,
256
in two of the 2:2D hybrids, the entire allosteric effect is accounted for by the both
of the heterotropic interactions plus the contribution from the 23 Å homotropic
interaction, while the 2:2D(32&45) hybrid obtained by using the [b,a] mutant
protein is equal to just the sum of the 32 Å and 45 Å heterotropic interactions.
Characterization of the 2:2H hybrids.  The three 2:2H hybrids were
formed and isolated as described in Chapter V using three different mutant
proteins and the monomer exchange procedure discussed in Chapter II, with
two of the three 2:2H hybrids (the 2:2H(30&45) hybrids) isolating the same six
pair-wise allosteric interactions.  The 2:2H(30&45) hybrids were made by using
either the [b,b] mutant protein (R252A/D12A/R25E/R232E/Q233E – Fig. 6-12
A) or the [a,b] mutant protein (R162E/R25E/R232E/Q233E – Fig. 6-12 B), and in
either case the following interactions were isolated: two copies each of the 30 Å
and 45 Å heterotropic interactions, one copy of the 28 Å homotropic interaction
between active sites, and one copy of the 40 Å homotropic interaction between
allosteric sites.  The third 2:2H hybrid, the 2:2H(22&32) hybrid formed by using
the [b,a] mutant protein (R252A/D12A/K213E/R232E/Q233E – Fig. 6-12 C),
also isolates the 28 Å and 40 Å homotropic interactions, however it isolates two
copies each of the 22 Å and 32 Å heterotropic interactions instead of the 30 Å
and 45 Å heterotropic interactions.
The allosteric characterizations of each of the three 2:2H hybrids at pH
6.0, 7.0 and 8.0 are shown in Figs. 6-12, A, B and C, and a summary of all the
parameters determined by this analysis is found in Table 6-4.  Of the three 2:2H
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FIGURE 6-12  The two-dimensional schematics of the three 2:2H hybrids
isolated and the steady-state characterization of their allosteric properties at pH
6.0 (l), 7.0 (o) and 8.0 (s). The data was obtained at 25°C and using 50 mM
MES-KOH at pH 6.0, 50 mM MOPS-KOH at pH 7.0 and 50 mM EPPS-KOH at
pH 8.0.  The concentration of MgATP was equal to 3 mM.  All the curves
correspond to the best fit of these data to Eq. 2-4 and the error bars represent ±
the standard error.  (A)  The 2:2H(30&45) hybrid obtained by using the [b,b]
mutant protein and its allosteric characterization.  (B)  The 2:2H(30&45) hybrid
obtained by using the [a,b] mutant protein and its allosteric characterization.  (C)
The 2:2H(22&32) hybrid and its allosteric characterization.
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TABLE 6-4  A summary of the kinetic and thermodynamic parameters
obtained for the 2:2H hybrids at 25°C, pH 6.0, 7.0 and 8.0 and [MgATP] = 3
mM
2:2 Hybrid   
† 
Kiao  (mM)   
† 
Kiyo  (mM)   
† 
Qay   
† 
DGay
(kcal/mol)
pH 6.0
2:2H(30&45)
([b,b])
0.043 ± 0.002 0.087 ± 0.046 0.54 ± 0.05 0.36 ± 0.06
2:2H(30&45)
([a,b])
0.055 ± 0.007 0.55 ± 0.45 0.59 ± 0.09 0.31 ± 0.09
2:2H(22&32) 0.025 ± 0.001 0.038 ± 0.004 0.067 ± 0.007 1.60 ± 0.07
pH 7.0
2:2H(30&45)
([b,b])
0.018 ± 0.001 0.0088 ±0.0020 0.25 ± 0.02 0.83 ± 0.05
2:2H(30&45)
([a,b])
0.022 ± 0.001 3.1 ± 0.9 0.15 ± 0.05 1.14 ± 0.14
2:2H(22&32) 0.016 ± 0.001 0.0083 ± 0.0001 0.0035 ± 0.0002 3.35 ± 0.05
pH 8.0
2:2H(30&45)
([b,b])
0.032 ± 0.002 0.0046 ± 0.0006 0.099 ± 0.006 1.37 ± 0.04
2:2H(30&45)
([a,b])
0.029 ± 0.001 3.9 ± 0.6 0.094 ± 0.021 1.40 ± 0.14
2:2H(22&32) 0.026 ± 0.001 0.0083 ± 0.0004 0.0013 ± 0.0001 3.92 ± 0.03
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hybrids, only the 2:2H(30&45) hybrid isolated by using the [a,b] mutant protein
(Fig. 6-12 B) displays a decreased binding affinity for PEP (  
† 
Kiyo ) when compared
to the other two 2:2H hybrids. This observation has also been made for the
2:2V(22&45) hybrid and the 2:2D(32&45) hybrid, both of which use the [a,b]
mutant protein, but with different charge tags.  Due to this decreased binding
affinity, the data are unable to reach saturation before 5 mM PEP at pH 7.0 and
8.0, thus binding of PEP at the mutated allosteric sites may influence the
measured coupling for this particular 2:2H(30&45) hybrid resulting in an
increased apparent coupling at pH 7.0 and 8.0.  This possible effect from PEP
binding to the mutated allosteric sites is substantiated by the fact that the
coupling free energy for the 2:2H(30&45) hybrid obtained by using the [a,b]
mutant protein is somewhat greater than the other 2:2H(30&45) hybrid at pH 7.0
and 8.0 (see Table 6-4).
Characterization of the 28 Å homotropic interaction between active sites via the
2:2H hybrids.  Figures 6-13 A, B and C summarize the results regarding the
cooperativity in Fru-6-P binding determined for the 28 Å homotropic interaction
between active sites for the three 2:2H hybrids.  Once again we see the same
overall pattern in the Hill number.  For all three 2:2H hybrids, the Hill numbers
for Fru-6-P binding in the absence and saturating presence of PEP are
equivalent, and in this case are all equal to approximately 1.  Therefore,
  
† 
Qaa = Qaa / yy  and the homotropic interaction between active sites does not
contribute to the overall heterotropic allosteric effect for these 2:2 hybrids.
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FIGURE 6-13  The characterization of the 28 Å homotropic interaction between
active sites by following the dependence of the Hill number (  
† 
nH) determined for
Fru-6-P binding as a function of increasing concentrations of PEP for the 2:2H
hybrids.  The data was obtained at 25°C and at pH 6.0 (l) using 50 mM MES-
KOH, at pH 7.0 (o) using 50 mM MOPS-KOH and at pH 8.0 (s) using 50 mM
EPPS-KOH.  The concentration of MgATP was equal to 3 mM, and the error bars
represent ± the standard error.  (A)  The 2:2H(30&45) hybrid obtained by using
the [b,b] mutant protein.  (B)  The 2:2H(30&45) hybrid obtained by using the
[a,b] mutant protein.  (C)  The 2:2H(22&32) hybrid.
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More specifically, the Hill numbers for Fru-6-P binding measured for the
2:2H(30&45) hybrid obtained by using the [b,b] mutant protein (Fig. 6-13 A)
behave just like the other 2:2 hybrids obtained by using the same mutant protein
(the 2:2V(30&32) and 2:2D(22&30) hybrids).  The Hill numbers begin and end at
1 displaying subsaturating heterotropic cooperativity at pH 7.0 and 8.0, but not
at 6.0 because the coupling (  
† 
Qay ) measured for the 30 Å heterotropic interaction
is equal to 1 at pH 6.0.  The other 2:2H(30&45) hybrid obtained by using the [a,b]
mutant construct (Fig. 6-13 B) also behaves like the other 2:2 hybrids obtained
from using that particular mutant protein (the 2:2V(22&45) and 2:2D(32&45)
hybrids).  The Hill numbers essentially stay at 1 until the higher concentrations
of PEP at which point evidence of subsaturating heterotropic cooperativity
possibly occurs.  This behavior is consistent with the elevated   
† 
Kiyo  value for this
2:2 hybrid, and the Hill number is assumed to return to a value of 1 since that is
the case for all of the other 2:2 hybrids investigated.  The final 2:2H hybrid, the
2:2H(22&32) hybrid obtained from using the [b,a] mutant protein (Fig. 6-13 C),
is the only 2:2 hybrid that does not conform to the previous hybrids made
utilizing the [b,a] mutant protein.  The Hill number begins and ends at 1 while
displaying subsaturating heterotropic cooperativity at all three pH values,
whereas the Hill numbers for the other 2:2 hybrids formed utilizing the [b,a]
mutant protein stayed constant as a function of PEP concentration.  However,
the subsaturating effect observed for the 2:2H(22&32) hybrid is consistent with
the fact that both of the couplings (  
† 
Qay ) measured for the 22 Å and 32 Å
heterotropic interactions are less than 1 at all three pH values and that the
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maximum Hill number is measured at pH 8.0.
Characterization of the 40 Å homotropic interaction between allosteric sites via
the 2:2H hybrids.  The 40 Å homotropic interaction between allosteric sites is the
last allosteric interaction to characterize, and the results from measuring the Hill
number for PEP binding as a function of Fru-6-P concentration are shown in
Figs. 6-14 A and B.  Due to the elevated   
† 
Kiyo  value for the 2:2H(30&45) obtained
by using the [a,b] mutant protein, the individual PEP saturation profiles were
unable to define a lower plateau within the range of PEP concentrations
available, thus the 40 Å homotropic interaction was unable to be characterized
for that particular 2:2 hybrid.  Fortunately however, we were able to characterize
the 40 Å homotropic interaction for the other 2:2H(30&45) hybrid obtained by
using the [b,b] mutant protein and the results are shown in Fig. 6-14 A.  The Hill
number for PEP binding at pH 7.0 and 8.0 begins at a value greater than 1 at low
Fru-6-P and proceeds to 1 at high Fru-6-P, conforming to the same behavior
observed for the 23 Å homotropic interaction discussed previously.
Unfortunately, the Hill numbers were difficult to determine for the 2:2H(30&45)
hybrid obtained by using the [b,b] mutant protein (similar to the problem
encountered for the 2:2V(30&32) hybrid discussed earlier using the same mutant
protein), thus the number of points is decreased, and data were even unable to
be collected at pH 6.0.  However, even with the limited amount of data, Eq. 6-12
was used to determine the Hill numbers in the absence of Fru-6-P at pH 7.0
and8.0, and those results are summarized in Table 6-5 (the Hill number in the
saturating presence of Fru-6-P was assumed to be 1;   
† 
Qyy /aa = 1).  Furthermore,
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FIGURE 6-14  The characterization of the 40 Å homotropic interaction between
allosteric sites by following the dependence of the Hill number (  
† 
nH) determined
for PEP binding as a function of increasing concentrations of Fru-6-P for two of
the 2:2H hybrids.  The data was obtained at 25°C and at pH 6.0 (l) using 50 mM
MES-KOH, at pH 7.0 (o) using 50 mM MOPS-KOH and at pH 8.0 (s) using 50
mM EPPS-KOH.  The concentration of MgATP was equal to 3 mM, and the error
bars represent ± the standard error.  (A)  The 2:2H(30&45) hybrid obtained by
using the [b,b] mutant protein.  (B)  The 2:2H(22&32) hybrid.
A
2:2H(30&45)
[b,b]
B
2:2H(22&32)
[b,a]
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TABLE 6-5  A summary of the kinetic and thermodynamic parameters
obtained in characterizing the 40 Å homotropic interaction between
allosteric sites
Hybrid and
pH
  
† 
nH   
† 
Qyy
  
† 
Qyy /aa
Qyy
È 
Î 
Í 
Í 
˘ 
˚ 
˙ 
˙ 
 1 /2
  
† 
DG40Å *
(kcal/mol)
2:2H(30&45)
7.0 1.58 ± 0.24 14.14 ± 16.70 0.27 ± 0.16 0.78 ± 0.35
8.0 1.70 ± 0.19 32.15 ± 41.35 0.18 ± 0.11 1.03 ± 0.38
2:2H(22&32)
6.0 1.51 ± 0.11 9.49 ± 4.48 0.32 ± 0.08 0.67 ± 0.14
7.0 1.77 ± 0.05 59.23 ± 25.97 0.13 ± 0.03 1.21 ± 0.13
8.0 1.71 ± 0.04 34.77 ± 9.73 0.17 ± 0.02 1.05 ± 0.08
*
  
† 
DG40Å =
1
2
DGyy /aa - DGyy( ) = -RT
Qyy /aa
Qyy
È 
Î 
Í 
Í 
˘ 
˚ 
˙ 
˙ 
1 /2
Equation 6-10 was used to calculate   
† 
Qyy , and the reciprocal of that value raised
to the one-half power was used to determine the contribution of the 40 Å
homotropic interaction to the coupling measured for the 2:2H(30&45) hybrid.
The Gibbs free energy equation (Eq. 2-6) was then used to convert the coupling
contribution into free energy terms.  Thus, the 40 Å interaction was found to
contribute approximately 0.8 kcal/mol at pH 7.0 and about 1 kcal/mol at pH 8.0
to the overall inhibition measured for the 2:2H(30&45) hybrid.
The 2:2H(22&32) hybrid also displayed the same trend in PEP
cooperativity, and the same data analysis was performed to determine the
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contribution of the 40 Å homotropic interaction in the 2:2H(22&32) hybrid at pH
6.0, 7.0 and 8.0.  The results are also summarized in Table 6-5 and agree within
error to the contribution measured for the same interaction found in the
2:2H(30&45) hybrid.
At pH 6.0, the 40 Å interaction contributes approximately 0.7 kcal/mol, at
pH 7.0 about 1.2 kcal/mol and at pH 8.0 approximately 1.0 kcal/mol.  Thus, for
the 2:2H hybrids, the 28 Å homotropic interaction between active sites
contributes nothing while the 40 Å interaction contributes significantly to the
observed allosteric effect measured in the 2:2H hybrids.
How the allosteric interactions combine in the 2:2H hybrids.  A comparison of
the coupling free energies calculated for each 2:2H hybrid to the sum of the
individual heterotropic interactions found within each 2:2 hybrid plus the 40 Å
homotropic interaction is made in Figs. 6-15 A, B and C.  The coupling free
energy calculated for the 2:2H(30&45) hybrid obtained by using the [b,b] mutant
protein is equivalent (within error) to the sum of the individual coupling free
energies measured for the 30 Å and 45 Å heterotropic interactions and the
contribution calculated for the 40 Å homotropic interaction at pH 7.0 and 8.0
(Fig. 6-15 A ).  However, since the contribution of the 40 Å homotropic
interaction was not able to be calculated at pH 6.0, the contribution determined
for the 40 Å homotropic interaction from the 2:2H(22&32) hybrid was used
instead, and the coupling free energy determined for the 2:2 hybrid is less than
the sum of the individual coupling free energies.  Although this phenomenon is
unexplained, the results are consistent with other 2:2 hybrids.
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FIGURE 6-15  The comparison of the sum of the individual coupling free
energies determined for the heterotropic interactions and the 40 Å homotropic
contribution to the coupling free energy determined for the 2:2H hybrids at pH
6.0, 7.0 and 8.0.  (A and B)  The bar on the left at each pH corresponds to the sum
of the coupling free energies determined for the 30 Å interaction (light gray), the
45 Å interaction (black), and the 40 Å homotropic interaction (horizontal lines,
asterisks means it was measured via the 2:2H(22&32) hybrid).  The bar on the
right corresponds to the coupling free energy measured for either the
2:2H(30&45) hybrid obtained by using the [b,b] mutant protein (diagonal stripes
- A) or the 2:2H(30&45) hybrid obtained by using the [a,b] mutant protein
(polka-dots - B).  (C)  The bar on the left at each pH corresponds to the sum of
the coupling free energies determined for the 22 Å interaction (white), the 32 Å
interaction (dark gray), and the 40 Å homotropic interaction (horizontal lines),
while the bar on the right corresponds to the coupling free energy determined
for the 2:2H(22&32) hybrid (bricks).
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As for the 2:2H(30&45) hybrid obtained by using the [a,b] mutant protein,
the same trend is seen as the coupling free energy for the 2:2 hybrid is
equivalent to the sum at pH 7.0 and 8.0, but less than the sum at pH 6.0 (Fig. 6-
15 B ); however, all the data pertaining to the contribution of the 40 Å
homotropic interaction was obtained from the 2:2H(22&32) hybrid.
The remaining 2:2H hybrid, the 2:2H(22&32) hybrid, was also found to
have a coupling free energy equivalent (within error) to the sum of the coupling
free energies measured for its individual allosteric interactions, but only at pH
6.0 as seen in Fig. 6-15 C .  At 7.0 and 8.0, the coupling free energy for the
2:2H(22&32) hybrid is actually greater than the sum of the coupling free
energies of the 22 Å and 32 Å heterotropic interactions and the contribution
measured for the 40 Å homotropic interaction, with the greatest discrepancy
occurring at pH 7.0 (~ 1 kcal/mol, only ~ 0.5 kcal/mol at pH 8.0).  Of all the 2:2
hybrids investigated, this is the only case in which the data does not agree with
the expected results.
Discussion
At the beginning of this chapter, we set out to address three different
issues through the characterization of the 2:2 hybrids.  The first of these issues
was determining the contributions of each of the six unique homotropic
interactions to the inhibition measured for each 2:2 hybrid.  In each of the 2:2
hybrids, two homotropic interactions are isolated (besides the two copies of two
heterotropic interactions), and consist of one homotropic interaction between
active sites and one homotropic interaction between allosteric sites.
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Furthermore, three different pairs of homotropic interactions are isolated in the
various 2:2 hybrids characterized.  The 2:2V hybrids isolate the 47 Å homotropic
interaction between active sites and the 39.9 Å homotropic interaction between
allosteric sites, the 2:2D hybrids isolate the 45 Å homotropic interaction between
active sites and the 23 Å homotropic interaction between allosteric sites, and the
2:2H hybrids isolate the 28 Å homotropic interaction between active sites and
the 40 Å  homotropic interaction between allosteric sites.
From measuring the cooperativity in Fru-6-P binding as a function of PEP
concentration, we were able to calculate the contributions each of the three
homotropic interactions between active sites make to the apparent heterotropic
allosteric effect measured for the 2:2 hybrids.  For all three homotropic
interactions between active sites (47 Å, 45 Å and 28 Å), the net change in the Hill
number measured for Fru-6-P binding in the absence and saturating presence of
PEP is zero, thus   
† 
Qaa  and   
† 
Qaa / yy  are equivalent for all three homotropic
interactions between active sites.  Consequently, none of the homotropic
interactions between active sites contribute to the measured allosteric effect
between Fru-6-P and PEP since the contribution to the allosteric effect is
determined from the ratio of   
† 
Qaa / yy  to   
† 
Qaa  (Eq. 6-2).
By performing the reverse experiment and determining the cooperativity
in PEP binding as a function of Fru-6-P concentration, we were able to calculate
the contributions each of the homotropic interactions between allosteric sites
makes to the heterotropic allosteric effect measured for the 2:2 hybrids.  For the
39.9 Å homotropic interaction, the net change in the Hill number measured for
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PEP binding in the absence and saturating presence of Fru-6-P was zero, thus
  
† 
Qyy  and   
† 
Qyy /aa  are equal to one another, resulting in no net allosteric effect from
the 39.9#Å homotropic interaction.  On the other hand, the net change in the Hill
number for PEP binding in the absence and saturating presence of Fru-6-P was
negative for both the 23 Å and 40 Å homotropic interactions.  Thus,   
† 
Qyy  is
greater than   
† 
Qyy /aa  resulting in an augmentation in the allosteric effect measured
for the 2:2 hybrids (  
† 
DGhomo-allos  > 0).  In summary, of the six homotropic
interactions possible in the native enzyme, we determined that 4 of the
homotropic interactions contribute nothing to the observed allosteric effect
between Fru-6-P and PEP, and 2 of the homotropic interactions between
allosteric sites (23 Å and the 40 Å) contribute between 0.4 kcal/mol to 1.2
kcal/mol depending on if it is the 23 Å or 40 Å homotropic interaction and the
pH at which the contribution is measured.
The second issue we wanted to address at the outset of this chapter was
subsaturating heterotropic cooperativity (in Fru-6-P binding), and for the most
part, the expectations agreed with the experimental results.  When both
heterotropic couplings were greater than 1, subsaturating heterotropic
cooperativity occurred with the largest maximum Hill number measured at pH
8.0, consistent with how pH affects Fru-6-P-PEP coupling.  However, most of the
unexplainable data regarding the Hill number for Fru-6-P binding were
obtained from the hybrids constructed using the [a,b] mutant protein (isolates
the 45 Å heterotropic interaction in its 1|1 hybrid with wild-type).  For the
2:2V(22&45) and 2:2H(32&45) hybrids, the Hill number essentially stays at 1
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regardless of the PEP concentration or pH.  This implies that one of the
heterotropic interactions has a coupling equal to 1, but for the 2:2H(32&45)
hybrid obtained using the [b,a] mutant protein, subsaturating heterotropic
cooperativity is observed.  Thus, the mutations used in making the [a,b] mutant
protein more than likely interfere with the transmission of the allosteric signal
for the 45 Å interaction since that is the common link among the 2:2 hybrids
displaying this strange behavior in Fru-6-P binding.
Finally, how the pair-wise allosteric interactions combine in the simplest
of oligomers, a dimer, is the final issue we wanted address with the allosteric
characterizations of not only the 2:2 hybrids (2|2), but the 1:3 hybrids as well
(1|1).  From our previous work with the 1:3 hybrids, we calculated the coupling
free energies for the four heterotropic interactions (22 Å, 30 Å, 32 Å and 45 Å) at
pH 6.0, 7.0 and 8.0, and from our current investigation we calculated the
allosteric contributions of the six homotropic interactions as well as the overall
coupling free energy measured for each of the nine 2:2 hybrids at pH 6.0, 7.0 and
8.0.  With all of the necessary parameters determined (  
† 
DG2:2 hybrid ,   
† 
DGay1 ,   
† 
DGay2 ,
  
† 
DGhomo-allos  and   
† 
DGhomo-active ) we are equipped to assess which of the allosteric
models previously described are accurate in describing the observed allosteric
effect for each of the nine 2:2 hybrids.
For the most part, at pH 7.0 and 8.0, the “conformational free/linkage”
model more adequately describes the measured allosteric effect for BsPFK since
the coupling free energy for the nine 2:2 hybrids is within 0.5 kcal/mol (or less)
to the sum of the coupling free energies determined for the individual
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heterotropic interactions and the homotropic contribution.  Only the
2:2D(32&45) hybrid obtained using the [b,a] mutant protein behaves in a
manner not predicted by the conformational free/linkage” model since the
measured coupling free energy for the 2:2 hybrid is significantly less (about 0.5 –
1.0 kcal/mol) than the sum of the coupling free energies determined for the
individual heterotropic interactions and the homotropic contribution.  However,
neither the concerted or sequential models adequately describe this behavior
either.  The minor discrepancies observed at pH 7.0 and 8.0 for the other eight
2:2 hybrids we believe can be explained by one of two factors.  The first factor is
the possible influence from PEP binding to the mutated allosteric sites and
influencing the coupling free energy measured for the 2:2 hybrid.  In a few cases
when measuring   
† 
Qay  (monitoring the   
† 
K1 /2  for Fru-6-P as a function of PEP
concentration), an upper plateau is not suitably reached prior to about 5 mM
PEP, and we believe this allows the binding of PEP at the mutated allosteric sites
to potentially influence the allosteric effect measured for the 2:2 hybrid, leading
to a greater apparent coupling free energy.  Unfortunately, control hybrids for
these 2:2 hybrids were unable to be made to determine exactly at what point
PEP binding to the mutated allosteric sites occurs.  However, in some cases
when both the   
† 
Kiyo  and coupling for the 2:2 hybrid (  
† 
Q2:2 Hybrid) are relatively
small, the point at which PEP binds to the mutated allosteric sites can be defined
experimentally.  This is shown in Fig. 6-16 using the allosteric characterization of
the 2:2V(30&32) hybrid as an example.  At all three pH values, the upper
plateau, defining   
† 
Kiao , is reached well before 1 mM PEP, however at about 5 mM
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FIGURE 6-16  The dependence upon the apparent   
† 
K1/2  for Fru-6-P as a function
of PEP concentration for the 2:2V(30&32) hybrid obtained from using the [b,a]
mutant protein.  The gray region indicates the point at which PEP binds at the
mutated allosteric sites and begins to influence the apparent   
† 
K1/2  for Fru-6-P (~5
mM).  The steady-state characterization was performed at pH 6.0 (l), 7.0 (o)
and 8.0 (s), and at 25°C using 50 mM MES-KOH at pH 6.0, 50 mM MOPS-KOH
at pH 7.0 and 50 mM EPPS-KOH at pH 8.0.  The concentration of MgATP was
equal to 3 mM and the error bars represent ± the standard error.
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PEP the apparent   
† 
K1 /2  for Fru-6-P begins to edge upwards, increasing with
increasing concentrations of PEP at all three pH values.  These points identify
the concentration of PEP in which PEP binds to the mutated allosteric sites and
begins to influence Fru-6-P affinity at the native active sites.  In our original
analysis when this second phase was observed, those data points were just
simply removed from the analysis.  From these results and several others just
like Fig. 6-16, we believe that PEP binding at the mutated allosteric sites is a
suitable explanation for why the coupling free energy determined for some of
the 2:2 hybrids is greater than the sum of the coupling free energies of the
individual allosteric interactions.
The other possible explanation to why the coupling free energy for some
of the 2:2 hybrids is somewhat different than the sum of the allosteric
interactions isolated within a given 2:2 hybrid is the uncertainty in the coupling
free energy determined for the 45 Å heterotropic interaction, and the possibility
of its contribution being eliminated in those 2:2 hybrids formed by using the
[a,b] mutant protein.  Due to the very minimal amount of coupling present in
the 45 Å heterotropic interaction, it was especially challenging to measure an
accurate   
† 
Qay  for the 45 Å heterotropic interaction, as evidenced by the level of
error in both Q and ∆G (Chapter IV).  Thus, if the contribution for the 45 Å
heterotropic interaction is removed from the analysis of the pertinent 45 Å
heterotropic-interaction-containing 2:2 hybrids, then the coupling free energy
measured for the relevant 2:2 hybrids is equivalent to the sum of the coupling
free energies for the individual allosteric interactions (minus the 45 Å
277
contribution).
Another phenomenon observed in our data when comparing the
coupling free energies of the individual 2:2 hybrids to the sum of the coupling
free energies determined for the allosteric interactions isolated within that given
2:2 hybrid, is that at pH 6.0 the coupling free energy for the 2:2 hybrid is
sometimes lower than the sum for a few of the 2:2 hybrids.  Unfortunately, we
have no explanation to why this occurs, but in most instances the 45 Å
heterotropic interaction is involved so that may explain part of the problem.
However, in the case of the 2:2D(22&30) hybrid, we have no explanation for the
possible reasons why the coupling for the 2:2 hybrid is so low.
All in all however, considering all of the mutations we have introduced at
the binding sites and on the surface, we feel that the “conformational
free/linkage” model most accurately describes the observed allosteric effect
between Fru-6-P and PEP and vice versa for all nine of the 2:2 hybrids
investigated.  Furthermore, by taking our divide-and-conquer approach and
gaining a better understanding of how inhibition occurs in not only the 2:2
hybrids, but the 1:3 hybrids as well, we now hope to address how inhibition
occurs in the native tetramer, and more specifically to identify the structural
aspects of how inhibition occurs in the native tetramer.
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CHAPTER VII
CONCLUSIONS
At the onset of this investigation, our major goal was to resolve the
allosteric contributions of the 10 unique pair-wise allosteric interactions found
within BsPFK to the inhibition by PEP binding.  In order to accomplish this goal,
we created numerous hybrid tetramers of BsPFK to contain a specific number of
native binding sites and mutated binding sites in known structural
relationships, such that the mutated binding sites could not bind Fru-6-P or PEP.
Upon isolating and characterizing these various hybrid tetramers, the
contributions of all 10 unique allosteric interactions were measured permitting
us to “map” the entire inhibition landscape in BsPFK.
The first hybrid tetramers constructed and characterized were the 1:3
hybrids (1|1, 1|0 and 4|1), and they were utilized for several purposes.  First
and foremost, the four 1|1 hybrids individually isolated each of the four
heterotropic interactions permitting the characterization of each heterotropic
interaction one at a time.  Next, the 1|0 hybrids were used to “correct” for the
contributions to these apparent couplings (  
† 
Qay ) of PEP binding to the mutated
allosteric sites.  Lastly, a wild-type control hybrid (4|1) was required to compare
the values obtained for the “corrected” contributions of the four heterotropic
interactions to the inhibition measured for the wild-type enzyme in the absence
of homotropic cooperativity between allosteric sites.  Thus, although the three
different 1:3 hybrids isolate a different number of native allosteric interactions
(one, none and four respectively), the 1:3 hybrids enabled us to address
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questions otherwise impossible to address in the native tetramer.
Next, the 2:2 hybrids (2|2) were characterized to determine the relative
contributions of each of the six homotropic interactions found within the native
enzyme.  Based upon the 2:2 hybrid investigated, a different set of six pair-wise
allosteric interactions were isolated: 2 copies of two different heterotropic
interactions, 1 copy of one homotropic interaction between active sites and 1
copy of one homotropic interaction between allosteric sites.  By simply
measuring both Fru-6-P and PEP cooperativity for the 2:2 hybrid, the coupling
free energies as well as the allosteric contributions of the two isolated
homotropic interactions were determined (Reinhart, 1988).  Moreover, different
2:2 hybrids were then investigated to determine the contributions of all six
homotropic interactions to the inhibitory response in BsPFK.
None of the pair-wise allosteric interactions would have been
characterized without the addition of the surface charge tags to the mutated
subunits (K90E/K91E, R232E/Q233E, or N303E/K304E).  Each charge tag was
responsible for the isolation and identification of either a 1:3 hybrid or a specific
2:2 hybrid/isomer from the other hybrid species.  Without the use of the three
different charge tags, deciphering the roles of the individual allosteric
interactions would have been impossible.  Fortunately, all of the previously
mentioned hybrid species were formed and isolated using either the monomer
or dimer exchange procedure and anion exchange chromatography.  A
summary of the coupling free energies determined from the allosteric
characterizations of all 10 pair-wise allosteric interactions are found in Table 7-1.
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TABLE 7-1  The coupling free energies (  
† 
DGay ,   
† 
DGyy  or   
† 
DGaa ) in kcal/mol
determined from the allosteric characterizations of the 10 pair-wise
allosteric interactions via the 1:3 and 2:2 hybrids at 25°C and [MgATP] = 3
mM
Interaction pH 6.0 pH 7.0 pH 8.0
∆Gay (heterotropic)
22 Å 0.41 ± 0.10 0.66 ± 0.10 1.48 ± 0.15
30 Å 0.00 ± 0.06 0.31 ± 0.11 0.49 ± 0.11
32 Å 0.34 ± 0.10 0.57 ± 0.10 0.82 ± 0.12
45 Å 0.23 ± 0.14 0.18 ± 0.14 0.17 ± 0.20
∆Gyy (homotropic)
23 Å -0.71 ± 0.21 -1.24 ± 0.10 -1.46 ± 0.14
39.9 Å 0 0 0
40 Å -1.33 ± 0.28 -2.41 ± 0.26 -2.09 ± 0.17
∆Gaa (homotropic)
28 Å 0 0 0
45 Å 0 0 0
47 Å 0 0 0
One major finding from this investigation, and the investigation of
Kimmel and Reinhart (2001), is the fact that the four heterotropic interactions are
unique in magnitude and vary in their individual contributions to the inhibitory
response depending upon pH.  Moreover, when we compared the coupling free
energies measured for each interaction to the coupling free energy determined
for the wild-type enzyme (4|4), the entire allosteric effect was not accounted for
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at any of the pH values investigated.  Initially we attributed this to the
mutations introduced at both the active and allosteric sites and on the surface of
the protein.  However, upon further consideration we discovered that the
homotropic interactions between the allosteric sites are also involved in PEP
inhibiting the enzyme.  This was confirmed by constructing a 4|1 hybrid in
which the cooperativity between the allosteric sites was removed.  Thus, when
comparing the coupling free energy measured for the 4|1 hybrid to the sum of
the coupling free energies determined for the four heterotropic interactions, we
ended up accounting for the entire allosteric response incurred by PEP!  This
result verified that our approach of isolating each of the four heterotropic
interactions found within BsPFK via the 1:3 hybrids only affects Fru-6-P and
PEP binding and not the allosteric coupling between the remaining native
binding sites.  More importantly however, the fact that each heterotropic
interaction is unique in magnitude instantly discounts the ability of the
concerted and sequential models to explain the observed allosteric effect in
BsPFK.
The characterizations of the homotropic interactions also yielded very
exciting results.  Of the six homotropic interactions found in the native tetramer,
four were found to be entirely uninvolved in the inhibitory response, including
all three of the homotropic interactions between active sites.  This result only
validated our previous data involving the 4|1 wild-type control hybrid because,
if the homotropic interactions between active sites were involved in the inhibition
process, then the coupling free energy measured for the 4|1 hybrid would not
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have equaled the sum of the coupling free energies measured for the four
heterotropic interactions.  However, two of the six homotropic interactions, the
23 Å and 40 Å homotropic interactions between allosteric sites, were found to
participate in the PEP inhibition of the enzyme because the Hill number for PEP
binding decreased in the saturating presence of Fru-6-P.  Thus, PEP’s effects are
augmented by the 23 Å and 40 Å homotropic interactions (Reinhart, 1988).  In
summary, of all 10 interactions, 6 play a role in the inhibition process revealing
an asymmetric response in PEP binding to this symmetrical enzyme.
Furthermore, using the various hybrid tetramers of BsPFK and taking a divide-
and-conquer approach, we have been able to take a convoluted mess of
allosteric communication pathways and resolve what role each interaction plays
in the inhibition process.
The other major goal we wanted to address was how the individual
allosteric interactions combine in the simplest of oligomers, a dimer.  Using all
of the data obtained from the characterizations of both the 1:3 and 2:2 hybrids,
we addressed this very issue.  In Chapter VI, we showed for the first time that
the predictions set forth by Reinhart (1988) regarding the allosteric behavior of a
symmetrical dimer were correct.  Essentially we showed that the entire
heterotropic effect between two heterotropic ligands could be accounted for in a
symmetrical dimer (containing one active site and one allosteric site per subunit)
by the individual contributions of the two heterotropic interactions and a ratio
of the contributions from both the homotropic interactions in the saturating
presence and absence of the heterotropic ligand.  Moreover, the contributions of
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these interactions could vary to any extent from one interaction dominating the
allosteric effect, to all of the interactions participating equally in the inhibition
process.  Regardless of these contributions, our data showed quite convincingly
that the entire allosteric effect could be accounted for using the predictions made
by Reinhart (1988).
The predictions made by Reinhart are based on a linked-function
analysis.  Thus, this entire investigation provides support that this approach in
characterizing an allosteric effect is the more appropriate method for
understanding how an effector molecule regulates enzyme activity.  In addition,
it is the formation of the ternary complex (enzyme with both substrate and
effector bound) that is the key to understanding an entire allosteric effect,
whereas the formation of the ternary complex is not even considered by the two-
state models.  The data regarding the 2:2 hybrid characterizations only provides
further evidence (besides what was already presented regarding the 1:3 hybrids)
that the predictions set forth by both the concerted and sequential models are
not accurate for describing the inhibition of BsPFK by PEP.
Where would I like this investigation to go next?  First, I would want the
structural aspect of allosteric regulation elucidated in BsPFK.  With the
contributions of the 10 allosteric interactions now defined, it would be my hope
that certain regions of the protein or even key residues could be identified as
being responsible for transmitting the inhibitory signal for certain allosteric
interactions.  This is already starting to be addressed in both EcPFK and BsPFK
by using single point mutations at locations identified by either a sequence
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alignment with a non-allosteric PFK or regions of the protein identified from the
crystal structure as possibly being involved due to their locations between
binding sites.
Another aspect of BsPFK’s regulation that needs to be addressed is the
identification of the residues that are ionized with the change in pH.  This would
only provide further information into the possible structural components
involved in the transmission of the allosteric signal.
I would also like to see a dimeric enzyme that is allosterically regulated
characterized using the same overall approach to compare with the results we
have obtained with the 1:3 and 2:2 hybrids.  I believe this would only
substantiate further the requirement for the linked-function approach to be
utilized whenever an allosteric effect is characterized.  All in all, I think a better
understanding of allosteric regulation has been gained from this investigation,
and I only hope those that follow in this work will build upon the foundation I
have laid as well as the foundation laid by those before me.
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